<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64295</article-id><article-id pub-id-type="doi">10.7554/eLife.64295</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Endothelial cell-type-specific molecular requirements for angiogenesis drive fenestrated vessel development in the brain</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-212421"><name><surname>Parab</surname><given-names>Sweta</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9932-5117</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212422"><name><surname>Quick</surname><given-names>Rachael E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2301-7238</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-212423"><name><surname>Matsuoka</surname><given-names>Ryota L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6214-2889</contrib-id><email>matsuor@ccf.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Cleveland Clinic Lerner College of Medicine of Case Western Reserve University</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Reviewing Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Senior Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>01</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e64295</elocation-id><history><date date-type="received" iso-8601-date="2020-10-23"><day>23</day><month>10</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-01-17"><day>17</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Parab et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Parab et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64295-v2.pdf"/><abstract><p>Vascular endothelial cells (vECs) in the brain exhibit structural and functional heterogeneity. Fenestrated, permeable brain vasculature mediates neuroendocrine function, body-fluid regulation, and neural immune responses; however, its vascular formation remains poorly understood. Here, we show that specific combinations of vascular endothelial growth factors (Vegfs) are required to selectively drive fenestrated vessel formation in the zebrafish myelencephalic choroid plexus (mCP). We found that the combined, but not individual, loss of Vegfab, Vegfc, and Vegfd causes severely impaired mCP vascularization with little effect on neighboring non-fenestrated brain vessel formation, demonstrating fenestrated-vEC-specific angiogenic requirements. This Vegfs-mediated vessel-selective patterning also involves Ccbe1. Expression analyses, cell-type-specific ablation, and paracrine activity-deficient <italic>vegfc</italic> mutant characterization suggest that vEC-autonomous Vegfc and meningeal fibroblast-derived Vegfab and Vegfd are critical for mCP vascularization. These results define molecular cues and cell types critical for directing fenestrated CP vascularization and indicate that vECs’ distinct molecular requirements for angiogenesis underlie brain vessel heterogeneity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>choroid plexus</kwd><kwd>angiogenesis</kwd><kwd>central nervous system</kwd><kwd>Vegfs</kwd><kwd>genetic interactions</kwd><kwd>zebrafish</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01 NS117510</award-id><principal-award-recipient><name><surname>Matsuoka</surname><given-names>Ryota L</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012380</institution-id><institution>Lerner Research Institute, Cleveland Clinic</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Matsuoka</surname><given-names>Ryota L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Identification of a developmental mechanism critical for the generation of brain vessel heterogeneity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Cerebrovascular diseases remain a leading cause of long-term disability worldwide (<xref ref-type="bibr" rid="bib61">Tong et al., 2019</xref>). Many of these diseases originate, at least in part, from genetic defects that impact the development and maturation of blood vessels in the brain and meninges. Understanding the molecular basis of brain and meningeal vascularization during development will help identify therapeutic targets for preventing or treating vascular abnormalities associated with these diseases. Current evidence shows that vascular endothelial cells (vECs) in the central nervous system (CNS) display heterogeneous structural and functional properties (<xref ref-type="bibr" rid="bib4">Augustin and Koh, 2017</xref>; <xref ref-type="bibr" rid="bib46">Mastorakos and McGavern, 2019</xref>; <xref ref-type="bibr" rid="bib51">O'Brown et al., 2018</xref>). Two striking examples of this heterogeneity are the vECs that form the semipermeable blood-brain barrier (BBB) and those that develop highly permeable fenestrae. Despite substantial progress in our understanding of CNS angiogenesis and BBB formation/maintenance (<xref ref-type="bibr" rid="bib2">Andreone et al., 2017</xref>; <xref ref-type="bibr" rid="bib5">Ben-Zvi et al., 2014</xref>; <xref ref-type="bibr" rid="bib18">Daneman et al., 2009</xref>; <xref ref-type="bibr" rid="bib25">Haigh et al., 2003</xref>; <xref ref-type="bibr" rid="bib36">Junge et al., 2009</xref>; <xref ref-type="bibr" rid="bib39">Kuhnert et al., 2010</xref>; <xref ref-type="bibr" rid="bib43">Liebner et al., 2008</xref>; <xref ref-type="bibr" rid="bib53">Raab et al., 2004</xref>; <xref ref-type="bibr" rid="bib56">Segarra et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Stenman et al., 2008</xref>; <xref ref-type="bibr" rid="bib65">Vanhollebeke et al., 2015</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Ye et al., 2009</xref>), little is known about the molecular mechanisms directing fenestrated vessel formation in the choroid plexus (CP) and circumventricular organs. Identification of molecular cues that govern the vascularization of these organs will accelerate our understanding of cerebrovascular development and heterogeneity, providing critical insights into their pathological processes.</p><p>The CPs consist of epithelial tissue masses located within the brain ventricles and are vascularized with fenestrated capillaries that lack the BBB (<xref ref-type="bibr" rid="bib7">Bill and Korzh, 2014</xref>; <xref ref-type="bibr" rid="bib15">Cserr, 1971</xref>; <xref ref-type="bibr" rid="bib17">Damkier et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Liddelow, 2015</xref>). The CPs serve to produce cerebrospinal fluid (CSF) and remove metabolic wastes from the CNS (<xref ref-type="bibr" rid="bib7">Bill and Korzh, 2014</xref>; <xref ref-type="bibr" rid="bib15">Cserr, 1971</xref>; <xref ref-type="bibr" rid="bib17">Damkier et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Liddelow, 2015</xref>), thereby regulating the CNS microenvironment. They also serve as an important source of the biologically active molecules involved in brain development and repair (<xref ref-type="bibr" rid="bib24">Ghersi-Egea et al., 2018</xref>), form the blood-CSF barrier (<xref ref-type="bibr" rid="bib7">Bill and Korzh, 2014</xref>; <xref ref-type="bibr" rid="bib15">Cserr, 1971</xref>; <xref ref-type="bibr" rid="bib17">Damkier et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Liddelow, 2015</xref>), provide immune surveillance, and regulate immune cell trafficking into the CSF in response to neuroinflammation and brain injury/disease (<xref ref-type="bibr" rid="bib44">Lopes Pinheiro et al., 2015</xref>; <xref ref-type="bibr" rid="bib71">Wilson et al., 2010</xref>). These CP’s crucial roles in brain development, homeostasis, and immunity are thought to require the establishment of fenestrated vasculature (<xref ref-type="bibr" rid="bib24">Ghersi-Egea et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Liddelow, 2015</xref>; <xref ref-type="bibr" rid="bib44">Lopes Pinheiro et al., 2015</xref>). Although the morphogen Sonic hedgehog is indicated to be involved in vascular outgrowth during CP development (<xref ref-type="bibr" rid="bib50">Nielsen and Dymecki, 2010</xref>), no molecular cue that drives fenestrated CP vascular development has been reported in any vertebrate species.</p><p>In mammals, CPs are located in the lateral, 3rd, and 4th ventricular brain surfaces (<xref ref-type="bibr" rid="bib42">Liddelow, 2015</xref>). This limits tissue accessibility for 3D imaging, making it difficult to analyze the blood vessel(s) that gives rise to the CP vasculature in these animal models. Here, we employed the zebrafish model to overcome this technical limitation and investigate the molecular genetic mechanisms governing fenestrated CP vascular development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Zebrafish CPs and molecularly heterogeneous networks of the brain and meningeal vasculature</title><p>In zebrafish, the CPs form in two distinct anatomical locations close to the dorsal surfaces of the brain meninges and are termed as the diencephalic and myelencephalic CP (dCP and mCP) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The mCP is larger in size and thought to be equivalent to the 4th ventricle CP in mammals due to its anatomical location being in close proximity to the 4th ventricle and cerebellum in zebrafish (<xref ref-type="bibr" rid="bib7">Bill and Korzh, 2014</xref>; <xref ref-type="bibr" rid="bib23">García-Lecea et al., 2008</xref>; <xref ref-type="bibr" rid="bib31">Henson et al., 2014</xref>). As previously reported (<xref ref-type="bibr" rid="bib31">Henson et al., 2014</xref>), we validated that the <italic>Et(cp:EGFP)</italic> enhancer trap line marks only epithelial cells in the dCP and mCP at 5 days post fertilization (dpf) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) since the EGFP<sup>+</sup> cells in the mCP were outlined by Claudin-5 tight junction protein expression, a marker for CP epithelial cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Moreover, mCP vasculature in zebrafish exhibits the following molecular signatures of fenestrated vessels (<xref ref-type="bibr" rid="bib62">Umans et al., 2017</xref>; <xref ref-type="bibr" rid="bib63">van Leeuwen et al., 2018</xref>): (1) high expression of the structural protein PLVAP, an endothelial marker for the high permeability state and (2) low expression of GLUT1 and Claudin5, endothelial markers for the BBB state (<xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). These observations suggest that the molecular signatures of CP epithelial and endothelial cells are well conserved between zebrafish and mammals. Importantly, our transmission electron microscopy analyses further revealed that CP epithelial cells of 10 dpf zebrafish larvae displayed anatomical features of their mammalian counterparts at the ultrastructural level, including tight junctions, microvilli, cilia, and desmosomes (<xref ref-type="fig" rid="fig1">Figure 1E–H’</xref>), providing additional evidences to support the notion of interspecies conservation and thus making the zebrafish model suitable for molecular genetics studies.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Fenestrated mCP vascular formation defects in <italic>vegfab</italic> and <italic>vegfc</italic> mutant zebrafish.</title><p>(<bold>A</bold>) Schematic representation of the dorsal view of the zebrafish head, indicating the locations of the diencephalic and myelencephalic CP (dCP and mCP, respectively). (<bold>B and C</bold>) Dorsal views of a 5 dpf <italic>Et(cp:EGFP)</italic> head immunostained for Claudin-5 (magenta), indicating EGFP<sup>+</sup> and Claudin-5<sup>+</sup> mCP epithelial cells. A magnified image of the boxed area is shown in (<bold>C</bold>). (<bold>D</bold>) Dorsal view of a 6 dpf <italic>Tg(plvap:EGFP);Tg(glut1b:mCherry)</italic> head immunostained for Claudin-5 (magenta) shows heterogeneous <italic>Tg(plvap:</italic>EGFP) and <italic>Tg(glut1b:</italic>mCherry) expression patterns in the brain and meningeal vasculature. Strong <italic>Tg(plvap:</italic>EGFP) and weak <italic>Tg(glut1b:</italic>mCherry) expression was observed in the mCP vasculature (white arrows). (<bold>E–H</bold>) Transmission electron microscopy images of 10 dpf wild-type (WT) mCP and its surrounding tissues (<bold>E</bold>) and of mCP epithelial cells (<bold>F–H</bold>). Magnified images of mCP epithelial cells (<bold>F–H</bold>) were taken in areas between the mCP and its neighboring tissues as indicated by the dashed line. mCP epithelial cells showed tight junctions (TJ) and microvilli (MV), the 9 + 2 arrangement of microtubules of cilia (<bold>G’</bold>), and desmosomes (<bold>H’</bold>). Magnified images of the boxed areas (<bold>G and H</bold>) are shown in (<bold>G’</bold>) and (<bold>H’</bold>), respectively. (<bold>I and J</bold>) Dorsal views of 10 dpf WT (<bold>I</bold>) and <italic>vegfab<sup>-/-</sup></italic> (<bold>J</bold>) cranial vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression and anti-Claudin-5 immunostaining (magenta) show a specific loss of the dorsal longitudinal vein (DLV) in <italic>vegfab<sup>-/-</sup></italic> larvae (yellow arrows). (<bold>K</bold>) Percentage of the fish of indicated genotype with and without the DLV at 10 dpf (n = 29 for WT and n = 30 for <italic>vegfab<sup>-/-</sup></italic> fish). (<bold>L–O</bold>) Dorsal views of 54 hpf WT (<bold>L</bold>), <italic>vegfab<sup>-/-</sup></italic> (<bold>M</bold>), <italic>vegfc<sup>-/-</sup></italic> (<bold>N</bold>), and <italic>vegfd<sup>-/-</sup></italic> (<bold>O</bold>) cranial vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression. Approximately half of the <italic>vegfab<sup>-/</sup></italic><sup>-</sup> and <italic>vegfc<sup>-/-</sup></italic> embryos examined lacked the DLV. (<bold>P</bold>) Percentage of the fish of indicated genotype with and without the DLV at 54 hpf (n = 21 for WT, n = 22 for <italic>vegfab<sup>-/-</sup></italic>, n = 24 for <italic>vegfc<sup>-/-</sup></italic>, and n = 23 for <italic>vegfd<sup>-/-</sup></italic> fish). (<bold>Q</bold>) Quantification of DLV lengths of the fish that formed the DLV at 54 hpf (n = 21 for WT, n = 11 for <italic>vegfab<sup>-/-</sup></italic>, n = 11 for <italic>vegfc<sup>-/-</sup></italic>, and n = 22 for <italic>vegfd<sup>-/-</sup></italic> fish). Data are means ± SD. Scale bars: 50 µm in (<bold>B</bold>), (<bold>C</bold>), (<bold>D</bold>), (<bold>J</bold>), (<bold>O</bold>); 10 µm in (<bold>E</bold>); 2 µm in (<bold>F</bold>); 100 nm in (<bold>G’</bold>) and (<bold>H’</bold>).</p><p> <supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Quantifications of DLV lengths and the ‘No DLV’ phenotype in 54 hpf WT and <italic>vegf</italic> mutant embryos.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64295-fig1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Molecularly heterogeneous networks of the brain and meningeal vasculature and developmental time courses of mCP vascularization.</title><p>(<bold>A</bold>) Dorsal view of a 10 dpf <italic>Tg(plvap:EGFP);Tg(glut1b:mCherry)</italic> head immunostained for Claudin-5 (magenta) shows heterogeneous <italic>Tg(plvap:</italic>EGFP) and <italic>Tg(glut1b:</italic>mCherry) expression levels in the brain and meningeal vasculature. Strong <italic>Tg(plvapb:</italic>EGFP) and weak <italic>Tg(glut1b:</italic>mCherry) expression was observed in the mCP vasculature. (<bold>B</bold>) Dorsal view of a 10 dpf <italic>Tg(kdrl:EGFP)</italic> larval head immunostained for Claudin-5 (magenta). (<bold>C–C&quot;</bold>) Magnified images of the top boxed area in (<bold>B</bold>) show Claudin-5<sup>+</sup> mesencephalic veins (MsV, yellow arrows). (<bold>D–D&quot;</bold>) Magnified images of the bottom boxed area in (<bold>B</bold>) show Claudin-5<sup>-</sup> mCP vasculature composed of the dorsal longitudinal vein (DLV) and posterior cerebral vein (PCeV). (<bold>E–H</bold>) Dorsal views of 32 (<bold>E</bold>), 46 (<bold>F</bold>), 54 (<bold>G</bold>), and 72 (<bold>H</bold>) hpf cranial vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression. The DLV began sprouting before 46 hpf (<bold>F</bold>) and extended posteriorly toward the myelencephalic choroid plexus (mCP) to connect with the bilateral PCeV around 54 hpf (<bold>G</bold>) to form the mCP vasculature through 72 hpf (<bold>H</bold>). (<bold>I</bold>) Schematic representation of the dorsal view of the cranial vasculature at 72 hpf. Scale bars: 50 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Characterization of DLV formation defects in <italic>vegfab</italic> and <italic>vegfc</italic> mutants at distinct larval stages and visualization of perfused cranial vasculature in WT and <italic>vegfab</italic> mutant larvae.</title><p>(<bold>A–D</bold>) Dorsal views of 102 hpf WT (<bold>A</bold>), <italic>vegfab<sup>-/-</sup></italic> (<bold>B</bold>), <italic>vegfc<sup>-/-</sup></italic> (<bold>C</bold>), and <italic>vegfd<sup>-/-</sup></italic> (<bold>D</bold>) cranial vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression. A significant fraction of <italic>vegfab<sup>-/</sup></italic><sup>-</sup> and vegfc<italic><sup>-/-</sup></italic> larvae lacked the DLV at 102 hpf. (<bold>E and F</bold>) Percentage of the fish of indicated genotype with and without the DLV at 102 (<bold>E</bold>) and 154 (<bold>F</bold>) hpf. A significantly higher fraction of <italic>vegfab<sup>-/</sup></italic><sup>-</sup> and <italic>vegfc<sup>-/-</sup></italic> fish lacked the DLV at 102 hpf (47% and 40%, respectively) than WT (0%) (n = 13 for WT, n = 19 for <italic>vegfab<sup>-/-</sup></italic>, n = 25 for <italic>vegfc<sup>-/-</sup></italic>, and n = 19 for <italic>vegfd<sup>-/-</sup></italic> fish examined at 102 hpf). At 154 hpf, while 63% of <italic>vegfab<sup>-/</sup></italic><sup>-</sup> fish exhibited the ‘No DLV’ phenotype, only 13% of <italic>vegfc<sup>-/-</sup></italic> fish showed this phenotype (n = 16 for WT, n = 27 for <italic>vegfab<sup>-/-</sup></italic>, n = 23 for <italic>vegfc<sup>-/-</sup></italic>, and n = 26 for <italic>vegfd<sup>-/-</sup></italic> fish examined at 154 hpf). Only a small fraction of <italic>vegfd<sup>-/-</sup></italic> fish examined lacked the DLV at 102 and 154 hpf (5% and 0%, respectively). (<bold>G–H&quot;</bold>) Dorsal views of 96 hpf <italic>vegfab<sup>+/+</sup></italic> (<bold>G–G&quot;</bold>) and <italic>vegfab<sup>-/-</sup></italic> (<bold>H–H&quot;</bold>) heads of larvae that carry the <italic>Tg(kdrl:EGFP)</italic> transgene (<bold>G and H</bold>) and that were injected with streptavidin-conjugated Qdot 655 nanocrystals (<bold>G’ and H’</bold>) (merged images shown in <bold>G&quot; and H&quot;</bold>). In <italic>vegfab<sup>+/+</sup></italic> fish (n = 10), the DLV is visualized by both <italic>Tg(kdrl:</italic>EGFP) expression (<bold>G</bold>) and blood-circulating Qdot 655 nanocrystals (<bold>G’</bold>). In contrast, in the <italic>vegfab<sup>-/-</sup></italic> larvae that lack the <italic>Tg(kdrl:</italic>EGFP)-positive DLV (<bold>H</bold>, n = 8), blood-circulating Qdot 655 nanocrystals did not label the DLV (<bold>H’</bold>), showing the lack of a perfused, functional DLV. Yellow arrows point to the presence and absence of the DLV in <italic>vegfab<sup>+/+</sup></italic> and <italic>vegfab<sup>-/-</sup></italic> larvae, respectively. Scale bars: 50 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Heatshock-induced overexpression of sFlt1 and sFlt4 partially phenocopied the DLV formation defects observed in <italic>vegfab</italic> and <italic>vegfc</italic> mutants, respectively.</title><p>(<bold>A</bold>) Experimental time course of the heat-shock treatments. <italic>Tg(hsp70l:sflt1)</italic>, <italic>Tg(hsp70l:sflt4)</italic>, and their control siblings were subjected to a heat-shock at 41, 49, 57, and 65 hpf and analyzed at 72 hpf. (<bold>B–G</bold>) Dorsal views of the cranial vasculature of 72 hpf <italic>Tg(kdrl:EGFP)</italic> (<bold>B and E</bold>), <italic>Tg(hsp70l:sflt1);Tg(kdrl:EGFP)</italic> (<bold>C and F</bold>), and <italic>Tg(hsp70l:sflt4);Tg(kdrl:EGFP)</italic> (<bold>D and G</bold>) larvae after treatment with (<bold>E–G</bold>) or without (<bold>B–D</bold>) multiple heatshocks. (<bold>H–K</bold>) Percentage of the 72 hpf fish with and without the DLV after the indicated treatment (<bold>H and I</bold>). Quantification of the DLV lengths of fish subjected to the indicated treatment (<bold>J and K</bold>). The results involving sFlt1 overexpression are shown in (<bold>H and J</bold>) and those involving sFlt4 overexpression are shown in (<bold>I and K</bold>). The results of their control siblings with and without the heatshocks are shared in the graphs for both groups. Heatshock-induced overexpression of sFlt4 led to a significantly increased percentage of the ‘No DLV’ phenotype (33%) compared to the other control groups (<bold>I</bold>), while DLV lengths were significantly shorter in the fish subjected to heatshock-induced overexpression of sFlt1 compared to the other control groups (<bold>J</bold>). The number of the animals examined is listed in the graph. Data are means ± SD. Scale bar: 50 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig1-figsupp3-v2.tif"/></fig></fig-group><p>Close examination of 6 and 10 dpf <italic>Tg(plvap:EGFP);Tg(glut1b:mCherry)</italic> double transgenic (Tg) reporter fish allowed us to observe a molecularly heterogeneous network of brain and meningeal vasculature; (1) blood vessels exhibiting high levels of <italic>Tg(plvap:</italic>EGFP), but low levels of <italic>Tg(glut1b:</italic>mCherry), expression; (2) those exhibiting low levels of <italic>Tg(plvap:</italic>EGFP), but high levels of <italic>Tg(glut1b:</italic>mCherry), expression; and (3) those with medium levels of both <italic>Tg(plvap:</italic>EGFP) and <italic>Tg(glut1b:</italic>mCherry) expression (<xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). In addition to their heterogeneous expression at the transcriptional level, we also observed the heterogeneous Claudin-5 protein expression in these brain and meningeal vessels (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B–D’’</xref>). Intriguingly, these networks of brain vasculature are all interconnected, raising the question of how molecularly heterogeneous networks of brain vasculature arise during development.</p></sec><sec id="s2-2"><title>Identification of angiogenic cues required for mCP vascular development</title><p>In order to explore molecular cues that direct CP vascularization, we screened the loss-of-function mutant zebrafish lacking Vegf activity because VEGF signaling has been indicated to be crucial for the maintenance of CP vascular perfusion and fenestrae in adult mice (<xref ref-type="bibr" rid="bib37">Kamba et al., 2006</xref>; <xref ref-type="bibr" rid="bib45">Maharaj et al., 2008</xref>). Since <italic>vegfaa<sup>bns1</sup></italic> mutants died at approximately 5 dpf due to severe early vascular formation defects (<xref ref-type="bibr" rid="bib54">Rossi et al., 2016</xref>), we focused our analysis on the <italic>vegfab<sup>bns92</sup></italic>, <italic>vegfc<sup>hu6410</sup></italic>, and <italic>vegfd<sup>bns257</sup></italic> mutants carrying a <italic>Tg(kdrl:EGFP)</italic> endothelial cell-specific reporter at 10 dpf – a developmental stage when most of the major blood vessels are formed (<xref ref-type="bibr" rid="bib34">Isogai et al., 2001</xref>). Intriguingly, we found that nearly 57% of 10 dpf <italic>vegfab</italic> mutants lacked the dorsal longitudinal vein (DLV), a main blood vessel that supplies blood to the mCP (<xref ref-type="bibr" rid="bib7">Bill and Korzh, 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1J and K</xref>), while all of the wild-type (WT) larvae, as well as a vast majority of the <italic>vegfc</italic> and <italic>vegfd</italic> mutants, examined at 10 dpf formed this vessel (<xref ref-type="fig" rid="fig1">Figure 1I and K</xref>; data not shown). Notably, while not fully penetrant in 10 dpf <italic>vegfab</italic> mutants, this vascular phenotype is prominent and specific to this vessel since most other brain and meningeal vessels formed (<xref ref-type="fig" rid="fig1">Figure 1I and J</xref>).</p><p>To determine whether this DLV defect in <italic>vegfab</italic> mutants is a developmental or maintenance deficit, we conducted their phenotypic analyses at various developmental stages. As previously indicated (<xref ref-type="bibr" rid="bib7">Bill and Korzh, 2014</xref>), we observed that (1) initial DLV sprouting occurs around 45 hours post fertilization (hpf); (2) the sprouting DLV extends toward the mCP and branches to begin joining the bilateral posterior cerebral vein (PCeV) around 54 hpf; and (3) the DLV and bilateral PCeV converge to form the mCP vasculature, which is nearly complete by 72 hpf (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E–I</xref>). To assess DLV formation in mutants, we used two different measurements. The first quantified the percentage of fish that lacked the DLV. The second measured the length of the DLV in all remaining fish that formed the DLV. At 54 hpf, while all the WT embryos formed the DLV (<xref ref-type="fig" rid="fig1">Figure 1L</xref>), we found that approximately 50% of <italic>vegfab</italic> and <italic>vegfc</italic> mutants lacked the DLV (<xref ref-type="fig" rid="fig1">Figure 1M,N,P</xref>). Most <italic>vegfd</italic> mutants formed the DLV (<xref ref-type="fig" rid="fig1">Figure 1O,P</xref>), and only 4% showed the ‘No DLV’ phenotype. We also found that DLV lengths were significantly shorter in <italic>vegfab</italic> mutants than in WT (<xref ref-type="fig" rid="fig1">Figure 1Q</xref>). While <italic>vegfc</italic> mutants displayed a lower percentage of the ‘No DLV’ phenotype as development proceeded at 102 and 154 hpf (41% and 12%), we observed that nearly 50–60% of <italic>vegfab</italic> mutants continue to exhibit this phenotype (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–F</xref>). Microangiography analysis of the circulatory system by injecting Qdot 655 streptavidin conjugated nanocrystals into the common cardinal vein of <italic>vegfab</italic> mutants revealed the absence of a perfused, functional DLV in the mutants that lack the <italic>Tg(kdrl:EGFP)</italic> endothelial reporter expression in this vessel (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2G–H’’</xref>). Moreover, under transmitted differential interference contrast imaging, these <italic>vegfab</italic> mutants displayed no blood flow or circulating blood cells in the region where the DLV normally forms (data not shown). These results showed that the ‘No DLV’ phenotype is a developmental defect leading to the complete absence of a perfused DLV and that Vegfab and Vegfc are crucial for DLV formation.</p><p>Consistent with these mutant results, we found that the heat-shock induced overexpression of a soluble form of Flt1 and Flt4 (sFlt1 and sFlt4), decoy receptors for Vegfa and Vegfc, respectively, partially recapitulated the DLV formation defects observed in <italic>vegfab</italic> and <italic>vegfc</italic> mutants (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). In this experiment, we utilized the <italic>Tg(hsp70l:sflt1)</italic> and <italic>Tg(hsp70l:sflt4)</italic> lines which, upon a heat-shock treatment, over-express sFlt1 and sFlt4 respectively, allowing for the inhibition of Vegfa- or Vegfc-induced signaling within limited timeframes (<xref ref-type="bibr" rid="bib47">Matsuoka et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Matsuoka et al., 2017</xref>). To ensure that overexpression of sFlt1 or sFlt4 begins prior to the onset of DLV sprouting and is maintained afterwards until imaging analysis, we gave fish multiple heat-shocks every 8 hr starting at 41 hpf. We found that while the heat-shocked <italic>Tg(hsp70l:sflt1)</italic> larvae did not display significantly higher penetrance of the ‘No DLV’ phenotype (21%) than that of non-heat-shocked (0%) and heat-shocked (10%) control fish (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3H</xref>), DLV lengths were significantly shorter in the rest of the <italic>Tg(hsp70l:sflt1)</italic> larvae that formed the DLV (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3J</xref>), partially phenocopying <italic>vegfab</italic> mutant DLV phenotypes (<xref ref-type="fig" rid="fig1">Figure 1P,Q</xref>). In addition, we also observed a significantly higher percentage of the ‘No DLV’ phenotype (33%) in <italic>Tg(hsp70l:sflt4)</italic> larvae after the same heat-shock treatments (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3I</xref>), although the rest of the <italic>Tg(hsp70l:sflt4)</italic> larvae formed a DLV of comparable lengths to those observed in control animals (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3K</xref>), which is consistent with <italic>vegfc</italic> mutant DLV phenotypes (<xref ref-type="fig" rid="fig1">Figure 1P,Q</xref>). These results suggest that temporally restricted inhibition of Vegfab- or Vegfc-dependent signaling during DLV formation is sufficient to abrogate this process.</p></sec><sec id="s2-3"><title>Multiple Vegf ligands function redundantly to drive mCP vascularization</title><p>The partially penetrant ‘No DLV’ phenotype observed in <italic>vegfab</italic> and <italic>vegfc</italic> mutants led us to hypothesize that Vegfab and Vegfc are functionally redundant in regulating this vascular process. To test this hypothesis, we set up incrosses of <italic>vegfab;vegfc</italic> double heterozygous adults and analyzed DLV formation in all progeny generated from these crosses (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We chose to analyze larvae at 96 hpf to minimize the effects of potential developmental delays in <italic>vegfab;vegfc</italic> double mutants. These analyses revealed that <italic>vegfab;vegfc</italic> double homozygous mutants displayed markedly enhanced penetrance and expressivity of mCP vascularization defects. Nearly 81% of <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> larvae exhibited the ‘No DLV’ phenotype at 96 hpf (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>). This penetrance is significantly higher than their <italic>vegfab<sup>-/-</sup></italic> (38%) and <italic>vegfc<sup>-/-</sup></italic> (16%) siblings (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Moreover, we found that <italic>vegfab<sup>+/-</sup>;vegfc<sup>+/-</sup></italic> larvae exhibited approximately threefold higher penetrance of this phenotype (22%) than their sibling <italic>vegfab<sup>+/-</sup></italic> (7%) and <italic>vegfc<sup>+/-</sup></italic> (8%) fish (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). These results showed that <italic>vegfab</italic> and <italic>vegfc</italic> genetically interact in DLV formation.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>vegfab</italic> genetically interacts with <italic>vegfc</italic> in mCP vascular development.</title><p>(<bold>A</bold>) Experimental setup for the results shown in (<bold>D–G</bold>). (<bold>B</bold>) Schematic representation of the dorsal view of 96 hpf WT cranial vasculature, illustrating distinct cranial vessels. PCeV: posterior cerebral vein, MCeV: middle cerebral vein, MsV: mesencephalic vein. (<bold>C and C’</bold>) Dorsal views of a 10 dpf <italic>Tg(plvap:EGFP);Tg(glut1b:mCherry)</italic> head immunostained for Claudin-5 (magenta) show that the DLV and PCeV exhibit stronger <italic>Tg(plvap:</italic>EGFP), and weaker <italic>Tg(glut1b:</italic>mCherry), expression than the MCeV and MsV do. (<bold>D and E</bold>) Dorsal views of 96 hpf <italic>vegfab<sup>+/+</sup>;vegfc<sup>+/+</sup></italic> (<bold>D</bold>) and <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> (<bold>E</bold>) cranial vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression show a specific loss of the DLV (yellow arrows) and PCeV (white arrows) in <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> larvae. (<bold>F</bold>) Percentage of 96 hpf fish of indicated genotype with and without the DLV (the number of the animals examined per genotype is listed in the panel). (<bold>G</bold>) Quantification of PCeV, MCeV, and MsV formation at 96 hpf. PCeV formation was severely and selectively compromised in <italic>vegfc<sup>-/-</sup>;vegfab<sup>-/-</sup></italic> larvae compared to the corresponding single mutants. (<bold>H–M</bold>) Brightfield images of 96 hpf WT (<bold>H</bold>), <italic>vegfab<sup>-/-</sup></italic> (<bold>I</bold>)<italic>, vegfc<sup>-/-</sup></italic> (<bold>J</bold>)<italic>, vegfd<sup>-/-</sup></italic> (<bold>K</bold>)<italic>, vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<bold>L</bold>), and <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> (<bold>M</bold>) larvae. (<bold>H’–M’</bold>) Lateral views of 96 hpf WT (<bold>H’</bold>), <italic>vegfab<sup>-/-</sup></italic> (<bold>I’</bold>)<italic>, vegfc<sup>-/-</sup></italic> (<bold>J’</bold>)<italic>, vegfd<sup>-/-</sup></italic> (<bold>K’</bold>)<italic>, vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<bold>L’</bold>), and <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> (<bold>M’</bold>) larval trunk vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression. (<bold>N</bold>) Quantification of average number of ISVs in 96 hpf fish of indicated genotype (the number of the animals examined per genotype is listed in the panel). No significant difference in the number of ISVs was observed across the genotypes. NS: not significant. Data are means ± SD. Scale bars: 50 µm in (<bold>C’</bold>), (<bold>E</bold>), and (<bold>M’</bold>); 1 mm in (<bold>M</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>vegfab</italic> genetically interacts with <italic>vegfd</italic> in mCP vascular development.</title><p>(<bold>A</bold>) Schematic representation of the dorsal view of WT cranial vasculature, illustrating the mCP vasculature (DLV, PCeV) and the neighboring cranial vessels (MsV, MCeV). (<bold>B</bold>) Percentage of 96 hpf fish of indicated genotype with and without the DLV. <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae displayed a significantly higher penetrance of the ‘No DLV’ phenotype (97%) than <italic>vegfab<sup>-/-</sup></italic> (69%) and <italic>vegfd<sup>-/-</sup></italic> (12.5%) larvae, showing that <italic>vegfab</italic> and <italic>vegfd</italic> genetically interacts in DLV formation (n = 24 for <italic>vegfd<sup>-/-</sup></italic>, n = 36 for <italic>vegfab<sup>-/-</sup></italic>, n = 41 for <italic>vegfab<sup>-/-</sup>;vegfd<sup>+/-</sup></italic>, and n = 29 for <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> fish). (<bold>C</bold>) Quantification of PCeV, MCeV, and MsV formation at 96 hpf. PCeV formation was severely compromised in <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae compared to the corresponding single mutants. At this stage, MsV, but not MCeV, formation was mildly affected in <italic>vegfab;vegfd</italic> double mutants compared to the corresponding single mutants. Data are means ± SD.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig2-figsupp1-v2.tif"/></fig></fig-group><p>It is possible that impaired DLV formation is caused by the defective formation of the neighboring blood vessels that give rise to the DLV. To address this possibility, we analyzed three of the DLV’s neighboring blood vessels (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), including the PCeV, middle cerebral veins (MCeV), and mesencephalic veins (MsV). Importantly, the MCeV and MsV exhibit molecular signatures shared by non-fenestrated vasculature (<xref ref-type="fig" rid="fig1">Figures 1D</xref> and <xref ref-type="fig" rid="fig2">2C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–C’’</xref>), while the PCeV displays those of fenestrated vessels (<xref ref-type="fig" rid="fig1">Figures 1D</xref> and <xref ref-type="fig" rid="fig2">2C’</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–D’’</xref>; <xref ref-type="bibr" rid="bib62">Umans et al., 2017</xref>; <xref ref-type="bibr" rid="bib63">van Leeuwen et al., 2018</xref>). Intriguingly, we found that PCeV formation defects were markedly enhanced in <italic>vegfab;vegfc</italic> double mutants when compared to their respective single mutants, while this was not the case with the formation of the MCeV and MsV (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). These results indicate that the redundant actions of Vegfab/Vegfc differentially regulate the formation of the brain blood vessels that exhibit distinct molecular signatures.</p><p>To investigate whether Vegfab/Vegfc-dependent angiogenesis is central to DLV and PCeV formation, we examined <italic>vegfab;vegfd</italic> double homozygous mutants at 96 hpf for comparison (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Surprisingly, despite the fact that <italic>vegfd</italic> mutants alone did not exhibit a significant increase in the ‘No DLV’ phenotype (12.5%) compared to the WT larvae of the same age (0%) (<xref ref-type="fig" rid="fig2">Figure 2F</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>), genetic deletion of one or both copies of <italic>vegfd</italic> in the <italic>vegfab</italic> mutant background dramatically increased the penetrance of this phenotype (88% for <italic>vegfab<sup>-/-</sup>;vegfd<sup>+/-</sup></italic> larvae; 97% for <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae) compared to that observed in their <italic>vegfab<sup>-/-</sup></italic> siblings (69%) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). We found that <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae also exhibited a pronounced defect in PCeV formation at 96 hpf, while only a mild defect in MsV, but not MCeV, formation was observed at this age (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). It is important to note that <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> and <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> larvae did not exhibit apparent differences in body size and/or gross morphology (<xref ref-type="fig" rid="fig2">Figure 2H–M</xref>).</p></sec><sec id="s2-4"><title>Genetic elimination of specific pairs of <italic>vegf</italic> genes impacts mCP vascularization</title><p>Remarkably, the severe DLV and PCeV formation defects in <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> and <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae were observed even at 10 dpf (<xref ref-type="fig" rid="fig3">Figure 3C,D</xref>). The results showed a tendency toward slightly lower penetrance of the ‘No DLV’ phenotype across genotypes at 10 dpf (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) as compared to those at 96 hpf (<xref ref-type="fig" rid="fig2">Figure 2F</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). This tendency may indicate that some of the larvae can recover from the lack of the DLV between 4 and 10 dpf. Nonetheless, 10 dpf <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> and <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae showed markedly higher penetrance of this phenotype (65% and 76%, respectively) relative to their <italic>vegfab<sup>-/-</sup></italic> siblings (38%) (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Similarly, we observed severe defects in PCeV formation in <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> and <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae, although none of the <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> single mutant fish examined at this stage showed this defect when compared to WT fish (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> and <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae displayed mild defects in MsV formation when compared to WT fish; however, no significant differences in MCeV and MsV formation were observed in these double mutants compared to <italic>vegfab<sup>-/-</sup></italic> fish (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). These results demonstrate that <italic>vegfab</italic> genetically interacts with <italic>vegfc</italic> and <italic>vegfd</italic> specifically in DLV and PCeV formation around this area of the brain.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Multiple Vegf ligands function redundantly to drive mCP vascularization.</title><p>(<bold>A–E</bold>) Dorsal views of 10 dpf WT (<bold>A</bold>), <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<italic>vegfc;vegfd</italic> DKO, <bold>B</bold>), <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> (<italic>vegfab;vegfc</italic> DKO, <bold>C</bold>), <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<italic>vegfab;vegfd</italic> DKO, <bold>D</bold>), and <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<italic>vegfab;vegfc;vegfd</italic> TKO, <bold>E</bold>) cranial vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression and anti-Claudin-5 immunostaining (magenta) show specific losses of the DLV (yellow arrows) and PCeV (white arrows) in <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> (<bold>C</bold>), <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<bold>D</bold>), and <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<bold>E</bold>) larvae. (<bold>F</bold>) Percentage of 10 dpf fish of indicated genotype with and without the DLV (the number of the animals examined per genotype is listed in the panel). (<bold>G</bold>) Quantification of PCeV, MCeV, and MsV formation at 10 dpf. (<bold>H</bold>) Schematic representations of the dorsal view of 10 dpf WT, <italic>vegfab<sup>-/-</sup></italic> (<italic>vegfab</italic> KO), <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> (<italic>vegfab;vegfc</italic> DKO), <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<italic>vegfab;vegfd</italic> DKO), and <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<italic>vegf</italic> TKO) cranial vasculature summarize the vascular phenotypes observed in these mutants. Genetic evidence shows that there are specific requirements for Vegfab/Vegfc/Vegfd-dependent angiogenesis involved in fenestrated mCP vascular development. Scale bar: 50 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Developmental relationships between FGPs and mCP vasculature in WT, <italic>vegfab<sup>-/-</sup></italic>, and <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae.</title><p>(<bold>A–C&quot;</bold>) Dorsal views of 120 hpf WT (<bold>A–A&quot;</bold>), <italic>vegfab<sup>-/-</sup></italic> (<bold>B–B&quot;</bold>), and <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<bold>C–C&quot;</bold>) heads of larvae that carried the <italic>Tg(kdrl:EGFP)</italic> (<bold>A–C</bold>) and <italic>Tg(lyve1:DsRed)</italic> (<bold>A’–C’</bold>) transgenes (merged images shown in <bold>A&quot;–C&quot;</bold>). All of the <italic>vegfab<sup>-/-</sup></italic> larvae that lacked the DLV (n = 7) formed FGPs in the dorsal surfaces of the brain meninges (<bold>B–B&quot;</bold>), as observed in WT larvae (n = 13). In contrast, <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae (<bold>C–C&quot;</bold>) that exhibited the complete loss of FGPs (n = 9) formed the DLV and PCeV, as observed in WT fish. Yellow arrows point to the DLV and white arrows to the FGPs. Scale bar: 50 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To test whether <italic>vegfc</italic> and <italic>vegfd</italic> genetically interact in mCP vascularization, we examined <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae at 10 dpf for comparison. These double mutants exhibited slightly increased ‘No DLV’ phenotype (16%) when compared to WT fish (0%), but did not show significantly enhanced penetrance when compared to <italic>vegfd<sup>-/-</sup></italic> larvae (9%) (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Moreover, most of the <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae examined formed the mCP and neighboring vasculature and did not display a significant difference in PCeV formation when compared to WT fish (<xref ref-type="fig" rid="fig3">Figure 3B,F,G</xref>). These results demonstrate that the genetic elimination of only the specific pairs of <italic>vegf</italic> genes has a profound impact on mCP vascularization and indicate that Vegfc and Vegfd play modulatory roles in regulating this process.</p><p>Since <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> and <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae did not display a fully penetrant ‘No DLV’ phenotype, we next analyzed <italic>vegfab;vegfc;vegfd</italic> triple mutants at 10 dpf. We found that all the triple mutants examined (n = 16) lacked the DLV as well as the PCeV, except for one larva (<xref ref-type="fig" rid="fig3">Figure 3E–G</xref>), demonstrating significantly enhanced penetrance of these phenotypes when compared to <italic>vegfab<sup>-/-</sup></italic> fish. However, this was not the case with MCeV and MsV formation. These extensive genetic analyses provide evidence that the functional redundancy among these three Vegf ligands selectively directs fenestrated DLV and PCeV formation leading to mCP vascularization (<xref ref-type="fig" rid="fig3">Figure 3H</xref>).</p></sec><sec id="s2-5"><title>Combined genetic inactivation of <italic>ccbe1</italic> and <italic>vegfab</italic> leads to significantly enhanced defects in DLV and PCeV formation</title><p>Prior studies have shown that Ccbe1, Adamts3, and Adamts14 serve to proteolytically cleave and convert the pro-active form of Vegfc into its mature form during lymphangiogenesis in zebrafish (<xref ref-type="bibr" rid="bib32">Hogan et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Le Guen et al., 2014</xref>; <xref ref-type="bibr" rid="bib70">Wang et al., 2020</xref>). Among these three proteins, <italic>ccbe1</italic> appears to be highly expressed in the developing brain and meningeal compartments based on its BAC transgenic reporter expression at 48 hpf (<xref ref-type="bibr" rid="bib70">Wang et al., 2020</xref>), while <italic>adamts3</italic> BAC transgenic reporter expression appear to be very low at the same stage. Since 48 hpf is a developmental time point when the DLV is extending toward the mCP, <italic>ccbe1</italic> could be a strong candidate that acts to activate Vegfc in this area of the brain.</p><p>To investigate a role for Ccbe1 in mCP vascularization, we took the approach of injecting ribonucleoprotein (RNP) complexes that are composed of <italic>ccbe1</italic>-specific CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and Cas9 protein. This approach using crRNA:tracrRNA:Cas9 protein RNP complexes was previously shown to be a highly efficient method to achieve bi-allelic inactivation of target genes when injected at the one-cell stage, which allows for the generation of F0 embryos that recapitulate homozygous mutant phenotypes (<xref ref-type="bibr" rid="bib33">Hoshijima et al., 2019</xref>). We tested this method and observed that simultaneous injection of three different crRNA RNP complexes targeted to a single gene works in a much more efficient manner to generate F0 embryos that lack target gene function and recapitulate homozygous mutant phenotypes (data not shown). Since it has been indicated that Ccbe1’s full lymphangiogenic activity in vivo requires its EGF and collagen domains (<xref ref-type="bibr" rid="bib55">Roukens et al., 2015</xref>), we designed three different crRNAs, all of which targeted the exons that encode the N-terminal domain of the Ccbe1 protein-coding sequences prior to the EGF domain (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Each of the designed crRNAs is thus expected to disrupt the function of Ccbe1 that is exerted through its EGF and collagen domains.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Combined genetic inactivation of <italic>ccbe1</italic> and <italic>vegfab</italic> leads to significantly enhanced defects in DLV and PCeV formation.</title><p>(<bold>A</bold>) Predicted domain structure of zebrafish Ccbe1. Ccbe1 consists of a signal peptide (SP), an EGF domain, a calcium-binding EGF domain (Ca-EGF), and two collagen repeat domains (ColA and ColB). Arrows indicate the approximate positions of the protein sequences corresponding to the target sequences of the three designed CRISPR RNA (crRNA). (<bold>B</bold>) Experimental flows of the microinjection experiments for panels (<bold>C and D</bold>). Injection cocktails containing Cas9 protein with or without the three <italic>ccbe1</italic> crRNA:tracrRNA duplex complexes were injected into one-cell stage embryos produced from <italic>Tg(kdrl:EGFP);Tg(lyve1:DsRed)</italic> fish crossed with wild-type AB counterparts. Injected progeny were analyzed at 120 hpf for the presence or absence of <italic>Tg(lyve1:</italic>DsRed)<sup>+</sup> FGPs in the dorsal meningeal surfaces of the optic tectum. (<bold>C</bold>) Brightfield and confocal images of 120 hpf <italic>Tg(kdrl:EGFP);Tg(lyve1:DsRed)</italic> larvae after no injection or Cas9 protein injection with and without the three <italic>ccbe1</italic> crRNA:tracrRNA complexes. Although the larvae injected with the <italic>ccbe1</italic> crRNA ribonucleoprotein (RNP) complexes exhibited no apparent differences in their gross morphology compared to uninjected and Cas9 injected controls, they completely lacked <italic>Tg(lyve1:</italic>DsRed)<sup>+</sup> FGPs (white arrows) in the dorsal meningeal surfaces of the optic tectum. (<bold>D</bold>) Percentage of 120 hpf larvae of indicated treatment with and without <italic>Tg(lyve1:</italic>DsRed)<sup>+</sup> FGPs in the dorsal meningeal surfaces of the optic tectum (n = 20 animals examined for each group). (<bold>E</bold>) Experimental flows of the microinjection experiments for panel (<bold>F and G</bold>). (<bold>F</bold>) Percentage of 54 hpf larvae of indicated treatment with and without the DLV (the number of the animals examined per treatment is listed in the panel). A significant fraction of the embryos injected with the <italic>ccbe1</italic> crRNA RNP complexes lacked the DLV at this stage. (<bold>G</bold>) Quantification of DLV lengths of the fish of indicated treatment that formed the DLV at 54 hpf. (<bold>H</bold>) Experimental flows of the microinjection experiments for panels (<bold>I–K</bold>). (<bold>I</bold>) Dorsal views of 96 hpf <italic>vegfab<sup>+/+</sup></italic> and <italic>vegfab<sup>-/-</sup></italic> larvae that carried <italic>Tg(kdrl:EGFP)</italic> and <italic>Tg(lyve1:DsRed)</italic> transgenes after Cas9 protein injection with and without the three <italic>ccbe1</italic> crRNA:tracrRNA complexes. While control solution injected <italic>vegfab<sup>+/+</sup></italic> and <italic>vegfab<sup>-/-</sup></italic> larvae formed <italic>Tg(lyve1:</italic>DsRed)<sup>+</sup> FGPs in the dorsal surfaces of the brain meninges, those injected with the <italic>ccbe1</italic> crRNA RNP complexes completely lacked FGPs regardless of <italic>vegfab</italic> genotypes. A significant fraction of <italic>vegfab<sup>-/-</sup></italic> larvae in both injection groups exhibited the ‘No DLV’ phenotype. (<bold>J</bold>) Percentage of 96 hpf larvae of indicated genotype and treatment with and without the DLV (the number of the animals examined per genotype is listed in the panel). <italic>vegfab<sup>-/-</sup></italic> larvae injected with the <italic>ccbe1</italic> crRNA RNP complexes displayed a markedly increased penetrance of the ‘No DLV’ phenotype. (<bold>K</bold>) Quantification of PCeV, MCeV, and MsV formation at 96 hpf. <italic>vegfab<sup>-/-</sup></italic> larvae injected with the Cas9 control solution as well as <italic>vegfab<sup>+/+</sup></italic> larvae injected with the <italic>ccbe1</italic> crRNA RNP complexes did not exhibit a defect in PCeV formation. However, <italic>vegfab<sup>-/-</sup></italic> larvae injected with the <italic>ccbe1</italic> crRNA RNP complexes exhibited severe defects in PCeV formation. Scale bars: 50 μm in (<bold>C</bold>) (fluorescence image), (<bold>J</bold>); 1 mm in (<bold>C</bold>) (brightfield image).</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Quantifications of DLV lengths and the ‘No DLV’ phenotype in 54 hpf <italic>ccbe1</italic> RNP-injected embryos and their sibling controls.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64295-fig4-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig4-v2.tif"/></fig><p>We first validated the efficacy of this triple crRNA RNP complex injection by examining the formation of fluorescent granular perithelial cells (FGPs) – also called Mato cells (<xref ref-type="bibr" rid="bib66">Venero Galanternik et al., 2017</xref>), meningeal mural Lymphatic Endothelial Cells (muLECs) (<xref ref-type="bibr" rid="bib9">Bower et al., 2017</xref>), or Brain Lymphatic Endothelial cells (BLECs) (<xref ref-type="bibr" rid="bib64">van Lessen et al., 2017</xref>) – in the dorsal surfaces of the brain meninges (<xref ref-type="fig" rid="fig4">Figure 4B–D</xref>). We refer to this cell type as FGPs hereafter. We chose to analyze FGP formation because <italic>ccbe1</italic> mutants exhibit a severe defect in this process as shown in <italic>vegfc</italic> null mutants (<xref ref-type="bibr" rid="bib64">van Lessen et al., 2017</xref>). To visualize FGPs, we used a <italic>Tg(lyve1:DsRed)</italic> reporter transgenic line. We observed that while all the uninjected and control Cas9 protein-injected <italic>Tg(kdrl:EGFP);Tg(lyve1:DsRed)</italic> larvae formed a bilateral loop of <italic>Tg(lyve1:</italic>DsRed)<sup>+</sup> FGPs in the dorsal surfaces of the brain meninges at 120 hpf, all the triple crRNA-injected larvae we examined completely lacked these FGP cells (<xref ref-type="fig" rid="fig4">Figure 4C,D</xref>). These control and crRNA-injected larvae did not display apparent differences in their gross morphology (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, brightfield panels). Given the fact that a vast majority of 5 dpf <italic>ccbe1</italic> heterozygous larvae form meningeal FGPs similar to WT fish (<xref ref-type="bibr" rid="bib64">van Lessen et al., 2017</xref>), we validated that this approach efficiently achieves bi-allelic genetic inactivation of <italic>ccbe1</italic>.</p><p>We hypothesized that if Vegfc requires Ccbe1-mediated proteolytic activation, these triple crRNA injected embryos will lack Vegfc activation, thus recapitulating <italic>vegfc</italic> null mutant phenotypes. To test this hypothesis, we first analyzed DLV formation in the triple crRNA injected embryos at 54 hpf (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), a developmental time point at which nearly 54% of <italic>vegfc</italic> mutants exhibited the ‘No DLV’ phenotype (<xref ref-type="fig" rid="fig1">Figure 1P</xref>). We found that approximately 20% of the triple crRNA-injected embryos displayed the ‘No DLV’ phenotype, while uninjected and control Cas9 protein-injected siblings all formed the DLV (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Similar to <italic>vegfc</italic> mutants examined at this developmental stage, the rest of the crRNA-injected embryos that formed the DLV did not exhibit DLV lengths shorter than those of the controls (<xref ref-type="fig" rid="fig4">Figure 4G</xref>).</p><p>Since <italic>vegfab</italic> and <italic>vegfc</italic> genetically interact in mCP vascular development, we next asked whether <italic>vegfab</italic> and <italic>ccbe1</italic> also genetically interact in this process. To achieve combined genetic inactivation of <italic>vegfab</italic> and <italic>ccbe1</italic>, we injected the triple crRNA RNPs into one-cell stage embryos generated from <italic>vegfab<sup>+/-</sup></italic> incrosses (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). We injected a solution containing Cas9 protein without the crRNA into their sibling embryos for comparison. We analyzed these injected larvae at 96 hpf to compare with the data of the larvae generated from <italic>vegfab;vegfc</italic> double heterozygous fish incrosses (<xref ref-type="fig" rid="fig2">Figure 2A–G</xref>). We simultaneously visualized <italic>Tg(kdrl:</italic>EGFP) and <italic>Tg(lyve1:</italic>DsRed) expression to analyze the formation of blood vessels and FGPs in every injected embryo. At 96 hpf, <italic>Tg(lyve1:</italic>DsRed)<sup>+</sup> FGPs were present in the control solution injected larvae regardless of their <italic>vegfab</italic> genotypes, while those injected with the <italic>ccbe1</italic> RNPs completely lacked these cells (<xref ref-type="fig" rid="fig4">Figure 4I</xref>), showing that the <italic>ccbe1</italic> RNPs-injected larvae subjected to this analysis also received effective gene inactivation of <italic>ccbe1</italic>. Intriguingly, similar to what we observed in <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> larvae, we found that <italic>vegfab<sup>-/-</sup></italic> larvae injected with the <italic>ccbe1</italic> RNPs exhibit a markedly increased penetrance of the ‘No DLV’ phenotype (52%) as compared to their <italic>vegfab<sup>-/-</sup></italic> siblings injected with the control solution (23%) or the <italic>ccbe1</italic> RNPs-injected <italic>vegfab<sup>+/+</sup></italic> siblings (3%) (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). Strikingly enhanced defects were also observed in PCeV formation in the <italic>ccbe1</italic> RNPs-injected <italic>vegfab<sup>-/-</sup></italic> larvae, while this was not the case for MCeV and MsV formation (<xref ref-type="fig" rid="fig4">Figure 4K</xref>). These results show genetic interactions between <italic>vegfab</italic> and <italic>ccbe1</italic> in DLV and PCeV formation, identifying Ccbe1 as an important molecular player involved in the Vegfab/Vegfc/Vegfd-dependent angiogenesis leading to mCP vascularization.</p></sec><sec id="s2-6"><title>Developmental relationships between meningeal FGPs and mCP vasculature</title><p>A previous study indicates that zebrafish FGPs regulate angiogenesis in the brain meningeal compartment (<xref ref-type="bibr" rid="bib9">Bower et al., 2017</xref>). Since the DLV and PCeV develop in close proximity to the dorsal surfaces of the brain meninges, we examined developmental relationships between FGPs and mCP vasculature (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). To assess a role for FGPs in mCP vascular development, we analyzed <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae at 120 hpf since FGPs require Vegfc/Vegfd signaling to migrate to the optic tectum by this stage (<xref ref-type="bibr" rid="bib9">Bower et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">van Lessen et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Venero Galanternik et al., 2017</xref>). To assess a role for mCP vasculature in FGP development, we analyzed 120 hpf <italic>vegfab<sup>-/-</sup></italic> larvae which lacked the DLV. We found that the <italic>vegfab<sup>-/-</sup></italic> fish lacking the DLV all formed FGPs similarly to their WT sibling controls, while <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae, which lacked FGPs, formed the DLV and PCeV (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Consistent with these <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> results, the <italic>ccbe1</italic> RNPs-injected larvae completely lacked FGPs, but formed the DLV and PCeV, at 120 hpf (<xref ref-type="fig" rid="fig4">Figure 4C,D</xref>). These observations demonstrate that the formation of FGPs and mCP vasculature is an independent developmental process. The recently discovered intracranial lymphatic vessels in zebrafish begin to form at much later stages of development (9–10 dpf) (<xref ref-type="bibr" rid="bib12">Castranova et al., 2021</xref>), thus mCP vascularization processes should not be affected by these intracranial lymphatics.</p></sec><sec id="s2-7"><title>Vegfab/Vegfc- and Vegfab/Vegfd-dependent angiogenesis in the formation of other vascular beds</title><p>To address the specificity and requirements for Vegfab/Vegfc- and Vegfab/Vegfd-dependent angiogenic signaling in the formation of other vascular beds, we examined intersegmental vessel (ISV) formation in the trunk of these double mutants at 96 hpf (<xref ref-type="fig" rid="fig2">Figure 2H’–M’</xref>). We chose 96 hpf for this analysis because ISV formation is complete before 72 hpf (<xref ref-type="bibr" rid="bib34">Isogai et al., 2001</xref>), and this was the developmental stage at which we noted severe defects in DLV and PCeV formation in these mutants (<xref ref-type="fig" rid="fig2">Figure 2F,G</xref>). We observed no significant differences in the number of ISVs between WT and any of the single or double mutant groups (<xref ref-type="fig" rid="fig2">Figure 2N</xref>). These data provide further evidence that Vegfab/Vegfc- and Vegfab/Vegfd-dependent angiogenic signaling is specifically required to drive mCP vascularization.</p></sec><sec id="s2-8"><title>Analysis of vEC molecular markers for the fenestrated and BBB states</title><p>We next asked how genetic elimination of these Vegf ligands affects the fenestrated state of the mCP vasculature. To this end, we analyzed <italic>Tg(plvap:</italic>EGFP) and <italic>Tg(glut1b:</italic>mCherry) reporter expression in <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> single mutants (<xref ref-type="fig" rid="fig5">Figure 5</xref>). At 10 dpf, WT fish exhibited strong <italic>Tg(plvap:</italic>EGFP) and faint <italic>Tg(glut1b:</italic>mCherry) reporter expression in the mCP vasculature, including in the DLV and PCeV (<xref ref-type="fig" rid="fig5">Figure 5A–A”</xref>). We observed that none of these single mutants displayed an obvious difference in the expression patterns of <italic>Tg(plvap:EGFP)</italic> and <italic>Tg(glut1b:mCherry)</italic> reporters in these vessels (<xref ref-type="fig" rid="fig5">Figure 5B–D”</xref>) as compared to WT fish, suggesting that the single mutants that formed the DLV and PCeV retain the fenestrated state of mCP vasculature.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Expression analysis of endothelial markers for the fenestrated and BBB states in WT, <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> mutants.</title><p>Dorsal views of 10 dpf WT (<bold>A–A&quot;</bold>), <italic>vegfab<sup>-/-</sup></italic> (<bold>B–B&quot;</bold>), <italic>vegfc<sup>-/-</sup></italic> (<bold>C–C&quot;</bold>), and <italic>vegfd<sup>-/-</sup></italic> (<bold>D–D&quot;</bold>) heads of the larvae that carried the <italic>Tg(plvap:EGFP)</italic> (<bold>A–D</bold>) and <italic>Tg(glut1b:mCherry)</italic> (<bold>A’–D’</bold>) transgenes (merged images shown in <bold>A&quot;–D&quot;</bold>). Only the <italic>vegfab<sup>-/-</sup></italic>, <italic>vegfc<sup>-/-</sup></italic>, and <italic>vegfd<sup>-/-</sup></italic> larvae that formed the DLV and PCeV were subjected to this analysis. High levels of <italic>Tg(plvap:</italic>EGFP), but low levels of <italic>Tg(glut1b:</italic>mCherry), expression were observed in the DLV and PCeV of WT fish (<bold>A–A’</bold>, n = 24). The expression patterns of the <italic>Tg(plvap:EGFP)</italic> and <italic>Tg(glut1b:mCherry)</italic> transgenes were not altered in any of the single mutants (n = 9 for <italic>vegfab<sup>-/-</sup></italic>, n = 4 for <italic>vegfc<sup>-/-</sup></italic>, and n = 4 for <italic>vegfd<sup>-/-</sup></italic> fish). Yellow arrows point to the DLV and white arrows to the PCeV. Scale bar: 50 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Analysis of Claudin-5 protein expression in the mCP vasculature of <italic>vegf</italic> single and double mutants.</title><p>(<bold>A–D&quot;</bold>) Magnified views of 10 dpf WT (<bold>A–A&quot;</bold>), <italic>vegfab<sup>-/-</sup></italic> (<bold>B–B&quot;</bold>), <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic> (<bold>C–C&quot;</bold>), and <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> (<bold>D–D&quot;</bold>) larvae carrying the <italic>Tg(kdrl:EGFP)</italic> transgene that were immunostained for GFP and Claudin-5 (magenta). In 10 WT fish, Claudin-5 immunoreactivity is prominent in mCP epithelial cells and weakly present in the tissues located ventrally to the DLV and PCeV but is barely detectable in the DLV and PCeV (<bold>A–A’</bold>). No obvious differences were observed in this low level of Claudin-5 expression in these vessels between WT and any of the <italic>vegfab<sup>-/-</sup></italic>, <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic>, and <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae that formed these vessels (<bold>B–D&quot;</bold>). Yellow arrows point to the DLV and white arrows to the PCeV. The number of the animals examined was: n = 65 for WT, n = 50 for <italic>vegfab<sup>-/-</sup></italic>, n = 26 for <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic>, and, n = 24 for <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> fish. Scale bar: 50 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Next, we examined Claudin-5 BBB marker expression in <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> single mutants and in combined mutants. We expected that if a loss of either of these Vegf ligands leads to a conversion of the mCP vasculature from the fenestrated to the BBB state, increased Claudin-5 expression should be observed in these vessels. In 10 dpf WT fish, Claudin-5 immunoreactivity is prominent in mCP epithelial cells and weakly present in the tissues located ventrally to the DLV and PCeV but is barely detectable in the DLV and PCeV (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–A’’</xref>). However, this low level of Claudin-5 expression in these vessels was not changed in the 10 dpf <italic>vegfab<sup>-/-</sup></italic>, <italic>vegfab<sup>-/-</sup>;vegfc<sup>-/-</sup></italic>, <italic>vegfab<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> and <italic>vegfc<sup>-/-</sup>;vegfd<sup>-/-</sup></italic> larvae that formed these vessels (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B–D’’</xref>; data not shown). These results imply that the fenestrated endothelial state of the mCP vasculature is not altered in the absence of these Vegf ligands.</p></sec><sec id="s2-9"><title>Expression patterns of <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> during mCP vascularization</title><p>To determine cellular mechanisms governing mCP vascularization, we examined the expression patterns of <italic>vegfab</italic>, <italic>vegfc</italic> and <italic>vegfd</italic>. To achieve this aim at the single-cell resolution, we generated new BAC transgenic reporter lines, each of which drives the expression of Gal4FF under the control of a <italic>vegfab</italic>, <italic>vegfc</italic>, or <italic>vegfd</italic> promoter in a BAC. We crossed each of these lines with <italic>Tg(UAS:EGFP)</italic> fish, which carry an EGFP gene downstream of the upstream activating sequence (UAS). We validated these BAC transgenic lines by observing their EGFP expression domains, which closely matched respective mRNA expression patterns (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A–F’</xref>). Thus, these BAC transgenic tools reliably reflect the endogenous expression patterns of <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic>.</p><p>To analyze the morphology of individual cells labeled by these BAC lines, we crossed each of them with <italic>Tg(UAS:EGFP-CAAX)</italic> fish, which carry a membrane-bound EGFP gene downstream of UAS. These generated double Tg fish are abbreviated <italic>TgBAC(vegfab:EGFP)</italic>, <italic>TgBAC(vegfc:EGFP)</italic>, and <italic>TgBAC(vegfd:EGFP)</italic> and were crossed with the endothelial cell-specific <italic>Tg(kdrl:ras-mCherry)</italic> line for expression analyses.</p><p>During the developmental stages at which the DLV extends toward the mCP and branches to join the PCeV (48–72 hpf), we observed that <italic>vegfab</italic> and <italic>vegfc</italic> are expressed in multiple cell types along the DLV migratory route (<xref ref-type="fig" rid="fig6">Figure 6A–D”</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1G–I, K, L</xref>). We identified two prominent regions of <italic>vegfab</italic> expression: (1) meningeal fibroblast-like cells near the dorsal midline junction (DMJ) where DLV sprouting initiates and (2) mCP cells where the DLV and PCeV join to form the mCP vasculature (<xref ref-type="fig" rid="fig6">Figure 6A–B”</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1H,K,L</xref>). The latter’s reporter expression marked Claudin-5<sup>+</sup> mCP epithelial cells at 72 hpf (<xref ref-type="fig" rid="fig6">Figure 6G–G”</xref>). We observed <italic>vegfc</italic> expression in (1) meningeal fibroblast-like cells near the DMJ and (2) in the migrating vECs, including the growing tip and trailing cells, which comprise the DLV (<xref ref-type="fig" rid="fig6">Figure 6C–D”</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1I</xref>). We also observed strong <italic>vegfd</italic> expression restricted to meningeal fibroblast-like cells at the DMJ and other regions, most of which are located anterior to growing DLV tip cells (<xref ref-type="fig" rid="fig6">Figure 6E–F”</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1J</xref>). These observations suggest that Vegfab and Vegfd control mCP vascular formation via paracrine mechanisms, while Vegfc acts as a paracrine and/or autocrine factor to regulate this process.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Expression analyses of <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> during mCP vascularization.</title><p>(<bold>A, A’</bold> and <bold>B–B&quot;</bold>) Lateral (<bold>A and A’</bold>) and dorsal (<bold>B–B&quot;</bold>) views of 48 hpf <italic>TgBAC(vegfab:EGFP);Tg(kdrl:ras-mCherry)</italic> embryos, showing <italic>TgBAC(vegfab:</italic>EGFP) expression in the dorsal midline junction (DMJ) and mCP regions. <italic>TgBAC(vegfab:</italic>EGFP) expression was not observed in the extending DLV (<bold>B–B&quot;</bold>). (<bold>C, C’</bold> and <bold>D–D&quot;</bold>) Lateral (<bold>C and C’</bold>) and dorsal (<bold>D–D&quot;</bold>) views of 48 hpf <italic>TgBAC(vegfc:EGFP);Tg(kdrl:ras-mCherry)</italic> embryos, showing <italic>TgBAC(vegfc:</italic>EGFP) expression in the endothelial cells that comprise the DLV (<bold>D–D&quot;</bold>). (<bold>E, E’</bold> and <bold>F–F&quot;</bold>) Lateral (<bold>E and E’</bold>) and dorsal (<bold>F–F&quot;</bold>) views of 48 hpf <italic>TgBAC(vegfd:EGFP);Tg(kdrl:ras-mCherry)</italic> embryos, showing <italic>TgBAC(vegfd:</italic>EGFP) expression in the meninges and DMJ. <italic>TgBAC(vegfd:</italic>EGFP) expression was not observed in the extending DLV (<bold>F–F&quot;</bold>). (<bold>G–G&quot;</bold>) Dorsal views of a 72 hpf <italic>TgBAC(vegfab:EGFP)</italic> larva immunostained for Claudin-5 (magenta). Magnified images of the mCP region are shown. Yellow arrows indicate EGFP<sup>+</sup> and Claudin-5<sup>+</sup> mCP epithelial cells. (<bold>H</bold>) Schematic of the <italic>ntla:EGFP</italic> construct used for injection experiments (<bold>I–L&quot;</bold>). (<bold>I–L&quot;</bold>) Dorsal views of 48 hpf <italic>TgBAC(vegfd:NTR)</italic> (<bold>I–J&quot;</bold>) and <italic>TgBAC(vegfab:NTR)</italic> (<bold>K–L&quot;</bold>) head of embryos that were injected with the <italic>ntla:EGFP</italic> construct at the one-cell stage. Magnified images of the boxed area in (<bold>I</bold>) and (<bold>K</bold>) are shown in (<bold>J–J&quot;</bold>) and (<bold>L–L&quot;</bold>), respectively. Most of the EGFP<sup>+</sup> cells (<bold>J and L</bold>) were co-localized with NTR-mCherry<sup>+</sup> meningeal cells (<bold>J’ and L’</bold>) in <italic>TgBAC(vegfd:NTR)</italic> (<bold>J–J&quot;</bold>) and <italic>TgBAC(vegfab:NTR)</italic> (<bold>L–L&quot;</bold>) embryos. Yellow arrows point to the co-localized cells (n = 3 embryos, 18 co-localized cells observed for <italic>TgBAC(vegfd:NTR)</italic>; n = 3 embryos, 19 co-localized cells observed for <italic>TgBAC(vegfab:NTR)</italic>). Scale bars: 50 μm in (<bold>A–F&quot;</bold>), (<bold>I</bold>), (<bold>J&quot;</bold>), (<bold>K</bold>); 25 μm in (<bold>G&quot;, L&quot;</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Validation and expression analyses of distinct <italic>vegf</italic> BAC transgenic lines.</title><p>(<bold>A–F’</bold>) Endogenous mRNA transcripts of <italic>vegfab</italic> (<bold>A and A’</bold>)<italic>, vegfc</italic> (<bold>C and C’</bold>), and <italic>vegfd</italic> (<bold>E and E’</bold>) at the indicated embryonic stages were detected by in situ hybridization. Lateral views of the EGFP expression patterns driven by the <italic>Tg(UAS:EGFP)</italic> embryo carrying the <italic>TgBAC(vegfab:gal4ff)</italic> (<bold>B and B’</bold>), <italic>TgBAC(vegfc:gal4ff)</italic> (<bold>D and D’</bold>), or <italic>TgBAC(vegfd:gal4ff)</italic> (<bold>F and F’</bold>) transgene. The EGFP expression patterns driven by each of the BAC transgenic lines closely matched those of the corresponding endogenous mRNA. (<bold>G–J</bold>) Dorsal views of 48 hpf <italic>Tg(kdrl:ras-mCherry)</italic> embryos with no additional gene (<bold>G</bold>) or carrying the <italic>TgBAC(vegfab:EGFP)</italic> (<bold>H</bold>), <italic>TgBAC(vegc:EGFP)</italic> (<bold>I</bold>), or <italic>TgBAC(vegd:EGFP)</italic> (<bold>J</bold>) transgene. No detectable auto-fluorescence was observed in the control embryo (<bold>G</bold>) under these microscopy settings. <italic>TgBAC(vegfab:</italic>EGFP), <italic>TgBAC(vegfc:</italic>EGFP), and <italic>TgBAC(vegfd:</italic>EGFP) expression was observed in dorsal meningeal surfaces and distinct cell types. (<bold>K and L</bold>) Lateral (<bold>K</bold>) and dorsal (<bold>L</bold>) views of 72 hpf <italic>TgBAC(vegfab:EGFP);Tg(kdrl:ras-mCherry)</italic> larvae, showing the <italic>TgBAC(vegfab:</italic>EGFP) expression in the DMJ and mCP. <italic>TgBAC(vegfab:</italic>EGFP) expression was not observed in the DLV. Scale bars: 200 μm in (<bold>F</bold>); 100 μm in (<bold>F’</bold>); 50 μm in (<bold>J</bold>), (<bold>K</bold>), (<bold>L</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title><italic>TgBAC(vegfd:</italic>EGFP) and <italic>TgBAC(vegfc:</italic>EGFP) expression patterns in WT and <italic>vegfab</italic> mutants which displayed the presence or absence of the DLV.</title><p>(<bold>A–C&quot;</bold>) Dorsal views of 54 hpf <italic>vegfab<sup>+/+</sup></italic> (<bold>A–A&quot;</bold>) and <italic>vegfab<sup>-/-</sup></italic> (<bold>B–C&quot;</bold>) heads of embryos that carried the <italic>TgBAC(vegd:EGFP)</italic> and <italic>Tg(kdrl:ras-mCherry)</italic> transgenes. <italic>vegfab<sup>-/-</sup></italic> embryos that exhibited the presence (<bold>B–B&quot;</bold>), or absence (<bold>C–C&quot;</bold>), of the DLV were examined. Overall <italic>TgBAC(vegd:</italic>EGFP) expression patterns and signal intensity did not apparently differ between <italic>vegfab<sup>+/+</sup></italic> (<bold>A’</bold>, n = 14) and <italic>vegfab<sup>-/-</sup></italic> embryos regardless of the presence (<bold>B’</bold>, n = 7), or absence (<bold>C’</bold>, n = 4), of the DLV. (<bold>D–F&quot;</bold>) Dorsal views of 48 hpf <italic>vegfab<sup>+/+</sup></italic> (<bold>D–D&quot;</bold>) and <italic>vegfab<sup>-/-</sup></italic> (<bold>E–F&quot;</bold>) heads of embryos that carried the <italic>TgBAC(vegc:EGFP)</italic> and <italic>Tg(kdrl:ras-mCherry)</italic> transgenes. <italic>vegfab<sup>-/-</sup></italic> embryos that exhibited the presence (<bold>E–E&quot;</bold>), or absence (<bold>F–F&quot;</bold>), of the DLV were examined. Overall <italic>TgBAC(vegc:</italic>EGFP) expression patterns and signal intensity did not apparently differ between <italic>vegfab<sup>+/+</sup></italic> (<bold>D’</bold>, n = 3) and <italic>vegfab<sup>-/-</sup></italic> embryos regardless of the presence (<bold>E’</bold>, n = 2), or absence (<bold>F’</bold>, n = 3), of the DLV. Scale bars: 50 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig6-figsupp2-v2.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Co-localization analyses in <italic>TgBAC(vegfab:NTR)</italic>, <italic>TgBAC(vegfc:NTR)</italic>, and <italic>TgBAC(vegfd:NTR)</italic> embryos that carried the <italic>Tg(sox10:EGFP)</italic> transgene.</title><p>(<bold>A–A&quot;</bold>) Confocal maximum projection images of the dorsal views of a 48 hpf <italic>Tg(ntla:gal4);Tg(UAS:Kaede);Tg(sox10:mRFP)</italic> embryo, showing intermingled distribution of Kaede<sup>+</sup> and mRFP<sup>+</sup> meningeal cells (n = 7 embryos; 180 <italic>Tg(ntla:gal4);Tg(UAS:</italic>Kaede)<sup>+</sup> cells examined; 1 cell co-localized with <italic>Tg(sox10:</italic>mRFP)<sup>+</sup> cell). Yellow arrows point to some of the Kaede<sup>+</sup> meningeal cells that were clearly not mRFP<sup>+</sup> even on the maximum projection images. (<bold>B–B&quot;</bold>) Confocal maximum projection images of the dorsal views of a 48 hpf <italic>Tg(sox10:EGFP);TgBAC(vegfab:NTR)</italic> embryo, showing non-overlapping distribution of EGFP<sup>+</sup> and NTR-mCherry<sup>+</sup> meningeal cells (n = 12 embryos; 80 <italic>TgBAC(vegfab:</italic>NTR)<sup>+</sup> cells examined; 2 cells co-localized with <italic>Tg(sox10:</italic>EGFP)<sup>+</sup> cells). Yellow arrows point to some of the NTR-mCherry<sup>+</sup> meningeal cells that were clearly not EGFP<sup>+</sup> even on the maximum projection images. (<bold>C–C&quot;</bold>) Confocal maximum projection images of the dorsal views of a 48 hpf <italic>Tg(sox10:EGFP);TgBAC(vegfc:NTR)</italic> embryo, showing non-overlapping distribution of EGFP<sup>+</sup> and NTR-mCherry<sup>+</sup> meningeal cells (n = 4 embryos; 66 <italic>TgBAC(vegfc:</italic>NTR)<sup>+</sup> cells examined; 0 cells co-localized with <italic>Tg(sox10:</italic>EGFP)<sup>+</sup> cells). Yellow arrows point to some of the NTR-mCherry<sup>+</sup> meningeal cells that were clearly not EGFP<sup>+</sup> even on the maximum projection images. (<bold>D–D&quot;</bold>) Confocal maximum projection images of the dorsal views of a 48 hpf <italic>Tg(sox10:EGFP);TgBAC(vegfd:NTR)</italic> embryo, showing non-overlapping distribution of EGFP<sup>+</sup> and NTR-mCherry<sup>+</sup> meningeal cells (n = 4 embryos; 66 <italic>TgBAC(vegfd:</italic>NTR)<sup>+</sup> cells examined; 2 cells co-localized with <italic>Tg(sox10:</italic>EGFP)<sup>+</sup> cells). Yellow arrows point to some of the NTR-mCherry<sup>+</sup> meningeal cells that were clearly not EGFP<sup>+</sup> even on the maximum projection images. Scale bar: 50 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig6-figsupp3-v2.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Co-localization analyses in <italic>TgBAC(vegfab:NTR)</italic>, <italic>TgBAC(vegfc:NTR)</italic>, and <italic>TgBAC(vegfd:NTR)</italic> embryos carrying the <italic>Tg(mpeg1.1:Dendra2)</italic> transgene.</title><p>(<bold>A–A&quot;</bold>) Confocal maximum projection images of the dorsal views of a 48 hpf <italic>Tg(mpeg1.1:Dendra2);TgBAC(vegfab:NTR)</italic> embryo, showing non-overlapping distribution of EGFP<sup>+</sup> and NTR-mCherry<sup>+</sup> meningeal cells (n = 16 embryos; 89 <italic>Tg(mpeg1.1:</italic>Dendra2)<sup>+</sup> cells examined; 0 cells co-localized with <italic>TgBAC(vegfab:</italic>NTR)<sup>+</sup> cells). (<bold>B–B&quot;</bold>) Confocal maximum projection images of the dorsal views of a 48 hpf <italic>Tg(mpeg1.1:Dendra2);TgBAC(vegfc:NTR)</italic> embryo, showing non-overlapping distribution of EGFP<sup>+</sup> and NTR-mCherry<sup>+</sup> meningeal cells (n = 17 embryos; 95 <italic>Tg(mpeg1.1:</italic>Dendra2)<sup>+</sup> cells examined; 0 cells co-localized with <italic>TgBAC(vegfc:</italic>NTR)<sup>+</sup> cells). (<bold>C–C&quot;</bold>) Confocal maximum projection images of the dorsal views of a 48 hpf <italic>Tg(mpeg1.1:Dendra2);TgBAC(vegfd:NTR)</italic> embryo, showing non-overlapping distribution of EGFP<sup>+</sup> and NTR-mCherry<sup>+</sup> meningeal cells (n = 8 embryos; 39 <italic>Tg(mpeg1.1:</italic>Dendra2)<sup>+</sup> cells examined; 0 cells co-localized with <italic>TgBAC(vegfd:</italic>NTR)<sup>+</sup> cells). Scale bar: 50 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig6-figsupp4-v2.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>Co-localization of the mesodermal cell marker and <italic>TgBAC(vegfc:NTR)<sup>+</sup></italic> meningeal cells, and close similarity in cell morphology between mesoderm-derived meningeal fibroblasts and <italic>vegf</italic>-expressing meningeal cells.</title><p>(<bold>A</bold>) Schematic of the <italic>ntla:EGFP</italic> construct used for injection experiments (<bold>B–E&quot;</bold>). (<bold>B–E&quot;</bold>) Dorsal views of 48 hpf <italic>Tg(ntla:NTR)</italic> (<bold>B–C&quot;</bold>) and <italic>TgBAC(vegfc:NTR)</italic> (<bold>D–E&quot;</bold>) heads of embryos that were injected with the <italic>ntla:EGFP</italic> construct at the one-cell stage. Magnified images of the boxed area in (<bold>B</bold>) and (<bold>D</bold>) are shown in (<bold>C–C&quot;</bold>) and (<bold>E–E&quot;</bold>), respectively. Most of the EGFP<sup>+</sup> cells (<bold>C and E</bold>) were co-localized with NTR-mCherry<sup>+</sup> meningeal cells (<bold>C’ and E’</bold>) in <italic>Tg(ntla:NTR)</italic> (<bold>C–C&quot;</bold>) and <italic>TgBAC(vegfc:NTR)</italic> (<bold>E–E&quot;</bold>) embryos. Yellow arrows point to the co-localized cells (n = 5 embryos, 71 co-localized cells observed for <italic>Tg(ntla:NTR)</italic>; n = 3 embryos, 10 co-localized cells observed for <italic>TgBAC(vegfc:NTR)</italic>). (<bold>F–H</bold>) Dorsal magnified views of 48 hpf <italic>Tg(ntla:Gal4-VP16);Tg(UAS:EGFP-CAAX)</italic>, abbreviated <italic>Tg(ntla:EGFP)</italic>, <italic>TgBAC(vegfd:EGFP)</italic>, and <italic>TgBAC(vegfab:EGFP)</italic> embryonic heads near the DMJ in the dorsal surfaces of the brain meninges. Close similarity in the morphology of the EGFP<sup>+</sup> meningeal cells marked by each of the lines was observed. Scale bars: 50 μm in (<bold>B–E&quot;</bold>); 25 μm in (<bold>H</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig6-figsupp5-v2.tif"/></fig></fig-group><p>Since our <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> expression analyses revealed their distinct and partially overlapping expression patterns, we investigated whether the deleterious mutations leading to a loss of Vegfab, Vegfc, or Vegfd functional proteins trigger transcriptional adaptation responses, a mechanism of genetic compensation that leads to the transcriptional modulation of related genes (<xref ref-type="bibr" rid="bib20">El-Brolosy et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Sztal and Stainier, 2020</xref>). For this purpose, we utilized the <italic>TgBAC(vegfc:EGFP)</italic> and <italic>TgBAC(vegfd:EGFP)</italic> lines to compare their expression patterns between <italic>vegfab<sup>+/+</sup></italic> and <italic>vegfab<sup>-/-</sup></italic> embryos generated from <italic>vegfab<sup>+/-</sup></italic> incrosses (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). We analyzed these embryos at 48 or 54 hpf – the developmental stages at which the DLV and PCeV are forming. We also compared the expression patterns of <italic>vegfab<sup>-/-</sup></italic> embryos that exhibited the presence, or absence, of the DLV. However, we did not find any obvious difference in <italic>TgBAC(vegfc:</italic>EGFP) and <italic>TgBAC(vegfd:</italic>EGFP) expression patterns between any of the <italic>vegfab</italic> genotypes and also between the <italic>vegfab<sup>-/-</sup></italic> embryos that displayed the presence, or absence, of the DLV (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). These observations indicate that although Vegfab, Vegfc, and Vegfd are functionally redundant in driving mCP vascularization, transcriptional adaptation may not be involved in this redundancy or mutations in only one of these <italic>vegf</italic> genes may not be sufficient to trigger transcriptional adaptation responses at the stages of mCP vessel development.</p></sec><sec id="s2-10"><title>DLV formation requires vEC-autonomous Vegfc signaling and paracrine Vegfab/Vegfd signaling</title><p>To determine the role of Vegfc as a paracrine and/or autocrine factor, we analyzed the separate <italic>vegfc</italic> mutation, <italic>vegfc<sup>um18</sup></italic>, which was previously isolated from a forward genetic screen (<xref ref-type="bibr" rid="bib67">Villefranc et al., 2013</xref>). This particular mutation was shown to generate a prematurely truncated Vegfc protein that lacks efficient secretory and paracrine activity but retains the ability to activate its Flt4 receptor (in another words, cell-autonomous activity of Vegfc is retained) (<xref ref-type="bibr" rid="bib67">Villefranc et al., 2013</xref>). Interestingly, we found that the homozygous embryos harboring this particular mutation did not exhibit a defect in DLV formation at 54 hpf (<xref ref-type="fig" rid="fig7">Figure 7A–D</xref>). This result is in contrast with that observed in the homozygous embryos of the same age that carry the <italic>vegfc<sup>hu6410</sup></italic> mutation which causes the early truncation of the Vegfc protein and leads to a deficiency in both paracrine and autocrine activities, resulting in the ‘No DLV’ phenotype (<xref ref-type="fig" rid="fig1">Figure 1N,P</xref>). These findings suggest that vEC-autonomous Vegfc function is important for DLV formation.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Endothelial-autonomous Vegfc and meningeal fibroblast-derived Vegfab and Vegfd are important for DLV formation.</title><p>(<bold>A–C</bold>) Dorsal views of 54 hpf <italic>vegfc<sup>+/+</sup></italic> (<bold>A</bold>), <italic>vegfc<sup>um18/+</sup></italic> (<bold>B</bold>), and <italic>vegfc<sup>um18/um18</sup></italic> (<bold>C</bold>) cranial vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression. <italic>vegfc<sup>um18/um18</sup></italic> fish did not exhibit a defect in DLV formation (<bold>C</bold>) in contrast to the ‘No DLV’ phenotype found in <italic>vegfc<sup>hu6410/hu6410</sup></italic> fish (<xref ref-type="fig" rid="fig1">Figure 1N</xref>). (<bold>D</bold>) Percentage of 54 hpf fish of indicated genotype with and without the DLV (n = 22 for <italic>vegfc<sup>+/+</sup></italic>, n = 52 for <italic>vegfc<sup>um18/+</sup></italic>, and n = 21 for <italic>vegfc<sup>um18/um18</sup></italic> fish). (<bold>E</bold>) Time course of the cell ablation experiments for panels (<bold>F–M</bold>). (<bold>F</bold>) Brightfield images of 72 hpf <italic>Tg(kdrl:EGFP)</italic>, <italic>Tg(sox10:NTR), TgBAC(vegfab:NTR)</italic>, and <italic>TgBAC(vegfd:NTR)</italic> larvae after treatment with DMSO or 10 mM Metronidazole (MTZ) from 34 to 72 hpf. (<bold>G–L</bold>) Dorsal views of 72 hpf <italic>Tg(kdrl:EGFP);TgBAC(vegfab:NTR)</italic> (<bold>G and H</bold>), <italic>Tg(kdrl:EGFP);TgBAC(vegfd:NTR)</italic> (<bold>I and J</bold>), and <italic>Tg(kdrl:EGFP);Tg(sox10:NTR)</italic> (<bold>K and L</bold>) cranial vasculature after treatment with DMSO (<bold>G, I, K</bold>) or MTZ (<bold>H, J, L</bold>) from 34 to 72 hpf. Efficient ablation of NTR-mCherry<sup>+</sup> cells was observed after treatment with MTZ (<bold>H, J, L</bold>) compared to their respective DMSO-treated controls (<bold>G, I, K</bold>). MTZ-treated <italic>TgBAC(vegfab:NTR)</italic> and <italic>TgBAC(vegfd:NTR)</italic>, but not <italic>Tg(sox10:NTR)</italic>, larvae lacked the DLV (arrows). (<bold>M</bold>) Percentage of the indicated 72 hpf transgenic fish with and without the DLV after treatment with DMSO or MTZ (the number of the animals examined per each treatment group is listed in the graph). MTZ-treated <italic>TgBAC(vegfab:NTR)</italic> and <italic>TgBAC(vegfd:NTR)</italic> larvae exhibited a drastic increase in the ‘No DLV’ phenotype when compared to their corresponding DMSO treatment groups and the MTZ-treated <italic>Tg(kdrl:EGFP)</italic> larval group. In contrast, MTZ-treated <italic>Tg(kdrl:EGFP)</italic> and <italic>Tg(sox10:NTR)</italic> animals showed no significant differences compared to their corresponding DMSO treatment groups. Scale bars: 1 mm in (<bold>F</bold>); 50 μm in (<bold>C</bold> and <bold>L</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig7-v2.tif"/></fig><p>Since we found that <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> are all expressed in meningeal fibroblast-like cells, we next sought to address the contribution of this cell type to mCP vascularization. Meningeal fibroblasts were previously shown to derive from both neural crest cells and the mesoderm (<xref ref-type="bibr" rid="bib57">Siegenthaler and Pleasure, 2011</xref>). To determine the identity of the meningeal fibroblast-like cells, we used the <italic>Tg(sox10:EGFP)</italic> line, which labels the cells derived from the neural crest. For this purpose, we crossed each of the BAC Tg lines with <italic>Tg(UAS:NTR-mCherry)</italic> fish, which carry a <italic>Nitroreductase-mCherry</italic> (<italic>NTR-mCherry)</italic> fusion gene downstream of UAS. These resulting double Tg fish are abbreviated <italic>TgBAC(vegfab:NTR)</italic>, <italic>TgBAC(vegfc:NTR)</italic>, and <italic>TgBAC(vegfd:NTR)</italic>. We found that a vast majority (over 96%) of the NTR-mCherry expression driven by each of the BAC lines did not co-localize with the <italic>Tg(sox10:</italic>EGFP) expression in the dorsal surfaces of the meninges, including at the DMJ at 48 hpf (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). However, we noted that the <italic>Tg(sox10:</italic>EGFP)<sup>+</sup> cells and NTR-mCherry<sup>+</sup> fibroblast-like cells marked by each of these BAC lines were present in the meninges in an intermingled manner as observed in mesoderm-specific <italic>Tg(ntla:Gal4);Tg(Kaede)</italic> embryos crossed with the <italic>Tg(sox10:mRFP)</italic> neural crest line (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3A–A’’</xref>), suggesting that the meningeal fibroblast-like cells are likely meningeal fibroblasts of mesodermal origin.</p><p>Immune cells, including macrophages and neutrophils, are also known to reside in brain meningeal compartments; however, we observed that meningeal <italic>Tg(mpeg1.1:</italic>Dendra2)<sup>+</sup> macrophages were not co-localized with the NTR-mCherry<sup>+</sup> cells marked by each of the BAC lines (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>) and that <italic>Tg(lyz:</italic>EGFP)<sup>+</sup> neutrophils do not reside in the dorsal surfaces of the brain meninges at 48 hpf, including in the regions near the DMJ and mCP (data not shown).</p><p>To investigate whether mesoderm-derived meningeal fibroblasts are a Vegfs-expressing cell type, we engineered a plasmid in which EGFP expression is driven under the control of the putative zebrafish <italic>ntla</italic> promoter, the 2.1 kb regulatory elements used previously to generate the <italic>Tg(ntla:Gal4)</italic> line (<xref ref-type="fig" rid="fig6">Figure 6H</xref>; <xref ref-type="bibr" rid="bib27">Harvey et al., 2010</xref>; <xref ref-type="bibr" rid="bib41">Lee et al., 2013</xref>). When we injected this plasmid at the one-cell stage, we observed sparsely labeled EGFP<sup>+</sup> cells in the dorsal brain meninges that were mostly co-localized (over 82%) with the NTR-mCherry<sup>+</sup> cells in <italic>Tg(ntla:Gal4);Tg(UAS:NTR-mCherry)</italic> embryos (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5B–C’’</xref>). Thus, this plasmid injection can reliably label mesoderm-derived cell lineages, including meningeal fibroblasts and vECs, in a mosaic fashion. Next, we injected the same plasmid into <italic>TgBAC(vegfab:NTR)</italic>, <italic>TgBAC(vegfc:NTR)</italic>, or <italic>TgBAC(vegfd:NTR)</italic> one-cell stage embryos. We observed that the NTR-mCherry<sup>+</sup> cells marked by each of the BAC lines were also co-localized with the EGFP<sup>+</sup> cells in the meninges, including in the region near the DMJ (<xref ref-type="fig" rid="fig6">Figure 6I–L”</xref> and <xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5D–E’’</xref>). Moreover, we observed close similarities in cell morphology between the meningeal cells marked by <italic>TgBAC(vegfd:EGFP)</italic>, <italic>TgBAC(vegfab:EGFP)</italic>, and the <italic>Tg(ntla:Gal4)</italic> embryos carrying the <italic>Tg(UAS:EGFP-CAAX)</italic> transgene (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5F–H</xref>). These results provide evidence that mesoderm-derived meningeal fibroblasts are a source of these Vegf ligands in the dorsal meningeal compartments of the brain.</p><p>To determine the function of the meningeal fibroblasts labeled by <italic>vegfab</italic> and <italic>vegfd</italic> BAC reporter expression, we eliminated these cell types using an established chemogenetic ablation approach in zebrafish that utilizes the bacterial enzyme Nitroreductase (NTR) to induce apoptotic cell death upon administration of its substrate prodrug metronidazole (MTZ) (<xref ref-type="bibr" rid="bib16">Curado et al., 2007</xref>). This approach allows target cell ablation in a spatiotemporally controlled manner. Since a vast majority of the meningeal fibroblast-like cells labeled by these BAC Tg lines were negative for <italic>Tg(sox10:</italic>EGFP) expression, we generated <italic>Tg(sox10:gal4VP-16);Tg(UAS:NTR-mCherry)</italic>, abbreviated <italic>Tg(sox10:NTR)</italic>, animals to ablate neural crest-derived meningeal fibroblasts for comparison. To minimize toxic effects of cell ablation during early embryogenesis, we began treating <italic>TgBAC(vegfab:NTR)</italic>, <italic>TgBAC(vegfd:NTR)</italic>, and <italic>Tg(sox10:NTR)</italic> embryos with 10 mM MTZ starting at 34 hpf and analyzed them at 72 hpf (<xref ref-type="fig" rid="fig7">Figure 7E, F</xref>). We also treated <italic>Tg(kdrl:EGFP)</italic> embryos with 10 mM MTZ or DMSO as controls to assess the effect of MTZ treatment itself on DLV formation. We validated that these NTR lines and the time course we employed induced the efficient ablation of target cells upon MTZ administration (<xref ref-type="fig" rid="fig7">Figure 7G–L</xref>). We observed that the MTZ-treated <italic>Tg(kdrl:EGFP)</italic> and <italic>Tg(sox10:NTR)</italic> larvae did not show any significant difference in the percentage of the ‘No DLV’ phenotype (9% and 15%, respectively) when compared to their respective DMSO-treated groups (3% and 3%, respectively) (<xref ref-type="fig" rid="fig7">Figure 7M</xref>). However, we found that the MTZ-treated <italic>TgBAC(vegfab:NTR)</italic> and <italic>TgBAC(vegfd:NTR)</italic> larvae exhibited a pronounced increase in this phenotype (90% and 78%, respectively) when compared to their corresponding DMSO-treated groups (27% and 0%, respectively) as well as the MTZ-treated <italic>Tg(kdrl:EGFP)</italic> group (9%) (<xref ref-type="fig" rid="fig7">Figure 7M</xref>). Given our observations that <italic>vegfab</italic> BAC reporter expression marked mesoderm-derived meningeal fibroblasts and mCP epithelial cells while <italic>vegfd</italic> BAC reporter expression marked only mesoderm-derived meningeal fibroblasts around the DMJ and mCP regions (<xref ref-type="fig" rid="fig6">Figure 6A, B”, E and F”</xref>), these findings suggest that mesoderm-derived meningeal fibroblasts are an important source of these Vegf ligands necessary for DLV formation. Notably, these results also suggest that neural crest-derived meningeal fibroblasts are not crucial for this process, indicating that meningeal fibroblasts of distinct origins differentially contribute to mCP vascularization.</p></sec><sec id="s2-11"><title>Expression patterns of <italic>vegfaa</italic> and its requirement for mCP vascular formation</title><p>Since Vegfaa plays a key role in angiogenesis during early embryogenesis in zebrafish (<xref ref-type="bibr" rid="bib54">Rossi et al., 2016</xref>), we next asked what role Vegfaa plays in mCP vascular development. <italic>vegfaa</italic> mutants are known to exhibit severe early vascular defects (<xref ref-type="bibr" rid="bib54">Rossi et al., 2016</xref>), which makes it difficult to precisely assess a role for Vegfaa in angiogenesis at later developmental stages. To overcome this technical limitation, we generated a new BAC transgenic reporter line, <italic>TgBAC(vegfaa:gal4ff)</italic>, which drives the expression of Gal4FF under the control of a <italic>vegfaa</italic> promoter in a BAC. By crossing this line with <italic>Tg(UAS:EGFP)</italic> fish, we were able to observe that the EGFP expression domains driven by this BAC transgenic line closely matched the endogenous mRNA expression patterns of <italic>vegfaa</italic> (<xref ref-type="fig" rid="fig8">Figure 8A–B’</xref>). Thus, this BAC transgenic tool reliably reflects the endogenous expression patterns of <italic>vegfaa</italic>.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Expression patterns of <italic>vegfaa</italic> and its requirement for mCP vascular formation.</title><p>(<bold>A–B’</bold>) Lateral views of endogenous <italic>vegfaa</italic> mRNA expression patterns detected by in situ hybridization at 24 hpf (<bold>A and A’</bold>). Lateral views of the EGFP expression patterns driven by the <italic>Tg(UAS:EGFP)</italic> embryo carrying the <italic>TgBAC(vegfaa:gal4ff)</italic> transgene (<bold>B and B’</bold>). The EGFP expression domains closely matched the endogenous <italic>vegfaa</italic> mRNA expression patterns. (<bold>C, C’</bold> and <bold>D–D&quot;</bold>) Lateral (<bold>C and C’</bold>) and dorsal (<bold>D–D&quot;</bold>) views of 48 hpf <italic>TgBAC(vegfaa:EGFP);Tg(kdrl:ras-mCherry)</italic> embryos, showing the <italic>TgBAC(vegfaa:</italic>EGFP) expression in the cells located ventrally to the DLV. <italic>TgBAC(vegfaa:</italic>EGFP) expression was not observed in the extending DLV or in the dorsal surfaces of the brain meninges. (<bold>E</bold>) Time course of the cell ablation experiments for panels (<bold>F–J</bold>). (<bold>F and G</bold>) Brightfield images of 72 hpf <italic>TgBAC(vegfaa:NTR)</italic> larvae after treatment with DMSO (<bold>F</bold>) or 10 mM MTZ (<bold>G</bold>) from 34 to 72 hpf. (<bold>H and I</bold>) Dorsal views of 72 hpf <italic>TgBAC(vegfaa:NTR)</italic> cranial vasculature visualized by <italic>Tg(kdrl:</italic>EGFP) expression after treatment with DMSO (<bold>H</bold>) or MTZ (<bold>I</bold>) from 34 to 72 hpf. Efficient ablation of NTR-mCherry<sup>+</sup> cells was observed after treatment with MTZ (<bold>I</bold>) compared to the DMSO-treated control (<bold>H</bold>). MTZ-treated <italic>TgBAC(vegfaa:NTR)</italic> larvae formed the DLV (yellow arrows) and PCeV. (<bold>J</bold>) Percentage of the 72 hpf transgenic fish with and without the DLV after treatment with DMSO or MTZ. No significant difference was observed between MTZ-treated (n = 60) and DMSO-treated (n = 30) groups. Scale bars: 1 mm in (<bold>G</bold>); 200 μm in (<bold>B</bold>); 100 μm in (<bold>B’</bold>); 50 μm in (<bold>C</bold>), (<bold>C’</bold>), (<bold>D’</bold> and <bold>I</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64295-fig8-v2.tif"/></fig><p>We next generated <italic>TgBAC(vegfaa:gal4ff);Tg(UAS:EGFP-CAAX)</italic> fish, abbreviated <italic>TgBAC(vegfaa:EGFP)</italic>, to examine <italic>vegfaa</italic> expression patterns at the single-cell resolution as we identified the cell types that express <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> using their BAC lines. Intriguingly, in contrast to the <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> BAC reporter expression, we did not observe EGFP<sup>+</sup> meningeal fibroblast-like cells near the DMJ at 48 hpf in <italic>TgBAC(vegfaa:EGFP)</italic> embryos (<xref ref-type="fig" rid="fig8">Figure 8C–D”</xref>). <italic>TgBAC(vegfaa:</italic>EGFP)<sup>+</sup> cells were present in the brain parenchyma ventral to the DMJ, but not in the dorsal meningeal compartments of the brain (<xref ref-type="fig" rid="fig8">Figure 8C–D”</xref>).</p><p>Next, we generated <italic>TgBAC(vegfaa:gal4ff);Tg(UAS:NTR-mCherry)</italic> fish, abbreviated <italic>TgBAC(vegfaa:NTR)</italic>, to ablate Vegfaa-expressing cells in a temporally controlled manner, which allowed us to analyze potential Vegfaa function by minimizing early vascular defects caused by lack of Vegfaa function. To this end, we treated <italic>TgBAC(vegfaa:NTR)</italic> with 10 mM MTZ or DMSO from 34 to 72 hpf (<xref ref-type="fig" rid="fig8">Figure 8E</xref>) – exactly the same experimental time course we used to conduct the cell ablation shown in <xref ref-type="fig" rid="fig7">Figure 7E–M</xref>. Under this cell ablation condition, MTZ-treated <italic>TgBAC(vegfaa:NTR)</italic> fish developed a slight edema (<xref ref-type="fig" rid="fig8">Figure 8F,G</xref>); however, a vast majority of them (95%) formed the DLV and PCeV (<xref ref-type="fig" rid="fig8">Figure 8I,J</xref>) similarly to the DMSO-treated control siblings (93%) (<xref ref-type="fig" rid="fig8">Figure 8H,J</xref>). These expression and cell ablation results suggest that Vegfaa and Vegfaa-expressing cells are not involved in DLV and PCeV formation, supporting a model in which Vegfab/Vegfc/Vegfd redundant actions are central to this process.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here, we provide the first evidence for molecular cues and cell types responsible for driving the development of fenestrated CP vasculature in vertebrates. The present study also provides the first ultrastructural information about a zebrafish larval CP and its epithelial cells, which illustrates the conservation of the CPs across vertebrate species at the ultrastructural level. By conducting thorough phenotypic characterization of single, double, and triple loss-of-function zebrafish <italic>vegf</italic> mutants, we demonstrate that the functional redundancy among Vegfab, Vegfc, and Vegfd is key to driving fenestrated mCP vessel development since the individual mutants exhibited only mild or no defects in mCP vascular development. Additionally, we provide evidence that <italic>ccbe1</italic> and <italic>vegfab</italic> genetically interacts in mCP vascularization, identifying a novel role for Ccbe1 in cerebrovascular development, specifically in fenestrated CP vessel formation. Moreover, we identify cell types (vECs, mesoderm-derived meningeal fibroblasts, and mCP epithelial cells) that express <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> during mCP vascularization. These expression data combined with paracrine activity-deficient <italic>vegfc<sup>um18</sup></italic> mutant analysis and cell-type-specific chemogenetic cell ablation support a model in which endothelial-autonomous Vegfc and paracrine actions of Vegfab/Vegfd from mesoderm-derived meningeal fibroblasts are critical for DLV formation. Altogether, these findings define a developmental mechanism critical for the generation of brain vascular heterogeneity, specifically fenestrated blood vessels.</p><sec id="s3-1"><title>Combinations of angiogenic cues diversify region-specific, specialized vascular beds in the brain</title><p>Previous studies have shown that Wnt ligands (Wnt7a, Wnt7b, Norrin) and their receptors act in a partially redundant manner to direct the patterning and maintenance of BBB vascular beds in distinct regions of the CNS (<xref ref-type="bibr" rid="bib14">Cho et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Zhou and Nathans, 2014</xref>; <xref ref-type="bibr" rid="bib73">Zhou et al., 2014</xref>). Combined losses of the Norrin and Wnt7a/Wnt7b signaling components were shown to result in far more severe defects in BBB-forming vessel patterning and maintenance in specific areas of the brain than the defects caused by the individual loss of these components (<xref ref-type="bibr" rid="bib68">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Zhou and Nathans, 2014</xref>). These results suggest a model in which combinations of canonical Wnt ligands and receptors direct BBB-forming vascular bed development in a CNS region-specific manner. This model is further supported by the recent reports showing that β-catenin activation downstream of the canonical Wnt signaling is maintained at strikingly lower levels in the fenestrated vascular beds of the CPs and circumventricular organs than in BBB-forming vascular beds (<xref ref-type="bibr" rid="bib6">Benz et al., 2019</xref>; <xref ref-type="bibr" rid="bib69">Wang et al., 2019</xref>). However, these prior studies have raised an important question as to what molecular cues direct the development of the fenestrated vascular beds in the CPs and circumventricular organs.</p><p>Our findings here identify a mechanism whereby redundant Vegf ligands selectively drive fenestrated CP vascular formation in the zebrafish brain, filling this gap in our scientific knowledge and raising new questions: (1) Do these Vegfs control vessel fenestration similarly to the canonical Wnt/β-catenin signaling that regulates both vessel formation and specializations in BBB-forming vascular beds?; (2) Does fenestrated vascular bed formation in the dCP or circumventricular organs require the same or different combinations of Vegf ligands compared to those critical for fenestrated mCP vessel development?; (3) How are these multiple Vegf ligand-induced signals transmitted by their receptors and downstream signaling pathways?; (4) How do these Vegfs achieve fenestrated mCP vessel-selective patterning with little effect on neighboring non-fenestrated vasculature?; and (5) What are upstream developmental events that determine the spatiotemporally restricted Vegf expression patterns? Addressing these questions will help to further understand similarities and differences in vEC’s molecular requirements for angiogenesis leading to fenestrated and non-fenestrated brain vascular beds.</p></sec><sec id="s3-2"><title>Cellular mechanisms underlying mCP vessel-selective patterning by redundant Vegf ligands</title><p>How do multiple Vegfs functionally interact in directing mCP vascularization? Our expression analyses showed that mesoderm-derived meningeal fibroblasts are a common cell type that expresses <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> during mCP vascularization. In particular, <italic>vegfd</italic> expression is predominantly restricted to this cell type during this process, and ablation of Vegfd-expressing cells led to severely compromised DLV formation. Intriguingly, ablation of neural crest-derived meningeal fibroblasts did not result in impaired DLV formation. This result is consistent with our observations of these <italic>vegfs</italic>’ expression restricted to mesoderm-derived, but not neural crest-derived, meningeal fibroblasts. We further found that <italic>vegfaa</italic> is not expressed in meningeal fibroblasts and that ablation of Vegfaa-expressing cells did not abrogate DLV formation. Collectively, these observations suggest that meningeal fibroblasts, specifically those derived from the mesoderm, are a key cell type which drives DLV formation and that the multiple Vegfs’ functional redundancy likely occurs at the cell-type level.</p><p>Transcriptional adaptation is a recently described phenomenon involved in genetic compensation by which a mutation in one gene leads to the transcriptional modulation of related genes (<xref ref-type="bibr" rid="bib20">El-Brolosy et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Sztal and Stainier, 2020</xref>). To ask whether transcriptional adaptation explains the Vegfs’ functional redundancy in this context, we examined <italic>vegfc</italic> and <italic>vegfd</italic> expression in <italic>vegfab</italic> mutants using their respective BAC transgenic lines. However, we did not find evidence of obvious changes in their expression patterns/levels in the dorsal surfaces of the brain meninges or in the regions near the DMJ and mCP, regardless of whether the <italic>vegfab</italic> mutants formed or failed to form the DLV. This result implies that functional redundancy among these Vegfs may not involve local transcriptional adaptation responses in these areas of the brain at the stage of DLV extension toward the mCP (48–54 hpf), although further investigations will be needed.</p><p>Ccbe1 is a highly conserved, secreted protein essential for proteolytic activation of Vegfc and lymphangiogenesis (<xref ref-type="bibr" rid="bib8">Bos et al., 2011</xref>; <xref ref-type="bibr" rid="bib32">Hogan et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Le Guen et al., 2014</xref>). Intriguingly, combined genetic inactivation of <italic>vegfab</italic> and <italic>vegfc</italic> or <italic>vegfab</italic> and <italic>ccbe1</italic> displayed similarly increased penetrance and expressivity of DLV and PCeV defects, indicating that Ccbe1 is involved in mCP vascular development possibly through proteolytic activation of Vegfc. It will be important to further define Ccbe1-expressing cell type(s) and Ccbe1-mediated angiogenic regulation during mCP vascularization. Addressing these issues may explain how local, proteolytic activation of Vegf ligands mediated by molecules such as Ccbe1 contributes to the Vegfs-directed mCP vessel-selective patterning.</p></sec><sec id="s3-3"><title>Molecular mechanisms governing mCP vessel formation and fenestration</title><p>Do mCP vessel formation and fenestration rely on the same molecular cues? The mCP vasculature develops via the convergence of the DLV and PCeV. These converged vessels all exhibit the shared molecular signatures of the fenestrated state and become a functionally integrated vascular network. Almost all the <italic>vegfab;vegfc;vegfd</italic> triple mutants we examined lacked this entire network of the fenestrated vasculature. Although there is a possibility that the primary deficits in these mutants are the DLV/PCeV formation defects and that the lack of mCP vascularization is secondary to them, it is evident that mCP vessel formation requires the Vegfs-dependent angiogenesis.</p><p>In contrast, our expression analyses of several BBB and fenestration molecular markers in the <italic>vegf</italic> single or double mutants did not reveal obvious changes in Claudin-5 protein expression or <italic>Tg</italic>(<italic>plvap:</italic>EGFP)<italic>;Tg</italic>(<italic>glut1b:</italic>mCherry) reporter expression in these vessels. Given the fact that these analyses were feasible only for the mutants that formed the DLV and PCeV, it is possible that compensatory mechanisms which allow the development of these vessels in the <italic>vegf</italic> mutants also restore fenestration marker expression in these vessels. Alternatively, these results may indicate that the formation and fenestration of the mCP vasculature are governed by separate mechanisms. In light of the recent reports in the field (<xref ref-type="bibr" rid="bib1">Anbalagan et al., 2018</xref>; <xref ref-type="bibr" rid="bib69">Wang et al., 2019</xref>), we speculate that vessel fenestration in the CP may require combined actions of (1) endogenous inhibitor(s) of canonical Wnt/β-catenin signaling; (2) vascular permeability/inflammatory protein(s); and/or (3) signaling molecules inhibiting endothelial tight junction formation. These combined actions may allow vECs in the CP to (1) maintain low levels of Wnt/β-catenin signaling, (2) exhibit increased vascular permeability, and (3) form loose endothelial connections. Further investigations into these or alternative possibilities will address how mCP vessel fenestration is developed and maintained at the molecular levels.</p><p>In summary, defining the unique sets of angiogenic factors and their receptors required for the development and maintenance of each vascular bed within the CNS is fundamental in order to understand the pathophysiology, malformations, and diseases of the CNS vasculature. Given the broad range of pathophysiological processes regulated by Vegf signaling, our findings may provide insights into the underlying mechanisms involved in pathophysiological angiogenesis, vEC heterogeneity in other organs and tumors, as well as the clinical applications of angiogenic and anti-angiogenic therapy. Therefore, our elucidation of cellular and molecular events critical for fenestrated CP vascular development has general implications for understanding the establishment of organ-specific vascular beds and endothelial heterogeneity, in particular how fenestrated endothelial fate and its vessel formation are directed during development.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(kdrl:EGFP)<sup>s843</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib35">Jin et al., 2005</xref></td><td valign="top">ZFIN: s843</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(kdrl:Has.HRAS-mcherry)<sup>s896</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib13">Chi et al., 2008</xref></td><td valign="top">ZFIN: s896</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(UAS:EGFP)<sup>nkuasgfp1a</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib3">Asakawa et al., 2008</xref></td><td valign="top">ZFIN: nkuasgfp1a</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(UAS:EGFP-CAAX)<sup>m1230</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib21">Fernandes et al., 2012</xref></td><td valign="top">ZFIN: m1230</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(UAS-E1b:NfsB-mCherry)<sup>c264</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib19">Davison et al., 2007</xref></td><td valign="top">ZFIN: c264</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(UAS:Kaede)<sup>rk8</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib29">Hatta et al., 2006</xref></td><td valign="top">ZFIN: rk8</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(hsp70l:sflt1, cryaa-cerulean)<sup>bns80</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib47">Matsuoka et al., 2016</xref></td><td valign="top">ZFIN: bns80</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(hsp70l:sflt4, cryaa-cerulean)<sup>bns82</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib47">Matsuoka et al., 2016</xref></td><td valign="top">ZFIN: bns82</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(−4.9sox10:EGFP)<sup>ba2</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib11">Carney et al., 2006</xref></td><td valign="top">ZFIN: ba2</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(sox10:mRFP)<sup>vu234</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib38">Kucenas et al., 2008</xref></td><td valign="top">ZFIN: vu234</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(sox10:Gal4-VP16)<sup>sq9</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib41">Lee et al., 2013</xref></td><td valign="top">ZFIN: sq9</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(ntla:Gal4-VP16)<sup>sq12</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib41">Lee et al., 2013</xref></td><td valign="top">ZFIN: sq12</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>TgBAC(vegfab:gal4ff)<sup>bns273</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib49">Mullapudi et al., 2019</xref></td><td valign="top">ZFIN: bns273</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(glut1b:mCherry)<sup>sj1</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib62">Umans et al., 2017</xref></td><td valign="top">ZFIN: sj1</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(plvapb:EGFP)<sup>sj3</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib62">Umans et al., 2017</xref></td><td valign="top">ZFIN: sj3</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Et(cp:EGFP)<sup>sj2</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib31">Henson et al., 2014</xref></td><td valign="top">ZFIN: sj2</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(mpeg1.1:Dendra2)<sup>uwm12</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib28">Harvie et al., 2013</xref></td><td valign="top">ZFIN: uwm12</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(lyz:EGFP)<sup>nz117</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib26">Hall et al., 2007</xref></td><td valign="top">ZFIN: nz117</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(lyve1:DsRed)<sup>nz101</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib52">Okuda et al., 2012</xref></td><td valign="top">ZFIN: nz101</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>vegfaa<sup>bns1</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib54">Rossi et al., 2016</xref></td><td valign="top">ZFIN: bns1</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>vegfab<sup>bns92</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib54">Rossi et al., 2016</xref></td><td valign="top">ZFIN: bns92</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>vegfc<sup>hu6410</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib30">Helker et al., 2013</xref></td><td valign="top">ZFIN: hu6410</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>vegfc<sup>um18</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib67">Villefranc et al., 2013</xref></td><td valign="top">ZFIN: um18</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>vegfd<sup>bns257</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib22">Gancz et al., 2019</xref></td><td valign="top">ZFIN: bns257</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>TgBAC(vegfc:gal4ff)<sup>bns270</sup></italic></td><td valign="top">This paper</td><td valign="top">ZFIN: bns270</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>TgBAC(vegfd:gal4ff)<sup>lri95</sup></italic></td><td valign="top">This paper</td><td valign="top">ZFIN: lri95</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>TgBAC(vegfaa:gal4ff)<sup>lri96</sup></italic></td><td valign="top">This paper</td><td valign="top">ZFIN: lri96</td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">anti-GFP (chicken polyclonal)</td><td valign="top">Aves Labs</td><td valign="top">Cat#: GFP-1010</td><td valign="top">1:1000</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-DsRed (rabbit polyclonal)</td><td valign="top">Clontech Labs</td><td valign="top">Cat#: 632496</td><td valign="top">1:300</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-Claudin 5 (mouse monoclonal)</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat#: 35–2500</td><td valign="top">1:500</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>ccbe1</italic> crRNA1</td><td valign="top">This paper</td><td valign="top">CRISPR RNA</td><td valign="top"><named-content content-type="sequence">TTCTCCTCTCGGAAAGTCCA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>ccbe1</italic> crRNA2</td><td valign="top">This paper</td><td valign="top">CRISPR RNA</td><td valign="top"><named-content content-type="sequence">TACCCGTGCGTAAAGTCCAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>ccbe1</italic> crRNA3</td><td valign="top">This paper</td><td valign="top">CRISPR RNA</td><td valign="top"><named-content content-type="sequence">CTTCTGGAATACACTGACCC</named-content></td></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">Alt-R S.p. Cas9 Nuclease V3</td><td valign="top">Integrated DNA Technologies</td><td valign="top">Cat#: 1081058</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">DIG RNA Labeling Kit (SP6/T7)</td><td valign="top">Millipore Sigma</td><td valign="top">Cat#: 11175025910</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">mMessage mMachine T3 Transcription Kit</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat#: AM1348</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">RNA Clean and Concentrator-5 Kit</td><td valign="top">Zymo Research</td><td valign="top">Cat#: R1013</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Qdot 655 Streptavidin Conjugate</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat#: Q10123MP</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Metronidazole</td><td valign="top">Millipore Sigma</td><td valign="top">Cat#: M3761</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">LAS X Version 3.7.0.20979</td><td valign="top">Leica</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">NIS-Elements BR Imaging Software Version 5.10.01</td><td valign="top">Nikon</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">GraphPad Prism 8</td><td valign="top">GraphPad Software</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Adobe Photoshop CS6</td><td valign="top">Adobe</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Adobe Illustrator CS6</td><td valign="top">Adobe</td><td valign="top"/><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish husbandry and strains</title><p>All zebrafish husbandry was performed under standard conditions in accordance with institutional and national ethical and animal welfare guidelines. All zebrafish work was approved by the Cleveland Clinic’s Institutional Animal Care and Use Committee under the protocol number 2018–1970. The following lines were used in this study: <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> (<xref ref-type="bibr" rid="bib35">Jin et al., 2005</xref>); <italic>Tg(kdrl:Has.HRAS-mcherry)<sup>s896</sup></italic> (<xref ref-type="bibr" rid="bib13">Chi et al., 2008</xref>), abbreviated <italic>Tg(kdrl:ras-mCherry); Tg(UAS:EGFP)<sup>nkuasgfp1a</sup></italic> (<xref ref-type="bibr" rid="bib3">Asakawa et al., 2008</xref>); <italic>Tg(UAS:EGFP-CAAX)<sup>m1230</sup></italic> (<xref ref-type="bibr" rid="bib21">Fernandes et al., 2012</xref>); <italic>Tg(UAS-E1b:NfsB-mCherry)<sup>c264</sup></italic> (<xref ref-type="bibr" rid="bib19">Davison et al., 2007</xref>), abbreviated <italic>Tg(UAS:NTR-mCherry); Tg(UAS:Kaede)<sup>rk8</sup></italic> (<xref ref-type="bibr" rid="bib29">Hatta et al., 2006</xref>); <italic>Tg(hsp70l:sflt1, cryaa-cerulean)<sup>bns80</sup></italic> (<xref ref-type="bibr" rid="bib47">Matsuoka et al., 2016</xref>), abbreviated <italic>Tg(hsp70l:sflt1); Tg(hsp70l:sflt4, cryaa-cerulean)<sup>bns82</sup></italic> (<xref ref-type="bibr" rid="bib47">Matsuoka et al., 2016</xref>), abbreviated <italic>Tg(hsp70l:sflt4); Tg(−4.9sox10:EGFP)<sup>ba2</sup></italic> (<xref ref-type="bibr" rid="bib11">Carney et al., 2006</xref>), abbreviated <italic>Tg(sox10:EGFP); Tg(sox10:mRFP)<sup>vu234</sup></italic> (<xref ref-type="bibr" rid="bib38">Kucenas et al., 2008</xref>); <italic>Tg(sox10:Gal4-VP16)<sup>sq9</sup></italic> (<xref ref-type="bibr" rid="bib41">Lee et al., 2013</xref>); <italic>Tg(ntla:Gal4-VP16)<sup>sq12</sup></italic> (<xref ref-type="bibr" rid="bib41">Lee et al., 2013</xref>); <italic>TgBAC(vegfab:gal4ff)<sup>bns273</sup></italic> (<xref ref-type="bibr" rid="bib49">Mullapudi et al., 2019</xref>); <italic>Tg(glut1b:mCherry)<sup>sj1</sup></italic> (<xref ref-type="bibr" rid="bib62">Umans et al., 2017</xref>); <italic>Tg(plvapb:EGFP)<sup>sj3</sup></italic> (<xref ref-type="bibr" rid="bib62">Umans et al., 2017</xref>), abbreviated <italic>Tg(plvap:EGFP); Et(cp:EGFP)<sup>sj2</sup></italic> (<xref ref-type="bibr" rid="bib31">Henson et al., 2014</xref>); <italic>Tg(mpeg1.1:Dendra2)<sup>uwm12</sup></italic> (<xref ref-type="bibr" rid="bib28">Harvie et al., 2013</xref>); <italic>Tg(lyz:</italic>EGFP<italic>)<sup>nz117</sup></italic> (<xref ref-type="bibr" rid="bib26">Hall et al., 2007</xref>); <italic>Tg(lyve1:DsRed)<sup>nz101</sup></italic> (<xref ref-type="bibr" rid="bib52">Okuda et al., 2012</xref>); <italic>vegfaa<sup>bns1</sup></italic> (<xref ref-type="bibr" rid="bib54">Rossi et al., 2016</xref>); <italic>vegfab<sup>bns92</sup></italic> (<xref ref-type="bibr" rid="bib54">Rossi et al., 2016</xref>); <italic>vegfc<sup>hu6410</sup></italic> (<xref ref-type="bibr" rid="bib30">Helker et al., 2013</xref>); <italic>vegfc<sup>um18</sup></italic> (<xref ref-type="bibr" rid="bib67">Villefranc et al., 2013</xref>); and <italic>vegfd<sup>bns257</sup></italic> (<xref ref-type="bibr" rid="bib22">Gancz et al., 2019</xref>). Adult fish were maintained on a standard 14 hr light/10 hr dark daily cycle. Fish embryos/larvae were raised at 28.5°C. To prevent skin pigmentation, 0.003% phenylthiourea (PTU) was used beginning at 10–12 hpf for imaging. Fish larvae analyzed at 10 dpf were transferred to a tank containing approximately 250 mL water supplemented with 0.003% PTU (up to 25 larvae/tank) and fed with Larval AP100 (&lt;50 microns dry diet, Zeigler) starting at 5 dpf.</p></sec><sec id="s4-2"><title>Generation of new transgenic lines</title><p>The <italic>TgBAC(vegfc:gal4ff)<sup>bns270</sup></italic>, <italic>TgBAC(vegfd:gal4ff)<sup>lri95</sup></italic>, and <italic>TgBAC(vegfaa:gal4ff)<sup>lri96</sup></italic> fish lines were generated by following the standard BAC recombineering protocol described previously (<xref ref-type="bibr" rid="bib10">Bussmann and Schulte-Merker, 2011</xref>). Briefly, BAC clones CH211-83E15, CH211-79O8, and CH211-37K5 (BACPAC Resource Center) were engineered to replace the <italic>vegfc</italic>, <italic>vegfd</italic>, and <italic>vegfaa</italic> start codon with <italic>gal4ff</italic>, respectively. The engineered constructs were injected into one-cell stage eggs together with transposase mRNA transcribed in vitro.</p></sec><sec id="s4-3"><title>Genotyping of mutants</title><p>Genotyping of <italic>vegfd<sup>bns257</sup></italic> mutant fish was performed as previously described (<xref ref-type="bibr" rid="bib22">Gancz et al., 2019</xref>). Genotyping of <italic>vegfaa<sup>bns1</sup></italic> and <italic>vegfab<sup>bns92</sup></italic> mutant fish was performed by high-resolution melt analysis of PCR products using the following primers:</p><list list-type="simple"><list-item><p>vegfaa bns1 forward: 5’- <named-content content-type="sequence">CGAGAGCTGCTGGTAGACATC</named-content> −3’</p></list-item> <list-item><p>vegfaa bns1 reverse: 5’- <named-content content-type="sequence">GGATGTACGTGTGCTCGATCT</named-content> −3’</p></list-item> <list-item><p>vegfab bns92 forward: 5’- <named-content content-type="sequence">GTGCTGGGTGCTGCAATG</named-content> −3’</p></list-item> <list-item><p>vegfab bns92 reverse: 5’- <named-content content-type="sequence">CCAAGGTAATGTTGTATGTGACG</named-content> −3’</p></list-item></list><p>Genotyping of <italic>vegfc<sup>hu6410</sup></italic> and <italic>vegfc<sup>um18</sup></italic> mutant fish was performed by standard PCR using the following primers:</p><list list-type="simple"><list-item><p>vegfc hu6410 WT allele forward: 5’- <named-content content-type="sequence">CTTTCATCAATCTTGAACTTTT</named-content> −3’</p></list-item> <list-item><p>vegfc hu6410 WT allele reverse: 5’- <named-content content-type="sequence">AAACTCTTTCCCCACATCTA</named-content> −3’</p></list-item> <list-item><p>vegfc hu6410 mutant allele forward: 5’- <named-content content-type="sequence">GATGAACTCATGAGGATAGTTT</named-content> −3’</p></list-item> <list-item><p>vegfc hu6410 mutant allele reverse: 5’- <named-content content-type="sequence">TAAATTAATAGTCACTCACTTTACT</named-content> −3’</p></list-item> <list-item><p>vegfc um18 WT allele-specific forward: 5’- <named-content content-type="sequence">CTTCCTGCAGCTGTTTGTCAATAC</named-content> −3’</p></list-item> <list-item><p>vegfc um18 mutant allele-specific forward: 5’- <named-content content-type="sequence">CTTCCTGCAGCTGTTTGTCAATAT</named-content> −3’</p></list-item> <list-item><p>vegfc um18 common reverse: 5’- <named-content content-type="sequence">GCAACAATAAGGTGTTCCATTCGTG</named-content> −3’.</p> </list-item></list></sec><sec id="s4-4"><title>High-resolution melt analysis</title><p>A CFX96 Touch Real-Time PCR Detection System (Bio-Rad) was used for the PCR reactions and high-resolution melt analysis. Precision Melt Supermix for high-resolution melt analysis (Bio-Rad) was used in these experiments. PCR reaction protocols were: 95°C for 2 min, 46 cycles of 95°C for 10 s, and 60°C for 30 s. Following the PCR, a high-resolution melt curve was generated by collecting EvaGreen fluorescence data in the 65–95°C range. The analyses were performed on normalized derivative plots.</p></sec><sec id="s4-5"><title>Metronidazole (MTZ) treatment</title><p>For the cell ablation experiments in this study, MTZ substrate (Sigma, M3761) was used at 10 mM concentration dissolved in egg water containing 1% DMSO. Prior to treatment with 10 mM MTZ or 1% DMSO, embryos were manually dechorionated with forceps and incubated with freshly prepared 10 mM MTZ or 1% DMSO in egg water. Embryos were treated with 10 mM MTZ or 1% DMSO for indicated periods of time until imaging analyses without replacing solutions.</p></sec><sec id="s4-6"><title>Heat-shock treatments</title><p>Fish embryos/larvae raised at 28.5°C were subjected to a heat shock at 37°C for 1 hr by replacing egg water with pre-warmed (37°C) egg water. After each heat shock, the fish embryos/larvae were kept at room temperature for 10 min to cool down and then incubated at 28.5°C. Heat-shock experiments were performed as follows: <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic>, Tg<italic>(kdrl:EGFP)<sup>s843</sup>;Tg(hsp70l:sflt1, cryaa-cerulean)<sup>bns80</sup></italic>, and <italic>Tg(kdrl:EGFP)<sup>s843</sup>;Tg(hsp70l:sflt4, cryaa-cerulean)<sup>bns82</sup></italic> animals were subject to multiple heat shocks every 8 hr from 41 to 72 hpf.</p></sec><sec id="s4-7"><title>Immunohistochemistry</title><p>Immunohistochemistry was performed by following standard immunostaining procedures. Fish embryos/larvae were fixed in pH adjusted (pH 7.0) 4% paraformaldehyde (PFA)/phosphate buffered saline (PBS) overnight at 4°C and dehydrated through immersion in methanol serial dilutions (50%, 75%, then 100% methanol three times, 10 min each) at room temperature (RT). The dehydrated samples were stored in 100% methanol at −20°C at least for 2 hr before use. The samples were rehydrated through immersion in methanol serial dilutions (75%, 50% then 25% methanol, 10 min each) at RT and washed in 1% PBST (1% Triton X-100 in 0.1M PBS) followed by permeabilization in 10 µg/ml Proteinase K in 1% PBST at RT for 15 min. Samples were blocked at RT for 2–4 hr in the blocking solution containing 0.5% bovine serum albumin in 1% PBST and incubated with primary antibodies diluted in the blocking solution at 4°C overnight. The following primary antibodies were used: chicken anti-GFP (Aves Labs at 1:1000), rabbit anti-DsRed (Clontech Labs at 1:300), and mouse anti-Claudin 5 (4C3C2, Thermo Fisher Scientific at 1:500). The next day, the samples were washed six times in 1% PBST at RT for 10 min each and incubated with Alexa Fluor dyes conjugated secondary antibodies (Invitrogen at 1:500) diluted in the blocking solution at 4°C overnight. The samples were washed six times in 1% PBST at RT for 10 min each and then imaged.</p></sec><sec id="s4-8"><title>In situ hybridization</title><p>Whole-mount in situ hybridization was performed as previously described (<xref ref-type="bibr" rid="bib60">Thisse and Thisse, 2008</xref>). Digoxigenin (DIG)-labeled cRNA antisense probes for <italic>vegfaa</italic>, <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> were transcribed in vitro using a DIG RNA labeling kit (SP6/T7, Sigma). Targeted DNA sequences of each gene were amplified using the following gene-specific primers containing the T7 (5’- <named-content content-type="sequence">taatacgactcactatagg</named-content> −3’) or SP6 (5’- <named-content content-type="sequence">atttaggtgacactata</named-content> −3’) promoter sequence (underlined):</p><list list-type="simple"><list-item><p>Vegfaa forward: 5’- <named-content content-type="sequence">GGCAGAACTCTGCATGAAGGAAGG</named-content> −3’</p></list-item> <list-item><p>Vegfaa reverse: 5’- <named-content content-type="sequence">g<underline>taatacgactcactatagg</underline>gCGTCAGTATAATACACTTTACCAC</named-content> −3’</p></list-item> <list-item><p>Vegfab forward: 5’- <named-content content-type="sequence">ATGTCTAACTTGCTTTCTGAGACC</named-content> −3’</p></list-item> <list-item><p>Vegfab reverse: 5’- <named-content content-type="sequence">g<underline>atttaggtgacactata</underline>gTCACCTCCTTGGTTTGTCACATCTG</named-content> −3’</p></list-item> <list-item><p>Vegfc forward: 5’- <named-content content-type="sequence">ATGCACTTATTTGGATTTTCTGTC</named-content> −3’</p></list-item> <list-item><p>Vegfc reverse: 5’- <named-content content-type="sequence">g<underline>atttaggtgacactata</underline>gTTAGTCCAGTCTTCCCCAGTATGTG</named-content> −3’</p></list-item> <list-item><p>Vegfd forward: 5’- <named-content content-type="sequence">ATGAAGAAACAGAAATGTGCTGGAC</named-content> −3’</p></list-item> <list-item><p>Vegfd reverse: 5’- <named-content content-type="sequence">g<underline>atttaggtgacactata</underline>gTCACGTATAGTGTAGTCTGTGTGTC</named-content> −3’</p></list-item></list></sec><sec id="s4-9"><title>Plasmid and crRNA injections</title><p>For <italic>ntla:EGFP</italic> plasmid injection, the plasmid was generated by cloning the EGFP coding sequence downstream of approximately 2.1 kb <italic>ntla</italic> regulatory elements (<xref ref-type="bibr" rid="bib27">Harvey et al., 2010</xref>; <xref ref-type="bibr" rid="bib41">Lee et al., 2013</xref>) flanked by Tol2 sites. The 2.1 kb <italic>ntla</italic> regulatory elements were amplified by PCR from genomic DNA of zebrafish embryos using the following primers: <italic>ntla</italic> promoter forward: 5’- <named-content content-type="sequence">atta<underline>atcgat</underline>ATACAATTCCTTTGTGCTGTTGCAACAC</named-content> −3’ <italic>ntla</italic> promoter reverse: 5’- <named-content content-type="sequence">atta<underline>gaattc</underline>ATTTCCGATCAAATAAAGCTTGAGAT</named-content> −3’.</p><p><italic>Cla I</italic> and <italic>EcoR I</italic> restriction enzyme sites (underlined) were incorporated into the primers to allow cloning. The engineered construct (12 pg per embryo) was injected together with transposase mRNA (<italic>tol2</italic> mRNA, 25 pg per embryo) into <italic>Tg(UAS-E1b:NfsB-mCherry)<sup>c264</sup></italic> one-cell stage embryos that carry the <italic>Tg(ntla:Gal4-VP16)<sup>sq12</sup></italic>, <italic>TgBAC(vegfab:gal4ff)<sup>bns273</sup></italic>, <italic>TgBAC(vegfc:gal4ff)<sup>bns270</sup></italic>, or <italic>TgBAC(vegfd:gal4ff)<sup>lri95</sup></italic> transgene. The injected embryos were fixed in 4% PFA/PBS (pH 7.0) overnight at 4°C and subjected to immunohistochemistry by following the immunostaining procedures as described without dehydrating fixed embryos through immersion in methanol serial dilutions. Anti-GFP and anti-DsRed antibodies were used to immunostain these embryo samples.</p><p>For <italic>ccbe1</italic> crRNA injection, crRNA:tracrRNA:Cas9 ribonucleoprotein (RNP) complexes were prepared as previously described (<xref ref-type="bibr" rid="bib33">Hoshijima et al., 2019</xref>). Briefly, duplex buffer (Integrated DNA Technologies, IDT) was used to make 100 μM stock solution of individual crRNA and tracrRNA. Each of crRNA stock solution (100 μM) was mixed with an equal volume of tracrRNA (100 μM) and annealed in a PCR machine as previously described (<xref ref-type="bibr" rid="bib33">Hoshijima et al., 2019</xref>) to generate crRNA:tracrRNA duplex complexes (50 μM). 50 μM crRNA:tracrRNA duplex solution was diluted in duplex buffer to generate 25 μM stock solution, which was stored at −20°C. The following sequences of <italic>ccbe1</italic> crRNAs were used: <italic>ccbe1</italic> crRNA1: <named-content content-type="sequence">TTCTCCTCTCGGAAAGTCCA</named-content>; <italic>ccbe1</italic> crRNA2: <named-content content-type="sequence">TACCCGTGCGTAAAGTCCAC</named-content>; <italic>ccbe1</italic> crRNA3: <named-content content-type="sequence">CTTCTGGAATACACTGACCC</named-content>.</p><p>25 μM stock solution of Cas9 protein (S.p. Cas9 nuclease, V3, IDT) was prepared as previously described (<xref ref-type="bibr" rid="bib33">Hoshijima et al., 2019</xref>). Injection cocktails (4 μL) that contained the crRNA:tracrRNA:Cas9 RNP complexes were prepared as follows: 0.4 μL 25 μM crRNA1:tracrRNA, 0.4 μL 25 μM crRNA2:tracrRNA, 0.4 μL 25 μM crRNA3:tracrRNA, 1.2 μL 25 μM Cas9 protein stock, 1.2 μL H<sub>2</sub>O, and 0.4 μL 0.5% phenol red solution (Sigma). Control injection cocktails (4 μL) without cRNAs were prepared as follows: 1.2 μL 25 μM Cas9 protein stock, 2.4 μL H<sub>2</sub>O, and 0.4 μL 0.5% phenol red solution. Both injection cocktails were freshly prepared on the day of injection. Prior to microinjection, both injection cocktails were incubated at 37°C for 5 min and then kept at room temperature. Approximately 2 nL of injection cocktails was injected into the cytoplasm of one-cell stage embryos.</p></sec><sec id="s4-10"><title>Confocal and stereo microscopy</title><p>A Leica TCS SP8 confocal laser scanning microscope (Leica) was used for live, immunofluorescence, and transmitted differential interference contrast imaging. Fish embryos and larvae were anaesthetized with a low dose of tricaine, embedded in a layer of 1% low-melt agarose in a glass-bottom Petri dish (MatTek), and imaged using a 10X dry or 25X water immersion objective lens. For microangiography, Qdot 655 streptavidin-conjugated nanocrystals (Thermo Fisher Scientific) were injected into the common cardinal vein and imaged after 30 min. An SMZ-18 stereomicroscope (Nikon) was used for brightfield images of anaesthetized fish.</p></sec><sec id="s4-11"><title>Transmission electron microscopy</title><p>10 dpf wild-type larvae were anesthetized with tricaine and fixed by immersion in 2.5% glutaraldehyde/4% PFA/0.2 M sodium cacodylate (pH 7.4) for 2 days at 4°C. Samples were post-fixed in 1% osmium tetroxide for 1 hr and incubated in 1% uranyl acetate in Maleate buffer for 1 hr. Samples were dehydrated through immersion in methanol serial dilutions and embedded in epoxy resin. Ultrathin sections of 85 nm were cut with a diamond knife, collected on copper grids, and stained with uranyl acetate and lead citrate. Images were captured using a transmission electron microscope (FEI Tecnai G2 Spirit BioTWIN).</p></sec><sec id="s4-12"><title>Quantification of DLV, PCeV, MCeV, and MsV formation</title><p>Fish carrying the <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> reporter were used for this quantification. Fish embryos/larvae at all indicated developmental stages were analyzed for the presence or absence of the DLV. DLV lengths were measured in 2 and 3 dpf DLV-forming embryos/larvae by defining the region of interest (ROI) using the polyline tool in Leica Application Suite X (LAS X) software. To quantify and compare bilaterally formed PCeV, MCeV, and MsV, the following criteria were used to score the extent of each vessel’s formation: (1) Score 2 - when the bilateral vessels are both fully formed; (2) Score 1.5 - when the vessel on one side is fully formed, but that on the other side is partially formed; (3) Score 1 - when the vessel on one side is fully formed, but that on the other side is absent; (4) Score 0.5 - when the vessel on one side is partially formed, but that on the other side is absent; and (5) Score 0 - when the bilateral vessels are both absent.</p></sec><sec id="s4-13"><title>Analysis of Claudin-5 protein expression in the mCP vasculature</title><p>Claudin-5 is strongly expressed in non-fenestrated brain vascular endothelium, while only weakly, or nearly undetectable, expression was observed in fenestrated mCP vascular endothelium (<xref ref-type="bibr" rid="bib63">van Leeuwen et al., 2018</xref>). To analyze Claudin-5 protein expression levels in fenestrated mCP vECs in WT, <italic>vegfab<sup>bns92</sup></italic>, <italic>vegfc<sup>hu6410</sup></italic>, <italic>vegfd<sup>bns257</sup></italic> mutants alone, and in combinations, 10 dpf mutant larvae carrying the <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> reporter were immunostained for GFP and Claudin-5. Images were taken under the same microscopy settings across genotypes for comparison. The Claudin-5 immunostaining signals in the DLV and PCeV were qualitatively analyzed after imaging.</p></sec><sec id="s4-14"><title>Analysis of <italic>Tg(glut1b:</italic>mCherry) and <italic>Tg(plvap:</italic>EGFP) expression in the mCP vasculature</title><p>The <italic>Tg(glut1b:mCherry)</italic> reporter gene is strongly expressed in the vECs that comprise non-fenestrated brain blood vessels, while only weakly, or nearly undetectable, expression was observed in fenestrated CP vascular endothelium (<xref ref-type="bibr" rid="bib62">Umans et al., 2017</xref>). In contrast, the <italic>Tg(plvap:EGFP)</italic> reporter gene is strongly expressed in fenestrated CP vascular endothelium (<xref ref-type="bibr" rid="bib62">Umans et al., 2017</xref>). To analyze <italic>Tg(glut1b:mCherry)</italic> and <italic>Tg(plvap:EGFP)</italic> reporter expression patterns in the cranial vasculature of <italic>vegfab<sup>bns92</sup></italic>, <italic>vegfc<sup>hu6410</sup></italic>, and <italic>vegfd<sup>bns257</sup></italic> mutants, each heterozygous mutant fish carrying both of the <italic>Tg(glut1b:mCherry)<sup>sj1</sup></italic> and Tg<italic>(plvapb:EGFP)<sup>sj3</sup></italic> transgenes were outcrossed with the corresponding heterozygous counterparts. The double transgenic progeny carrying <italic>Tg(glut1b:mCherry)<sup>sj1</sup>;Tg(plvapb:EGFP)<sup>sj3</sup></italic> reporters were fixed at 10 dpf and immunostained with anti-GFP and anti-DsRed antibodies. Images were taken under the same microscopy settings across genotypes for comparison. The <italic>Tg(glut1b:</italic>mCherry) and <italic>Tg(plvap:</italic>EGFP) reporter expression in the DLV and PCeV was qualitatively analyzed after imaging.</p></sec><sec id="s4-15"><title>Quantification of intersegmental vessel (ISV) formation</title><p> <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> reporter fish were used to quantify ISV formation in WT, single mutants of <italic>vegfab<sup>bns92</sup></italic>, <italic>vegfc<sup>hu6410</sup></italic>, and <italic>vegfd<sup>bns257</sup></italic>, and double mutant animals of <italic>vegfab<sup>bns92</sup>;vegfc<sup>hu6410</sup></italic> and <italic>vegfab<sup>bns92</sup>;vegfd<sup>bns257</sup></italic> at 96 hpf. For each fish, 10 ISVs in the trunk region of 2 somites directly anterior, and two somites directly posterior, to the anal opening were analyzed. The number of ISVs, including truncated ones, was quantified.</p></sec><sec id="s4-16"><title>Co-localization analysis of <italic>Tg(sox10:</italic>EGFP)-positive or <italic>Tg(mpeg1.1:</italic>Dendra2)-positive meningeal cells</title><p>To analyze <italic>TgBAC(vegfab:</italic>gal4ff<italic>)<sup>bns273</sup>-, TgBAC(vegfc:</italic>gal4ff<italic>)<sup>bns270</sup></italic>- or <italic>TgBAC(vegfd:</italic>gal4ff<italic>)<sup>lri95</sup></italic>-positive meningeal cells, <italic>TgBAC(vegfab:gal4ff)<sup>bns273</sup>, TgBAC(vegfc:gal4ff)<sup>bns270</sup></italic> and <italic>TgBAC(vegfd:gal4ff)<sup>lri95</sup></italic> fish carrying <italic>Tg(UAS-E1b:NfsB-mCherry)<sup>c264</sup></italic> and <italic>Tg(−4.9sox10:EGFP)<sup>ba2</sup></italic> or <italic>Tg(UAS-E1b:NfsB-mCherry)<sup>c264</sup></italic> and <italic>Tg(mpeg1.1:Dendra2)<sup>uwm12</sup></italic> transgenes were imaged at 48 hpf. High-magnification z-plane confocal images were collected at every 1 µm interval using a 25X water immersion objective lens to visualize NTR-mCherry<sup>+</sup> cells present in the dorsal surfaces of the brain meninges, particularly near the DMJ. These images were analyzed for the co-localization of NTR-mCherry<sup>+</sup> cells and <italic>Tg(sox10:</italic>EGFP)<sup>+</sup> neural crest-derived meningeal cells or <italic>Tg(mpeg1.1:</italic>Dendra2)<sup>+</sup> macrophages at every single z-plane.</p></sec><sec id="s4-17"><title>Analysis of FGP development in the dorsal surfaces of the brain meninges</title><p> <italic>Tg(kdrl:EGFP)<sup>s843</sup>;Tg(lyve1:DsRed)<sup>nz101</sup></italic> double Tg reporter fish were used to visualize blood vessels and FGPs simultaneously in the dorsal surfaces of the brain meninges. To determine the developmental relationships between FGPs and mCP vasculature, <italic>vegfab<sup>+/-</sup></italic>, as well as <italic>vegfc<sup>+/-</sup>;vegfd<sup>-/-</sup></italic>, adult fish that carried these Tg reporters were incrossed. The double transgenic progeny from these incrosses was imaged at 120 hpf and genotyped afterwards. For validation of <italic>ccbe1</italic> crRNA injection experiments, <italic>Tg(kdrl:EGFP);Tg(lyve1:DsRed)</italic> double Tg fish were outcrossed with wild-type zebrafish AB strains. The progeny were injected at the one-cell stage, and the double transgenic progeny were imaged at 120 hpf. For experiments involving combined gene inactivation of <italic>ccbe1</italic> and <italic>vegfab, vegfab<sup>+/-</sup></italic> adult fish that carried the <italic>Tg(kdrl:EGFP);Tg(lyve1:DsRed)</italic> reporters were incrossed, and progeny were injected at the one-cell stage. The double transgenic progeny were imaged at 96 hpf and genotyped afterwards. For all the experiments, a <italic>Tg(lyve1:</italic>DsRed<italic>)<sup>+</sup></italic> bilateral loop of FGPs that formed in the dorsal meningeal surfaces of the optic tectum were analyzed for presence or complete absence.</p></sec><sec id="s4-18"><title>Statistical analysis</title><p>Statistical differences for mean values among multiple groups were determined using a one-way analysis of variance (ANOVA) followed by Tukey's or Dunnett’s multiple comparison test. Fisher's exact test was used to determine significance when comparing the degree of penetrance of observed phenotypes. The criterion for statistical significance was set at <italic>P</italic>&lt;0.05. Error bars are SD.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Didier Stainier for his generous support during the project; Drs. Nathan Lawson, Michael Taylor, and Saulius Sumanas for kindly providing us with fish lines; and Drs. Judith Drazba, Gauravi Deshpande, and Mei Yin for imaging. This work was supported by funding from the National Institutes of Health (R01 NS117510) and start-up funds from the Cleveland Clinic Foundation to RLM.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Data curation, Software, Validation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All zebrafish work was approved by the Cleveland Clinic's Institutional Animal Care and Use Committee under the protocol number 2018-1970. Every effort was made to minimize suffering and distress of the animals used throughout this study.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-64295-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 and 4.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anbalagan</surname> <given-names>S</given-names></name><name><surname>Gordon</surname> <given-names>L</given-names></name><name><surname>Blechman</surname> <given-names>J</given-names></name><name><surname>Matsuoka</surname> <given-names>RL</given-names></name><name><surname>Rajamannar</surname> <given-names>P</given-names></name><name><surname>Wircer</surname> <given-names>E</given-names></name><name><surname>Biran</surname> <given-names>J</given-names></name><name><surname>Reuveny</surname> <given-names>A</given-names></name><name><surname>Leshkowitz</surname> <given-names>D</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name><name><surname>Levkowitz</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pituicyte cues regulate the development of permeable Neuro-Vascular interfaces</article-title><source>Developmental Cell</source><volume>47</volume><fpage>711</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.10.017</pub-id><pub-id pub-id-type="pmid">30449506</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreone</surname> <given-names>BJ</given-names></name><name><surname>Chow</surname> <given-names>BW</given-names></name><name><surname>Tata</surname> <given-names>A</given-names></name><name><surname>Lacoste</surname> <given-names>B</given-names></name><name><surname>Ben-Zvi</surname> <given-names>A</given-names></name><name><surname>Bullock</surname> <given-names>K</given-names></name><name><surname>Deik</surname> <given-names>AA</given-names></name><name><surname>Ginty</surname> <given-names>DD</given-names></name><name><surname>Clish</surname> <given-names>CB</given-names></name><name><surname>Gu</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Blood-Brain barrier permeability is regulated by lipid Transport-Dependent suppression of Caveolae-Mediated transcytosis</article-title><source>Neuron</source><volume>94</volume><fpage>581</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.043</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asakawa</surname> <given-names>K</given-names></name><name><surname>Suster</surname> <given-names>ML</given-names></name><name><surname>Mizusawa</surname> <given-names>K</given-names></name><name><surname>Nagayoshi</surname> <given-names>S</given-names></name><name><surname>Kotani</surname> <given-names>T</given-names></name><name><surname>Urasaki</surname> <given-names>A</given-names></name><name><surname>Kishimoto</surname> <given-names>Y</given-names></name><name><surname>Hibi</surname> <given-names>M</given-names></name><name><surname>Kawakami</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish</article-title><source>PNAS</source><volume>105</volume><fpage>1255</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1073/pnas.0704963105</pub-id><pub-id pub-id-type="pmid">18202183</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname> <given-names>HG</given-names></name><name><surname>Koh</surname> <given-names>GY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology</article-title><source>Science</source><volume>357</volume><elocation-id>eaal2379</elocation-id><pub-id pub-id-type="doi">10.1126/science.aal2379</pub-id><pub-id pub-id-type="pmid">28775214</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Zvi</surname> <given-names>A</given-names></name><name><surname>Lacoste</surname> <given-names>B</given-names></name><name><surname>Kur</surname> <given-names>E</given-names></name><name><surname>Andreone</surname> <given-names>BJ</given-names></name><name><surname>Mayshar</surname> <given-names>Y</given-names></name><name><surname>Yan</surname> <given-names>H</given-names></name><name><surname>Gu</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mfsd2a is critical for the formation and function of the blood–brain barrier</article-title><source>Nature</source><volume>509</volume><fpage>507</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/nature13324</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benz</surname> <given-names>F</given-names></name><name><surname>Wichitnaowarat</surname> <given-names>V</given-names></name><name><surname>Lehmann</surname> <given-names>M</given-names></name><name><surname>Germano</surname> <given-names>RF</given-names></name><name><surname>Mihova</surname> <given-names>D</given-names></name><name><surname>Macas</surname> <given-names>J</given-names></name><name><surname>Adams</surname> <given-names>RH</given-names></name><name><surname>Taketo</surname> <given-names>MM</given-names></name><name><surname>Plate</surname> <given-names>KH</given-names></name><name><surname>Guérit</surname> <given-names>S</given-names></name><name><surname>Vanhollebeke</surname> <given-names>B</given-names></name><name><surname>Liebner</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Low wnt/β-catenin signaling determines leaky vessels in the subfornical organ and affects water homeostasis in mice</article-title><source>eLife</source><volume>8</volume><elocation-id>e43818</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.43818</pub-id><pub-id pub-id-type="pmid">30932814</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bill</surname> <given-names>BR</given-names></name><name><surname>Korzh</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Choroid plexus in developmental and evolutionary perspective</article-title><source>Frontiers in Neuroscience</source><volume>8</volume><elocation-id>363</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2014.00363</pub-id><pub-id pub-id-type="pmid">25452709</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bos</surname> <given-names>FL</given-names></name><name><surname>Caunt</surname> <given-names>M</given-names></name><name><surname>Peterson-Maduro</surname> <given-names>J</given-names></name><name><surname>Planas-Paz</surname> <given-names>L</given-names></name><name><surname>Kowalski</surname> <given-names>J</given-names></name><name><surname>Karpanen</surname> <given-names>T</given-names></name><name><surname>van Impel</surname> <given-names>A</given-names></name><name><surname>Tong</surname> <given-names>R</given-names></name><name><surname>Ernst</surname> <given-names>JA</given-names></name><name><surname>Korving</surname> <given-names>J</given-names></name><name><surname>van Es</surname> <given-names>JH</given-names></name><name><surname>Lammert</surname> <given-names>E</given-names></name><name><surname>Duckers</surname> <given-names>HJ</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo</article-title><source>Circulation Research</source><volume>109</volume><fpage>486</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.250738</pub-id><pub-id pub-id-type="pmid">21778431</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bower</surname> <given-names>NI</given-names></name><name><surname>Koltowska</surname> <given-names>K</given-names></name><name><surname>Pichol-Thievend</surname> <given-names>C</given-names></name><name><surname>Virshup</surname> <given-names>I</given-names></name><name><surname>Paterson</surname> <given-names>S</given-names></name><name><surname>Lagendijk</surname> <given-names>AK</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Lindsey</surname> <given-names>BW</given-names></name><name><surname>Bent</surname> <given-names>SJ</given-names></name><name><surname>Baek</surname> <given-names>S</given-names></name><name><surname>Rondon-Galeano</surname> <given-names>M</given-names></name><name><surname>Hurley</surname> <given-names>DG</given-names></name><name><surname>Mochizuki</surname> <given-names>N</given-names></name><name><surname>Simons</surname> <given-names>C</given-names></name><name><surname>Francois</surname> <given-names>M</given-names></name><name><surname>Wells</surname> <given-names>CA</given-names></name><name><surname>Kaslin</surname> <given-names>J</given-names></name><name><surname>Hogan</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mural lymphatic endothelial cells regulate meningeal angiogenesis in the zebrafish</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>774</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1038/nn.4558</pub-id><pub-id pub-id-type="pmid">28459441</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussmann</surname> <given-names>J</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rapid BAC selection for tol2-mediated transgenesis in zebrafish</article-title><source>Development</source><volume>138</volume><fpage>4327</fpage><lpage>4332</lpage><pub-id pub-id-type="doi">10.1242/dev.068080</pub-id><pub-id pub-id-type="pmid">21865323</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carney</surname> <given-names>TJ</given-names></name><name><surname>Dutton</surname> <given-names>KA</given-names></name><name><surname>Greenhill</surname> <given-names>E</given-names></name><name><surname>Delfino-Machin</surname> <given-names>M</given-names></name><name><surname>Dufourcq</surname> <given-names>P</given-names></name><name><surname>Blader</surname> <given-names>P</given-names></name><name><surname>Kelsh</surname> <given-names>RN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A direct role for Sox10 in specification of neural crest-derived sensory neurons</article-title><source>Development</source><volume>133</volume><fpage>4619</fpage><lpage>4630</lpage><pub-id pub-id-type="doi">10.1242/dev.02668</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castranova</surname> <given-names>D</given-names></name><name><surname>Samasa</surname> <given-names>B</given-names></name><name><surname>Venero Galanternik</surname> <given-names>M</given-names></name><name><surname>Jung</surname> <given-names>HM</given-names></name><name><surname>Pham</surname> <given-names>VN</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Live imaging of intracranial lymphatics in the zebrafish</article-title><source>Circulation Research</source><volume>128</volume><fpage>42</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.317372</pub-id><pub-id pub-id-type="pmid">33135960</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname> <given-names>NC</given-names></name><name><surname>Shaw</surname> <given-names>RM</given-names></name><name><surname>De Val</surname> <given-names>S</given-names></name><name><surname>Kang</surname> <given-names>G</given-names></name><name><surname>Jan</surname> <given-names>LY</given-names></name><name><surname>Black</surname> <given-names>BL</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Foxn4 directly regulates tbx2b expression and atrioventricular canal formation</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1101/gad.1629408</pub-id><pub-id pub-id-type="pmid">18347092</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>C</given-names></name><name><surname>Smallwood</surname> <given-names>PM</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Reck and Gpr124 are essential receptor cofactors for Wnt7a/Wnt7b-Specific signaling in mammalian CNS angiogenesis and Blood-Brain barrier regulation</article-title><source>Neuron</source><volume>95</volume><fpage>1221</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.08.032</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cserr</surname> <given-names>HF</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Physiology of the choroid plexus</article-title><source>Physiological Reviews</source><volume>51</volume><fpage>273</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1152/physrev.1971.51.2.273</pub-id><pub-id pub-id-type="pmid">4930496</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curado</surname> <given-names>S</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Jungblut</surname> <given-names>B</given-names></name><name><surname>Mumm</surname> <given-names>J</given-names></name><name><surname>Schroeter</surname> <given-names>E</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Conditional targeted cell ablation in zebrafish: a new tool for regeneration studies</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>1025</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21100</pub-id><pub-id pub-id-type="pmid">17326133</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damkier</surname> <given-names>HH</given-names></name><name><surname>Brown</surname> <given-names>PD</given-names></name><name><surname>Praetorius</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cerebrospinal fluid secretion by the choroid plexus</article-title><source>Physiological Reviews</source><volume>93</volume><fpage>1847</fpage><lpage>1892</lpage><pub-id pub-id-type="doi">10.1152/physrev.00004.2013</pub-id><pub-id pub-id-type="pmid">24137023</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daneman</surname> <given-names>R</given-names></name><name><surname>Agalliu</surname> <given-names>D</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Kuhnert</surname> <given-names>F</given-names></name><name><surname>Kuo</surname> <given-names>CJ</given-names></name><name><surname>Barres</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis</article-title><source>PNAS</source><volume>106</volume><fpage>641</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1073/pnas.0805165106</pub-id><pub-id pub-id-type="pmid">19129494</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davison</surname> <given-names>JM</given-names></name><name><surname>Akitake</surname> <given-names>CM</given-names></name><name><surname>Goll</surname> <given-names>MG</given-names></name><name><surname>Rhee</surname> <given-names>JM</given-names></name><name><surname>Gosse</surname> <given-names>N</given-names></name><name><surname>Baier</surname> <given-names>H</given-names></name><name><surname>Halpern</surname> <given-names>ME</given-names></name><name><surname>Leach</surname> <given-names>SD</given-names></name><name><surname>Parsons</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Transactivation from Gal4-VP16 transgenic insertions for tissue-specific cell labeling and ablation in zebrafish</article-title><source>Developmental Biology</source><volume>304</volume><fpage>811</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.01.033</pub-id><pub-id pub-id-type="pmid">17335798</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Brolosy</surname> <given-names>MA</given-names></name><name><surname>Kontarakis</surname> <given-names>Z</given-names></name><name><surname>Rossi</surname> <given-names>A</given-names></name><name><surname>Kuenne</surname> <given-names>C</given-names></name><name><surname>Günther</surname> <given-names>S</given-names></name><name><surname>Fukuda</surname> <given-names>N</given-names></name><name><surname>Kikhi</surname> <given-names>K</given-names></name><name><surname>Boezio</surname> <given-names>GLM</given-names></name><name><surname>Takacs</surname> <given-names>CM</given-names></name><name><surname>Lai</surname> <given-names>SL</given-names></name><name><surname>Fukuda</surname> <given-names>R</given-names></name><name><surname>Gerri</surname> <given-names>C</given-names></name><name><surname>Giraldez</surname> <given-names>AJ</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genetic compensation triggered by mutant mRNA degradation</article-title><source>Nature</source><volume>568</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1064-z</pub-id><pub-id pub-id-type="pmid">30944477</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname> <given-names>AM</given-names></name><name><surname>Fero</surname> <given-names>K</given-names></name><name><surname>Arrenberg</surname> <given-names>AB</given-names></name><name><surname>Bergeron</surname> <given-names>SA</given-names></name><name><surname>Driever</surname> <given-names>W</given-names></name><name><surname>Burgess</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Deep brain photoreceptors control light-seeking behavior in zebrafish larvae</article-title><source>Current Biology</source><volume>22</volume><fpage>2042</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2012.08.016</pub-id><pub-id pub-id-type="pmid">23000151</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gancz</surname> <given-names>D</given-names></name><name><surname>Raftrey</surname> <given-names>BC</given-names></name><name><surname>Perlmoter</surname> <given-names>G</given-names></name><name><surname>Marín-Juez</surname> <given-names>R</given-names></name><name><surname>Semo</surname> <given-names>J</given-names></name><name><surname>Matsuoka</surname> <given-names>RL</given-names></name><name><surname>Karra</surname> <given-names>R</given-names></name><name><surname>Raviv</surname> <given-names>H</given-names></name><name><surname>Moshe</surname> <given-names>N</given-names></name><name><surname>Addadi</surname> <given-names>Y</given-names></name><name><surname>Golani</surname> <given-names>O</given-names></name><name><surname>Poss</surname> <given-names>KD</given-names></name><name><surname>Red-Horse</surname> <given-names>K</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Yaniv</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct origins and molecular mechanisms contribute to lymphatic formation during cardiac growth and regeneration</article-title><source>eLife</source><volume>8</volume><elocation-id>e44153</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44153</pub-id><pub-id pub-id-type="pmid">31702554</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Lecea</surname> <given-names>M</given-names></name><name><surname>Kondrychyn</surname> <given-names>I</given-names></name><name><surname>Fong</surname> <given-names>SH</given-names></name><name><surname>Ye</surname> <given-names>ZR</given-names></name><name><surname>Korzh</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>In vivo analysis of choroid plexus morphogenesis in zebrafish</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e3090</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003090</pub-id><pub-id pub-id-type="pmid">18769618</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghersi-Egea</surname> <given-names>JF</given-names></name><name><surname>Strazielle</surname> <given-names>N</given-names></name><name><surname>Catala</surname> <given-names>M</given-names></name><name><surname>Silva-Vargas</surname> <given-names>V</given-names></name><name><surname>Doetsch</surname> <given-names>F</given-names></name><name><surname>Engelhardt</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease</article-title><source>Acta Neuropathologica</source><volume>135</volume><fpage>337</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1807-1</pub-id><pub-id pub-id-type="pmid">29368213</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haigh</surname> <given-names>JJ</given-names></name><name><surname>Morelli</surname> <given-names>PI</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name><name><surname>Haigh</surname> <given-names>K</given-names></name><name><surname>Tsien</surname> <given-names>J</given-names></name><name><surname>Damert</surname> <given-names>A</given-names></name><name><surname>Miquerol</surname> <given-names>L</given-names></name><name><surname>Muhlner</surname> <given-names>U</given-names></name><name><surname>Klein</surname> <given-names>R</given-names></name><name><surname>Ferrara</surname> <given-names>N</given-names></name><name><surname>Wagner</surname> <given-names>EF</given-names></name><name><surname>Betsholtz</surname> <given-names>C</given-names></name><name><surname>Nagy</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling</article-title><source>Developmental Biology</source><volume>262</volume><fpage>225</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/S0012-1606(03)00356-7</pub-id><pub-id pub-id-type="pmid">14550787</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>C</given-names></name><name><surname>Flores</surname> <given-names>MV</given-names></name><name><surname>Storm</surname> <given-names>T</given-names></name><name><surname>Crosier</surname> <given-names>K</given-names></name><name><surname>Crosier</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish</article-title><source>BMC Developmental Biology</source><volume>7</volume><elocation-id>42</elocation-id><pub-id pub-id-type="doi">10.1186/1471-213X-7-42</pub-id><pub-id pub-id-type="pmid">17477879</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname> <given-names>SA</given-names></name><name><surname>Tümpel</surname> <given-names>S</given-names></name><name><surname>Dubrulle</surname> <given-names>J</given-names></name><name><surname>Schier</surname> <given-names>AF</given-names></name><name><surname>Smith</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>No tail integrates two modes of mesoderm induction</article-title><source>Development</source><volume>137</volume><fpage>1127</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1242/dev.046318</pub-id><pub-id pub-id-type="pmid">20215349</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvie</surname> <given-names>EA</given-names></name><name><surname>Green</surname> <given-names>JM</given-names></name><name><surname>Neely</surname> <given-names>MN</given-names></name><name><surname>Huttenlocher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Innate immune response to Streptococcus iniae infection in zebrafish larvae</article-title><source>Infection and Immunity</source><volume>81</volume><fpage>110</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1128/IAI.00642-12</pub-id><pub-id pub-id-type="pmid">23090960</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatta</surname> <given-names>K</given-names></name><name><surname>Tsujii</surname> <given-names>H</given-names></name><name><surname>Omura</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cell tracking using a photoconvertible fluorescent protein</article-title><source>Nature Protocols</source><volume>1</volume><fpage>960</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.96</pub-id><pub-id pub-id-type="pmid">17406330</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helker</surname> <given-names>CS</given-names></name><name><surname>Schuermann</surname> <given-names>A</given-names></name><name><surname>Karpanen</surname> <given-names>T</given-names></name><name><surname>Zeuschner</surname> <given-names>D</given-names></name><name><surname>Belting</surname> <given-names>HG</given-names></name><name><surname>Affolter</surname> <given-names>M</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>Herzog</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The zebrafish common cardinal veins develop by a novel mechanism: lumen ensheathment</article-title><source>Development</source><volume>140</volume><fpage>2776</fpage><lpage>2786</lpage><pub-id pub-id-type="doi">10.1242/dev.091876</pub-id><pub-id pub-id-type="pmid">23698350</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henson</surname> <given-names>HE</given-names></name><name><surname>Parupalli</surname> <given-names>C</given-names></name><name><surname>Ju</surname> <given-names>B</given-names></name><name><surname>Taylor</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Functional and genetic analysis of choroid plexus development in zebrafish</article-title><source>Frontiers in Neuroscience</source><volume>8</volume><elocation-id>364</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2014.00364</pub-id><pub-id pub-id-type="pmid">25426018</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname> <given-names>BM</given-names></name><name><surname>Bos</surname> <given-names>FL</given-names></name><name><surname>Bussmann</surname> <given-names>J</given-names></name><name><surname>Witte</surname> <given-names>M</given-names></name><name><surname>Chi</surname> <given-names>NC</given-names></name><name><surname>Duckers</surname> <given-names>HJ</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting</article-title><source>Nature Genetics</source><volume>41</volume><fpage>396</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1038/ng.321</pub-id><pub-id pub-id-type="pmid">19287381</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshijima</surname> <given-names>K</given-names></name><name><surname>Jurynec</surname> <given-names>MJ</given-names></name><name><surname>Klatt Shaw</surname> <given-names>D</given-names></name><name><surname>Jacobi</surname> <given-names>AM</given-names></name><name><surname>Behlke</surname> <given-names>MA</given-names></name><name><surname>Grunwald</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Highly efficient CRISPR-Cas9-Based methods for generating deletion mutations and F0 embryos that lack gene function in zebrafish</article-title><source>Developmental Cell</source><volume>51</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.004</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isogai</surname> <given-names>S</given-names></name><name><surname>Horiguchi</surname> <given-names>M</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development</article-title><source>Developmental Biology</source><volume>230</volume><fpage>278</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1006/dbio.2000.9995</pub-id><pub-id pub-id-type="pmid">11161578</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>SW</given-names></name><name><surname>Beis</surname> <given-names>D</given-names></name><name><surname>Mitchell</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cellular and molecular analyses of vascular tube and lumen formation in zebrafish</article-title><source>Development</source><volume>132</volume><fpage>5199</fpage><lpage>5209</lpage><pub-id pub-id-type="doi">10.1242/dev.02087</pub-id><pub-id pub-id-type="pmid">16251212</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junge</surname> <given-names>HJ</given-names></name><name><surname>Yang</surname> <given-names>S</given-names></name><name><surname>Burton</surname> <given-names>JB</given-names></name><name><surname>Paes</surname> <given-names>K</given-names></name><name><surname>Shu</surname> <given-names>X</given-names></name><name><surname>French</surname> <given-names>DM</given-names></name><name><surname>Costa</surname> <given-names>M</given-names></name><name><surname>Rice</surname> <given-names>DS</given-names></name><name><surname>Ye</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TSPAN12 regulates retinal vascular development by promoting norrin- but not Wnt-induced FZD4/beta-catenin signaling</article-title><source>Cell</source><volume>139</volume><fpage>299</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.07.048</pub-id><pub-id pub-id-type="pmid">19837033</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamba</surname> <given-names>T</given-names></name><name><surname>Tam</surname> <given-names>BY</given-names></name><name><surname>Hashizume</surname> <given-names>H</given-names></name><name><surname>Haskell</surname> <given-names>A</given-names></name><name><surname>Sennino</surname> <given-names>B</given-names></name><name><surname>Mancuso</surname> <given-names>MR</given-names></name><name><surname>Norberg</surname> <given-names>SM</given-names></name><name><surname>O'Brien</surname> <given-names>SM</given-names></name><name><surname>Davis</surname> <given-names>RB</given-names></name><name><surname>Gowen</surname> <given-names>LC</given-names></name><name><surname>Anderson</surname> <given-names>KD</given-names></name><name><surname>Thurston</surname> <given-names>G</given-names></name><name><surname>Joho</surname> <given-names>S</given-names></name><name><surname>Springer</surname> <given-names>ML</given-names></name><name><surname>Kuo</surname> <given-names>CJ</given-names></name><name><surname>McDonald</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>290</volume><fpage>H560</fpage><lpage>H576</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00133.2005</pub-id><pub-id pub-id-type="pmid">16172168</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucenas</surname> <given-names>S</given-names></name><name><surname>Takada</surname> <given-names>N</given-names></name><name><surname>Park</surname> <given-names>HC</given-names></name><name><surname>Woodruff</surname> <given-names>E</given-names></name><name><surname>Broadie</surname> <given-names>K</given-names></name><name><surname>Appel</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CNS-derived Glia ensheath peripheral nerves and mediate motor root development</article-title><source>Nature Neuroscience</source><volume>11</volume><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1038/nn2025</pub-id><pub-id pub-id-type="pmid">18176560</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhnert</surname> <given-names>F</given-names></name><name><surname>Mancuso</surname> <given-names>MR</given-names></name><name><surname>Shamloo</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>HT</given-names></name><name><surname>Choksi</surname> <given-names>V</given-names></name><name><surname>Florek</surname> <given-names>M</given-names></name><name><surname>Su</surname> <given-names>H</given-names></name><name><surname>Fruttiger</surname> <given-names>M</given-names></name><name><surname>Young</surname> <given-names>WL</given-names></name><name><surname>Heilshorn</surname> <given-names>SC</given-names></name><name><surname>Kuo</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124</article-title><source>Science</source><volume>330</volume><fpage>985</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1126/science.1196554</pub-id><pub-id pub-id-type="pmid">21071672</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Guen</surname> <given-names>L</given-names></name><name><surname>Karpanen</surname> <given-names>T</given-names></name><name><surname>Schulte</surname> <given-names>D</given-names></name><name><surname>Harris</surname> <given-names>NC</given-names></name><name><surname>Koltowska</surname> <given-names>K</given-names></name><name><surname>Roukens</surname> <given-names>G</given-names></name><name><surname>Bower</surname> <given-names>NI</given-names></name><name><surname>van Impel</surname> <given-names>A</given-names></name><name><surname>Stacker</surname> <given-names>SA</given-names></name><name><surname>Achen</surname> <given-names>MG</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>Hogan</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis</article-title><source>Development</source><volume>141</volume><fpage>1239</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1242/dev.100495</pub-id><pub-id pub-id-type="pmid">24523457</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>RT</given-names></name><name><surname>Knapik</surname> <given-names>EW</given-names></name><name><surname>Thiery</surname> <given-names>JP</given-names></name><name><surname>Carney</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>An exclusively mesodermal origin of fin mesenchyme demonstrates that zebrafish trunk neural crest does not generate ectomesenchyme</article-title><source>Development</source><volume>140</volume><fpage>2923</fpage><lpage>2932</lpage><pub-id pub-id-type="doi">10.1242/dev.093534</pub-id><pub-id pub-id-type="pmid">23739134</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liddelow</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Development of the choroid plexus and blood-CSF barrier</article-title><source>Frontiers in Neuroscience</source><volume>9</volume><elocation-id>32</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2015.00032</pub-id><pub-id pub-id-type="pmid">25784848</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebner</surname> <given-names>S</given-names></name><name><surname>Corada</surname> <given-names>M</given-names></name><name><surname>Bangsow</surname> <given-names>T</given-names></name><name><surname>Babbage</surname> <given-names>J</given-names></name><name><surname>Taddei</surname> <given-names>A</given-names></name><name><surname>Czupalla</surname> <given-names>CJ</given-names></name><name><surname>Reis</surname> <given-names>M</given-names></name><name><surname>Felici</surname> <given-names>A</given-names></name><name><surname>Wolburg</surname> <given-names>H</given-names></name><name><surname>Fruttiger</surname> <given-names>M</given-names></name><name><surname>Taketo</surname> <given-names>MM</given-names></name><name><surname>von Melchner</surname> <given-names>H</given-names></name><name><surname>Plate</surname> <given-names>KH</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name><name><surname>Dejana</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Wnt/β-catenin signaling controls development of the blood–brain barrier</article-title><source>Journal of Cell Biology</source><volume>183</volume><fpage>409</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1083/jcb.200806024</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes Pinheiro</surname> <given-names>MA</given-names></name><name><surname>Kooij</surname> <given-names>G</given-names></name><name><surname>Mizee</surname> <given-names>MR</given-names></name><name><surname>Kamermans</surname> <given-names>A</given-names></name><name><surname>Enzmann</surname> <given-names>G</given-names></name><name><surname>Lyck</surname> <given-names>R</given-names></name><name><surname>Schwaninger</surname> <given-names>M</given-names></name><name><surname>Engelhardt</surname> <given-names>B</given-names></name><name><surname>de Vries</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke</article-title><source>Biochimica Et Biophysica Acta</source><volume>1862</volume><fpage>461</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2015.10.018</pub-id><pub-id pub-id-type="pmid">26527183</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maharaj</surname> <given-names>ASR</given-names></name><name><surname>Walshe</surname> <given-names>TE</given-names></name><name><surname>Saint-Geniez</surname> <given-names>M</given-names></name><name><surname>Venkatesha</surname> <given-names>S</given-names></name><name><surname>Maldonado</surname> <given-names>AE</given-names></name><name><surname>Himes</surname> <given-names>NC</given-names></name><name><surname>Matharu</surname> <given-names>KS</given-names></name><name><surname>Karumanchi</surname> <given-names>SA</given-names></name><name><surname>D'Amore</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma</article-title><source>Journal of Experimental Medicine</source><volume>205</volume><fpage>491</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1084/jem.20072041</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastorakos</surname> <given-names>P</given-names></name><name><surname>McGavern</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The anatomy and immunology of vasculature in the central nervous system</article-title><source>Science Immunology</source><volume>4</volume><elocation-id>eaav0492</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aav0492</pub-id><pub-id pub-id-type="pmid">31300479</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname> <given-names>RL</given-names></name><name><surname>Marass</surname> <given-names>M</given-names></name><name><surname>Avdesh</surname> <given-names>A</given-names></name><name><surname>Helker</surname> <given-names>CS</given-names></name><name><surname>Maischein</surname> <given-names>HM</given-names></name><name><surname>Grosse</surname> <given-names>AS</given-names></name><name><surname>Kaur</surname> <given-names>H</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name><name><surname>Herzog</surname> <given-names>W</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Radial Glia regulate vascular patterning around the developing spinal cord</article-title><source>eLife</source><volume>5</volume><elocation-id>e20253</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.20253</pub-id><pub-id pub-id-type="pmid">27852438</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname> <given-names>RL</given-names></name><name><surname>Rossi</surname> <given-names>A</given-names></name><name><surname>Stone</surname> <given-names>OA</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CNS-resident progenitors direct the vascularization of neighboring tissues</article-title><source>PNAS</source><volume>114</volume><fpage>10137</fpage><lpage>10142</lpage><pub-id pub-id-type="doi">10.1073/pnas.1619300114</pub-id><pub-id pub-id-type="pmid">28855341</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullapudi</surname> <given-names>ST</given-names></name><name><surname>Boezio</surname> <given-names>GLM</given-names></name><name><surname>Rossi</surname> <given-names>A</given-names></name><name><surname>Marass</surname> <given-names>M</given-names></name><name><surname>Matsuoka</surname> <given-names>RL</given-names></name><name><surname>Matsuda</surname> <given-names>H</given-names></name><name><surname>Helker</surname> <given-names>CSM</given-names></name><name><surname>Yang</surname> <given-names>YHC</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Disruption of the pancreatic vasculature in zebrafish affects islet architecture and function</article-title><source>Development</source><volume>146</volume><elocation-id>dev173674</elocation-id><pub-id pub-id-type="doi">10.1242/dev.173674</pub-id><pub-id pub-id-type="pmid">31597659</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname> <given-names>CM</given-names></name><name><surname>Dymecki</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sonic hedgehog is required for vascular outgrowth in the hindbrain choroid plexus</article-title><source>Developmental Biology</source><volume>340</volume><fpage>430</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.01.032</pub-id><pub-id pub-id-type="pmid">20123094</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brown</surname> <given-names>NM</given-names></name><name><surname>Pfau</surname> <given-names>SJ</given-names></name><name><surname>Gu</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Bridging barriers: a comparative look at the blood-brain barrier across organisms</article-title><source>Genes &amp; Development</source><volume>32</volume><fpage>466</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1101/gad.309823.117</pub-id><pub-id pub-id-type="pmid">29692355</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname> <given-names>KS</given-names></name><name><surname>Astin</surname> <given-names>JW</given-names></name><name><surname>Misa</surname> <given-names>JP</given-names></name><name><surname>Flores</surname> <given-names>MV</given-names></name><name><surname>Crosier</surname> <given-names>KE</given-names></name><name><surname>Crosier</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish</article-title><source>Development</source><volume>139</volume><fpage>2381</fpage><lpage>2391</lpage><pub-id pub-id-type="doi">10.1242/dev.077701</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raab</surname> <given-names>S</given-names></name><name><surname>Beck</surname> <given-names>H</given-names></name><name><surname>Gaumann</surname> <given-names>A</given-names></name><name><surname>Yüce</surname> <given-names>A</given-names></name><name><surname>Gerber</surname> <given-names>HP</given-names></name><name><surname>Plate</surname> <given-names>K</given-names></name><name><surname>Hammes</surname> <given-names>HP</given-names></name><name><surname>Ferrara</surname> <given-names>N</given-names></name><name><surname>Breier</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor</article-title><source>Thrombosis and Haemostasis</source><volume>91</volume><fpage>595</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1160/TH03-09-0582</pub-id><pub-id pub-id-type="pmid">14983237</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>A</given-names></name><name><surname>Gauvrit</surname> <given-names>S</given-names></name><name><surname>Marass</surname> <given-names>M</given-names></name><name><surname>Pan</surname> <given-names>L</given-names></name><name><surname>Moens</surname> <given-names>CB</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulation of vegf signaling by natural and synthetic ligands</article-title><source>Blood</source><volume>128</volume><fpage>2359</fpage><lpage>2366</lpage><pub-id pub-id-type="doi">10.1182/blood-2016-04-711192</pub-id><pub-id pub-id-type="pmid">27557946</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roukens</surname> <given-names>MG</given-names></name><name><surname>Peterson-Maduro</surname> <given-names>J</given-names></name><name><surname>Padberg</surname> <given-names>Y</given-names></name><name><surname>Jeltsch</surname> <given-names>M</given-names></name><name><surname>Leppänen</surname> <given-names>VM</given-names></name><name><surname>Bos</surname> <given-names>FL</given-names></name><name><surname>Alitalo</surname> <given-names>K</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>Schulte</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Functional dissection of the CCBE1 protein: a crucial requirement for the collagen repeat domain</article-title><source>Circulation Research</source><volume>116</volume><fpage>1660</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.304949</pub-id><pub-id pub-id-type="pmid">25814692</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segarra</surname> <given-names>M</given-names></name><name><surname>Aburto</surname> <given-names>MR</given-names></name><name><surname>Cop</surname> <given-names>F</given-names></name><name><surname>Llaó-Cid</surname> <given-names>C</given-names></name><name><surname>Härtl</surname> <given-names>R</given-names></name><name><surname>Damm</surname> <given-names>M</given-names></name><name><surname>Bethani</surname> <given-names>I</given-names></name><name><surname>Parrilla</surname> <given-names>M</given-names></name><name><surname>Husainie</surname> <given-names>D</given-names></name><name><surname>Schänzer</surname> <given-names>A</given-names></name><name><surname>Schlierbach</surname> <given-names>H</given-names></name><name><surname>Acker</surname> <given-names>T</given-names></name><name><surname>Mohr</surname> <given-names>L</given-names></name><name><surname>Torres-Masjoan</surname> <given-names>L</given-names></name><name><surname>Ritter</surname> <given-names>M</given-names></name><name><surname>Acker-Palmer</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endothelial Dab1 signaling orchestrates neuro-glia-vessel communication in the central nervous system</article-title><source>Science</source><volume>361</volume><elocation-id>eaao2861</elocation-id><pub-id pub-id-type="doi">10.1126/science.aao2861</pub-id><pub-id pub-id-type="pmid">30139844</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegenthaler</surname> <given-names>JA</given-names></name><name><surname>Pleasure</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>We have got you 'covered': how the meninges control brain development</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>21</volume><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2010.12.005</pub-id><pub-id pub-id-type="pmid">21251809</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenman</surname> <given-names>JM</given-names></name><name><surname>Rajagopal</surname> <given-names>J</given-names></name><name><surname>Carroll</surname> <given-names>TJ</given-names></name><name><surname>Ishibashi</surname> <given-names>M</given-names></name><name><surname>McMahon</surname> <given-names>J</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Canonical wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature</article-title><source>Science</source><volume>322</volume><fpage>1247</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1126/science.1164594</pub-id><pub-id pub-id-type="pmid">19023080</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sztal</surname> <given-names>TE</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcriptional adaptation: a mechanism underlying genetic robustness</article-title><source>Development</source><volume>147</volume><elocation-id>dev186452</elocation-id><pub-id pub-id-type="doi">10.1242/dev.186452</pub-id><pub-id pub-id-type="pmid">32816903</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id><pub-id pub-id-type="pmid">18193022</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname> <given-names>X</given-names></name><name><surname>Yang</surname> <given-names>Q</given-names></name><name><surname>Ritchey</surname> <given-names>MD</given-names></name><name><surname>George</surname> <given-names>MG</given-names></name><name><surname>Jackson</surname> <given-names>SL</given-names></name><name><surname>Gillespie</surname> <given-names>C</given-names></name><name><surname>Merritt</surname> <given-names>RK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The burden of cerebrovascular disease in the united states</article-title><source>Preventing Chronic Disease</source><volume>16</volume><elocation-id>E52</elocation-id><pub-id pub-id-type="doi">10.5888/pcd16.180411</pub-id><pub-id pub-id-type="pmid">31022369</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umans</surname> <given-names>RA</given-names></name><name><surname>Henson</surname> <given-names>HE</given-names></name><name><surname>Mu</surname> <given-names>F</given-names></name><name><surname>Parupalli</surname> <given-names>C</given-names></name><name><surname>Ju</surname> <given-names>B</given-names></name><name><surname>Peters</surname> <given-names>JL</given-names></name><name><surname>Lanham</surname> <given-names>KA</given-names></name><name><surname>Plavicki</surname> <given-names>JS</given-names></name><name><surname>Taylor</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CNS angiogenesis and barriergenesis occur simultaneously</article-title><source>Developmental Biology</source><volume>425</volume><fpage>101</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2017.03.017</pub-id><pub-id pub-id-type="pmid">28365243</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Leeuwen</surname> <given-names>LM</given-names></name><name><surname>Evans</surname> <given-names>RJ</given-names></name><name><surname>Jim</surname> <given-names>KK</given-names></name><name><surname>Verboom</surname> <given-names>T</given-names></name><name><surname>Fang</surname> <given-names>X</given-names></name><name><surname>Bojarczuk</surname> <given-names>A</given-names></name><name><surname>Malicki</surname> <given-names>J</given-names></name><name><surname>Johnston</surname> <given-names>SA</given-names></name><name><surname>van der Sar</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A transgenic zebrafish model for the <italic>in vivo</italic> study of the blood and choroid plexus brain barriers using <italic>claudin 5</italic></article-title><source>Biology Open</source><volume>7</volume><elocation-id>bio030494</elocation-id><pub-id pub-id-type="doi">10.1242/bio.030494</pub-id><pub-id pub-id-type="pmid">29437557</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Lessen</surname> <given-names>M</given-names></name><name><surname>Shibata-Germanos</surname> <given-names>S</given-names></name><name><surname>van Impel</surname> <given-names>A</given-names></name><name><surname>Hawkins</surname> <given-names>TA</given-names></name><name><surname>Rihel</surname> <given-names>J</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Intracellular uptake of macromolecules by brain lymphatic endothelial cells during zebrafish embryonic development</article-title><source>eLife</source><volume>6</volume><elocation-id>e25932</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.25932</pub-id><pub-id pub-id-type="pmid">28498105</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanhollebeke</surname> <given-names>B</given-names></name><name><surname>Stone</surname> <given-names>OA</given-names></name><name><surname>Bostaille</surname> <given-names>N</given-names></name><name><surname>Cho</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Maquet</surname> <given-names>E</given-names></name><name><surname>Gauquier</surname> <given-names>A</given-names></name><name><surname>Cabochette</surname> <given-names>P</given-names></name><name><surname>Fukuhara</surname> <given-names>S</given-names></name><name><surname>Mochizuki</surname> <given-names>N</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent wnt/β-catenin pathway during brain angiogenesis</article-title><source>eLife</source><volume>4</volume><elocation-id>e06849</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.06489</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venero Galanternik</surname> <given-names>M</given-names></name><name><surname>Castranova</surname> <given-names>D</given-names></name><name><surname>Gore</surname> <given-names>AV</given-names></name><name><surname>Blewett</surname> <given-names>NH</given-names></name><name><surname>Jung</surname> <given-names>HM</given-names></name><name><surname>Stratman</surname> <given-names>AN</given-names></name><name><surname>Kirby</surname> <given-names>MR</given-names></name><name><surname>Iben</surname> <given-names>J</given-names></name><name><surname>Miller</surname> <given-names>MF</given-names></name><name><surname>Kawakami</surname> <given-names>K</given-names></name><name><surname>Maraia</surname> <given-names>RJ</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A novel perivascular cell population in the zebrafish brain</article-title><source>eLife</source><volume>6</volume><elocation-id>e24369</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.24369</pub-id><pub-id pub-id-type="pmid">28395729</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villefranc</surname> <given-names>JA</given-names></name><name><surname>Nicoli</surname> <given-names>S</given-names></name><name><surname>Bentley</surname> <given-names>K</given-names></name><name><surname>Jeltsch</surname> <given-names>M</given-names></name><name><surname>Zarkada</surname> <given-names>G</given-names></name><name><surname>Moore</surname> <given-names>JC</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name><name><surname>Alitalo</surname> <given-names>K</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development</article-title><source>Development</source><volume>140</volume><fpage>1497</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1242/dev.084152</pub-id><pub-id pub-id-type="pmid">23462469</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Cho</surname> <given-names>C</given-names></name><name><surname>Williams</surname> <given-names>J</given-names></name><name><surname>Smallwood</surname> <given-names>PM</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Junge</surname> <given-names>HJ</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interplay of the norrin and Wnt7a/Wnt7b signaling systems in blood-brain barrier and blood-retina barrier development and maintenance</article-title><source>PNAS</source><volume>115</volume><fpage>E11827</fpage><lpage>E11836</lpage><pub-id pub-id-type="doi">10.1073/pnas.1813217115</pub-id><pub-id pub-id-type="pmid">30478038</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Sabbagh</surname> <given-names>MF</given-names></name><name><surname>Gu</surname> <given-names>X</given-names></name><name><surname>Rattner</surname> <given-names>A</given-names></name><name><surname>Williams</surname> <given-names>J</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Beta-catenin signaling regulates barrier-specific gene expression in Circumventricular organ and ocular vasculatures</article-title><source>eLife</source><volume>8</volume><elocation-id>e43257</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.43257</pub-id><pub-id pub-id-type="pmid">30932813</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Muhl</surname> <given-names>L</given-names></name><name><surname>Padberg</surname> <given-names>Y</given-names></name><name><surname>Dupont</surname> <given-names>L</given-names></name><name><surname>Peterson-Maduro</surname> <given-names>J</given-names></name><name><surname>Stehling</surname> <given-names>M</given-names></name><name><surname>le Noble</surname> <given-names>F</given-names></name><name><surname>Colige</surname> <given-names>A</given-names></name><name><surname>Betsholtz</surname> <given-names>C</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>van Impel</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Specific fibroblast subpopulations and neuronal structures provide local sources of Vegfc-processing components during zebrafish lymphangiogenesis</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2724</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16552-7</pub-id><pub-id pub-id-type="pmid">32483144</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>EH</given-names></name><name><surname>Weninger</surname> <given-names>W</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Trafficking of immune cells in the central nervous system</article-title><source>Journal of Clinical Investigation</source><volume>120</volume><fpage>1368</fpage><lpage>1379</lpage><pub-id pub-id-type="doi">10.1172/JCI41911</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Cahill</surname> <given-names>H</given-names></name><name><surname>Yu</surname> <given-names>M</given-names></name><name><surname>Badea</surname> <given-names>TC</given-names></name><name><surname>Smallwood</surname> <given-names>PM</given-names></name><name><surname>Peachey</surname> <given-names>NS</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization</article-title><source>Cell</source><volume>139</volume><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.07.047</pub-id><pub-id pub-id-type="pmid">19837032</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Tischfield</surname> <given-names>M</given-names></name><name><surname>Williams</surname> <given-names>J</given-names></name><name><surname>Smallwood</surname> <given-names>PM</given-names></name><name><surname>Rattner</surname> <given-names>A</given-names></name><name><surname>Taketo</surname> <given-names>MM</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Canonical WNT signaling components in vascular development and barrier formation</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>3825</fpage><lpage>3846</lpage><pub-id pub-id-type="doi">10.1172/JCI76431</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling</article-title><source>Developmental Cell</source><volume>31</volume><fpage>248</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.08.018</pub-id><pub-id pub-id-type="pmid">25373781</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64295.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Reviewing Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p><p><bold>Acceptance summary:</bold></p><p>Your study makes an important contribution to the understanding of blood vessel formation and in particular, the role this plays in the developing CNS.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64295.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>We would like to thank all of the reviewers for their thoughtful, critical, and constructive feedback on our manuscript. These comments greatly helped us to improve our current study.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>In this manuscript Parab et al. investigate the molecular mechanisms governing the formation of fenestrated blood vessels in the myelencephalic choroid plexus. The authors use state of the art zebrafish transgenic lines and genetic tools. In general the manuscript is well written, data is nicely presented and controls are properly used an shown. The study is interesting as it shows the heterogeneity in the regulation of blood vessel formation. Based on the expression pattern of the different Vegf family ligands, this study also indicates the effect of local cues on blood vessel formation. However, mechanistics insight of how fenestration of those vessels is regulated are missing.</p></disp-quote><p>We appreciate this reviewer for her/his constructive comments and suggestions to improve this study. We address each of the points raised by the reviewer below.</p><disp-quote content-type="editor-comment"><p>Major comments:</p><p>The analysis of markers for fenestrated vessels is not clear. The authors show that vegfab<sup>-/-</sup>, vegfab-/vegfc<sup>-/-</sup> and vegfab<sup>-/-</sup>vegfd<sup>-/-</sup> show &quot;no DLV&quot; phenotypes. However, in Figure S3C they then go and study Claudin5 expression in DLV of those mutants. If at 10dpf around 30% of vegfab<sup>-/-</sup>, 65-70% of the vegfab<sup>-/-</sup>vegfc<sup>-/-</sup>, and aprox 80% of the vegfab<sup>-/-</sup>vegfd<sup>-/-</sup>, do not have DLV, what ZF mutants do the authors use to analyze claudin5 expression in the DLV? do they analyze the remaining percentage of the ones where the DLV is formed? and if so, what is the significance of this analysis? Could it be that in those mutants there are compensatory mechanisms occurring that assure DLV formation and expression of BBB markers? Could the authors clarify this? if so, a more appropriate analysis would be to analyze BBB markers in mutants with partial DLV.</p></disp-quote><p>We appreciate this comment and agree with the reviewer that our Claudin-5 expression analyses of only the mutants that formed the DLV could misrepresent the results due to the compensatory mechanisms among the Vegf ligands and possibly other unidentified factors. To address this concern, we have now clarified in both the Results and Materials and methods sections of the revised manuscript that this analysis was feasible only for the mutants that formed the DLV. Secondly, we performed additional experiments to examine additional fenestration and BBB endothelial markers by crossing each of the <italic>vegf</italic> mutants with the <italic>Tg(plvap:EGFP);Tg(glut1b:mCherry)</italic> double transgenic line. We have now added these completed analyses of the additional endothelial markers conducted in 10 dpf WT, <italic>vegfab<sup>-/-</sup></italic>, <italic>vegfc<sup>-/-</sup></italic>, and <italic>vegfd<sup>-/-</sup></italic> larvae to the revised manuscript (Figure 5). Lastly, we have described the limitations of these experimental analyses in the Discussion section by incorporating the possibility of compensatory actions that were brought to our attention by the reviewer.</p><disp-quote content-type="editor-comment"><p>While the rest of the conclusions are convincing, it still remains to be understood what regulates fenestration of those vessels compared to non-fenestrated ones. It would be interesting to further investigate and this still unknown question.</p></disp-quote><p>We fully agree with the reviewer that further investigation into regulators of mCP vascular fenestration will be a crucial next step and remains an important question to further address. Our perspectives with regards to this question are described in greater detail below in the response to this reviewer’s last comment.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Significance (Required)):</p><p>Nature and significance of the advance: the study shows significant advance in understanding the molecular mechanisms of brain vascularization</p></disp-quote><p>We appreciate this positive comment highlighting the significance of our study in the field.</p><disp-quote content-type="editor-comment"><p>Work in context of existing literature: based on the previous published literature, this study provides mechanistic insights into regulation of blood vessel formation in the choroid plexus. It would be more relevant if the authors would provide more data on why those vessels are fenestrated and the other not. What controls this fenestration?</p></disp-quote><p>To gain more insight into a potential role for Vegfs in the development of vessel fenestration in the mCP vasculature, we conducted expression analyses of additional fenestration and BBB endothelial markers in 10 dpf WT, <italic>vegfab<sup>-/-</sup></italic>, <italic>vegfc<sup>-/-</sup></italic>, and <italic>vegfd<sup>-/-</sup></italic> larvae as described above. However, no obvious differences were observed between WT and each of these mutants in the expression patterns of the <italic>Tg(plvap:EGFP);Tg(glut1b:mCherry)</italic> reporters which we utilized for this analysis. These observations combined with our analysis of Claudin-5 protein expression in these single and double mutants indicate that the lack of these Vegf ligands does not lead to an absence, or a conversion, of the mCP endothelial fenestrated state, although our analyses were conducted only for the mutants that formed the DLV and PCeV.</p><p>Considering these observations and the recent reports in the field, we have now formulated several hypotheses aimed at uncovering the molecular mechanisms underlying the fenestration of mCP vasculature. In light of recent studies (Wang et al., 2019; Anbalagan et al., 2018), we speculate that vessel fenestration in the CP may require combined actions of 1) endogenous inhibitor(s) of canonical Wnt/b-catenin signaling, 2) vascular permeability/inflammatory protein(s), and/or 3) signaling molecules inhibiting endothelial tight junction formation. These combined actions allow vascular endothelial cells in the CP to 1) maintain low levels of Wnt/b-catenin signaling, 2) exhibit increased vascular permeability, and 3) form loose endothelial connections, as compared to those forming the BBB in the other areas of the brain. Our future research efforts will test these hypotheses in order to define molecular players involved in CP vessel fenestration in the most comprehensive manner possible.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Parab et al. use the zebrafish model to study the requirement of angiogenic factor VEGFs in choroid plexus (CP) vascularization. Using a series of elegant genetic experiments and anatomical imaging, the authors clearly demonstrate that the combinations of vegfab, vegfc, and vegfd deficiency cause defective CP vascularization, as well as dorsal longitudinal vein (DLV) and posterior cerebral veins (PCeV) which are functionally integrated in the CP vasculature.</p><p>The question of what controls the CP vascularization with highly permeable fenestrate is clearly an important one, and this paper is impressive in terms of the thoroughness of genetic approaches brought to bear on it. The experiments are nicely carried out with quantitative measurements. However, it is not clear that the data presented are enough to explain the involvement of VEGFs in the CP vascularization. The important question is whether lack of the CP vasculature in the vegf mutants may be secondary to the DLV and PCeV phenotypes. It is not clear what directs the recruitment of these vessels into the CP.</p></disp-quote><p>We appreciate this reviewer for her/his positive and encouraging comments highlighting both the quality and significance of our study. We also appreciate the reviewer’s thoughtful comments on the requirements for Vegfs in CP vascularization. As the reviewer pointed out, there is a possibility that the DLV/PCeV development and mCP vascularization could have separate molecular requirements for angiogenesis and that the lack of mCP vascularization in the <italic>vegf</italic> mutants could be secondary to the DLV/PCeV defects. Although only small segments of the DLV and PCeV are present in close proximity to the mCP, these two vessels exhibit molecular signatures of fenestrated endothelial cells along the entire vessel – even in the brain/meningeal regions outside of the mCP. In mice, fenestrated endothelial cells are observed in the CPs, but do not appear to be present in their directly adjacent tissues (Wang et al., 2019), although it is possible that a blood vessel(s) giving rise to these CP fenestrated vasculature is present on the meningeal compartments and displays molecular signatures of fenestrated endothelial cells as observed similarly in zebrafish.</p><p>As previously reported (Bill B.R. et al., PLOS ONE 3:e3114, 2008), the DLV is clearly the only blood vessel that supplies blood to the mCP (at least up to 10 dpf) based on the blood flow observed under transmitted differential interference contrast (DIC) imaging microscopy, and this blood flow leaves the mCP through bilateral PCeVs. These closely connected endothelial cells comprising the functionally integrated mCP vasculature acquire similar endothelial features such as fenestration for the purpose of achieving a shared goal as the functional mCP vasculature in zebrafish. As the reviewer nicely summarized, our findings demonstrate that specific combinations of Vegfab, Vegfc, and Vegfd deficiency result in defective mCP vascularization and the lack of the DLV and PCeV. The DLV and PCeV converge to form the mCP vasculature, and all of these vessels exhibit the shared fenestrated endothelial state. Thus, we expect that the mCP vasculature is an integral constituent of the connected DLV and PCeV. Further dissections of these Vegf ligands’ functions in mCP vascularization versus DLV/PCeV formation would require more sophisticated strategies, experimental tools and approaches, even if feasible. However, since the reviewer’s point leaves an important question open and suggests another possible interpretation of the results, we have now added the relevant discussions to the revised manuscript.</p><p>With regard to the question of what directs the recruitment of these vessels into the CP, we speculate that <italic>vegfab</italic> expressed in the mCP epithelial cells plays an instructive role. However, there are currently no CP-specific promoter or zebrafish tools available in the community that allow us to perform genetic manipulation in the CP specifically. The most specific and powerful tool available in the community is the enhancer trapped <italic>Et(cp:EGFP)<sup>sj2</sup></italic> line. Although we have been trying to convert this pre-existing EGFP enhancer trap line into a Gal4 (KalTA4) line by following the recently published method (Auer T.O. et al., Genome Res. 24:142-153, 2014; Auer T.O. et al., Nat Protoc 9:2823-2840, 2014), the establishment of this new line would require substantial time, even if successful.</p><p>Alternatively, we attempted two-photon laser-mediated cell ablation that specifically targeted the <italic>vegfab</italic>-expressing mCP epithelial cells directed by the <italic>TgBAC(vegfab:gal4ff);Tg(UAS:EGFP-CAAX)</italic> line in order to investigate a role for these cells in DLV and PCeV formation. However, cell ablation of these cells prior to DLV sprouting (~42 hpf) was limited by the fact that only the visible EGFP-expressing cells can be targeted at that stage and that <italic>vegfab</italic>-expressing mCP epithelial cells continue to emerge while the DLV is extending toward the mCP. Given the concurrent and rapid development of the DLV and mCP, a two-photon laser-mediated cell ablation approach does not seem to be the best option.</p><p>Considering these current technical limitations, we now believe that establishing a CP-specific zebrafish tool by converting the existing <italic>Et(cp:EGFP)<sup>sj2</sup></italic> line into a Gal4 line will overcome some of these technical limitations and thus be an important next step. Successful generation of this new Gal4 line will allow ones to utilize the Gal4/UAS system to overexpress genes of interest in any form (eg. full-length, dominant-negative, constitutive-active, or truncated forms of genes) specifically in CP epithelial cells, thereby allowing for CP tissue-specific gene inactivation, overexpression, and rescue of mutants. Thus, the establishment of this sort of new CP-specific transgenic Gal4 line will be needed for us to further delve into the mechanisms of mCP vascular development.</p><disp-quote content-type="editor-comment"><p>1) Based on the observation that vegf mutants with DLV retain high expression of the permeability marker PLVP and low expression of BBB markers such as GLUT1 and Claudin-5, how the authors conclude that VEGFs do not influence DLV fenestration remains unclear. The authors cannot rule out the possibility that due to an incomplete penetrance these mutants may not have both DLV formation and fenestration phenotypes. The authors need to carry out in situ hybridization to examine the expression of vegfs in the vegf mutants with DLV.</p></disp-quote><p>We appreciate this comment and agree with the reviewer that our analyses of only the mutants that formed the DLV can misrepresent the results due to the incomplete penetrance and compensatory mechanisms that can occur in the <italic>vegf</italic> mutants we examined. Related to reviewer #1’s first major comments above, we have now clarified that this analysis was feasible only for the mutants that formed the DLV in both the Results and Materials and methods sections of the revised manuscript. We have also described the technical limitations and possible interpretations of these experimental analyses in the Discussion section by including the possibility of compensatory actions that were brought to our attention by this reviewer and reviewer #1.</p><p>With regards to <italic>vegf</italic> expression analyses in the <italic>vegf</italic> mutants that form the DLV, we conducted this analysis using our <italic>vegf</italic> BAC lines instead of performing <italic>in situ</italic> hybridization. We expect that this approach provides much more sensitive and higher resolution analyses than using <italic>in situ</italic> hybridization, which generally provides lower contrast and resolution due to higher background staining in the head of embryos/larvae at the relevant developmental stages of this analysis (eg. 48-72 hpf). We analyzed <italic>vegfc</italic> expression in <italic>vegfab</italic> mutants by examining the <italic>TgBAC(vegfc:</italic>gal4ff<italic>);Tg(UAS:</italic>EGFP-CAAX) reporter expression, which did not show any obvious differences in expression patterns and/or fluorescence signal intensity when compared to <italic>vegfab</italic> WT and Het sibling controls. Similarly, we observed no obvious difference in <italic>TgBAC(vegfd:</italic>gal4ff<italic>);Tg(UAS:</italic>EGFP-CAAX) reporter expression in <italic>vegfab</italic> mutants compared to their sibling controls. Lastly, our analysis of <italic>TgBAC(vegfab:</italic>gal4ff<italic>);Tg(UAS:</italic>EGFP-CAAX) reporter expression in <italic>vegfc</italic> mutants and their control siblings did not reveal any obvious difference between the mutants and controls. We have now added these results to the revised manuscript (Figure 6—figure supplement 2).</p><disp-quote content-type="editor-comment"><p>2) In Figure 1I and 1J, the authors need to clarify what expresses Claudin-5 in the absence of DLV in vegfab mutants. Is it possible that the vegfab mutants may fail to maintain VEGFR2 expression (kdrl:EGFP) but the mutants may still have DLV? It would be helpful if the authors could examine functional and morphological properties of DLV in the vegfab mutants using a fluorescent dye injection.</p></disp-quote><p>We appreciate this comment and have now clarified that there are Claudin-5-expressing cells which reside ventrally to the DLV and that they are visible in the presence or absence of the DLV. We also agree with the reviewer that examining whether a perfused, functional DLV is present or absent in <italic>vegfab</italic> mutants by fluorescent dye injections will clarify the concern regarding <italic>Tg(kdrl:EGFP)</italic> transgene downregulation/silencing in this mutant. To address this concern, we injected Qdot 655 streptavidin-conjugated nanocrystals through the common cardinal vein into 96 hpf WT and <italic>vegfab<sup>-/-</sup></italic> larvae that carry the <italic>Tg(kdrl:EGFP)</italic> reporter. This injection experiment allowed us to visualize endothelial cell-specific <italic>Tg(kdrl:</italic>EGFP) reporter expression and perfused, functional blood vessels labeled by blood-circulating Qdot 655 nanocrystals. We observed that in all <italic>vegfab<sup>-/-</sup></italic> mutants we examined (n=8) that lack the <italic>Tg(kdrl:</italic>EGFP)-positive DLV, Qdot 655 nanocrystals failed to label this vessel, illustrating the lack of a perfused, functional DLV. In addition, we examined blood flow and circulating blood cells in these WT and <italic>vegfab<sup>-/-</sup></italic> larvae under transmitted differential interference contrast (DIC) imaging microscopy and observed no blood flow in the area where the DLV normally forms. We have now added these experimental results to the revised manuscript (Figure 1—figure supplement 2G–H”).</p><disp-quote content-type="editor-comment"><p>3) In Figure S2G-P, the authors need to clarify the descriptions of sflt1 and sflt4 mutant phenotypes. Do the sflt1 mutants have no significant penetrance (21%) of the &quot;No DLV&quot; phenotype but some mutants (79%) form relatively short DLV? Do the sflt4 mutants have a significant penetrance (33%) of the &quot;No DLV&quot; phenotype but some mutants (67%) form normal DLV?</p></disp-quote><p>We appreciate this suggestion. The reviewer’s interpretation is correct. We have now clarified the descriptions of these results in the revised manuscript as suggested by the reviewer.</p><disp-quote content-type="editor-comment"><p>4) In Figure 2G, the authors need to define &quot;score.&quot;</p></disp-quote><p>We have now corrected this term into more defined titles in this and all the relevant graphs.</p><disp-quote content-type="editor-comment"><p>5) In Figure S5, the data are not enough to conclude that the mesoderm-derived meningeal fibroblasts express vegfs. The authors need to examine whether meningeal macrophages and/or glial cells express vegfs.</p></disp-quote><p>We appreciate this comment and agree with the reviewer that there are some other cell types that reside in meningeal compartments and that our current analysis cannot rule out the possibility that <italic>vegfab</italic>-, <italic>vegfc</italic>-, and/or <italic>vegfd</italic>-expressing cells are not mesoderm-derived meningeal fibroblasts. We have now examined the co-localization of meningeal macrophages and these <italic>vegf</italic>-expressing cells by crossing each of <italic>TgBAC(vegfab:NTR-mCherry)</italic>, <italic>TgBAC(vegfc:NTR-mCherry)</italic>, and <italic>TgBAC(vegfd:NTR-mCherry)</italic> fish with the <italic>Tg(mpeg1.1:Dendra2)<sup>uwm12</sup> </italic>transgenic reporter line that was previously shown to label macrophages in the brain and meninges (Ellett F. et al., <italic>Blood</italic> 117:e49-56, 2010). We have added these results to the revised manuscript (Figure 6—figure supplement 4).</p><p>In addition, to examine whether these <italic>vegf</italic>-expressing cells are mesoderm-derived meningeal fibroblasts, we injected a plasmid in which the promoter of the early mesoderm-specific gene, <italic>ntla</italic>, drives the expression of EGFP into 1-cell stage <italic>TgBAC(vegfab:NTR-mCherry)</italic>, <italic>TgBAC(vegfc:NTR-mCherry)</italic>, and <italic>TgBAC(vegfd:NTR-mCherry)</italic> embryos. To validate this approach, we injected this plasmid into 1-cell stage <italic>Tg(ntla:gal4);Tg(UAS:NTR-mCherry)</italic> embryos and observed that the EGFP and NTR-mCherry signals directed by the <italic>ntla</italic> promoter were mostly co-localized in the dorsal surfaces of the brain meninges. Using this <italic>ntla:EGFP</italic> plasmid injection approach, we found that NTR-mCherry<sup>+</sup> meningeal cells marked by each of the <italic>vegf</italic> BAC lines were co-localized with EGFP<sup>+</sup> mesoderm-derived meningeal cells. In addition, we took magnified confocal images of the meningeal cells labeled by <italic>Tg(ntla:gal4)</italic>, <italic>TgBAC(vegfab:gal4ff)</italic>, and <italic>TgBAC(vegfd:gal4ff)</italic> Gal4 drivers to show close similarity in their cell morphology. These results provide evidence that mesoderm-derived meningeal fibroblasts are a cell type that expresses these <italic>vegf</italic> genes. We have now added these results to the revised manuscript (Figure 6H– L” and Figure 6—figure supplement 5).</p><disp-quote content-type="editor-comment"><p>6) Combined with Figure S5 and Figure 5, these data suggest that ablation of vegfd- or vegfab-expressing cells leads to the failure of the DLV formation.</p></disp-quote><p>We appreciate this comment and agree with the reviewer that our data presented in the original manuscript are not sufficient to suggest that <italic>vegfd</italic>- or <italic>vegfab</italic>-expressing cells are mesoderm-derived meningeal fibroblasts and that these fibroblasts regulate DLV formation. Related to our responses to this reviewer’s comments above, we performed additional co-localization experiments as described and provide evidence that mesoderm-derived meningeal fibroblasts are a source of these Vegf ligands.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Significance (Required)):</p><p>As mentioned above, the authors' question of what controls the CP vascularization with highly permeable fenestrate is clearly an important one. The author's genetic approaches and anatomical imaging are significant.</p></disp-quote><p>We appreciate this reviewer for highlighting the significance of our study in the field.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Evidence, reproducibility and clarity (Required)):</p><p>I think this is a beautifully illustrated and solid piece of work and the combinatorial logic of the vegfs is shown meticulously, using several methods and numerous genetic models. In particular, I liked the validation of the autocrine function of vegfc, whereas I am not so familiar with potential pitfalls with the metronidazole-based deletion of putative producer cells. The authors have really achieved a very complete analysis of the redundancy of vegfs in mCP formation. I agree with most of their conclusions and the manuscript has excellent clarity.</p></disp-quote><p>We appreciate this reviewer for her/his favorable and encouraging comments highlighting both the quality and impact of our study.</p><disp-quote content-type="editor-comment"><p>I recommend publication after the issues below have been addressed.</p><p>A major concern is the limited focus of the manuscript, and whether the blood vasculature outside of the area of interest is normal or if its defects are behind the findings. As mainly meningeal fibroblasts produce the vegf ligands, the authors should include a paragraph describing the lymphatic vascular phenotypes as these can affect the blood vascular defects. And what happens to the FGP/Mato cells after the gene deletions.</p></disp-quote><p>We appreciate this suggestion and agree with the reviewer that examining FGP/Mato cells (also called as muLECs or BLECs) in these <italic>vegf</italic> mutants will provide insight into the correlation between the mCP vascular defects and the formation of FGP/Mato cells. We have now examined the formation of FGP/Mato cells in the dorsal surfaces of the brain meninges using the <italic>Tg(lyve1:DsRed)<sup>nz101</sup></italic> transgenic reporter line. The bottom line is that we did not find any correlation between mCP vascular defects and FGP/Mato formation defects since all of <italic>vegfc;vegfd</italic> double mutants (n=9), which completely lacked the FGP/Mato cells, formed the mCP vasculature, while all <italic>vegfab</italic> mutants that lacked the DLV (n=7) formed FGP/Mato cells similarly to their sibling WT controls (n=13). Intracranial lymphatic formation in zebrafish appears to begin at much later stages of development (9-10 dpf) (Castranova D. et al., Circ Res, doi: 10.1161/CIRCRESAHA.120.317372), thus mCP vascularization processes should not be affected by these intracranial lymphatics.</p><p>We have now added these experimental results and relevant discussions to our revised manuscript (Figure 3—figure supplement 1).</p><disp-quote content-type="editor-comment"><p>Furthermore, I am not entirely happy about the equation of Claudin-5 lacking vessels as fenestrated (also, the epithelium is highly Claudin-5 ositive, thus it is more difficult to be specific). There is no analysis of the fenestrae as such. The authors should use more than one marker, for example in the chapter on &quot;Analysis of BBB state…&quot;. To my knowledge, plvap would be a good marker for the fenestrae.</p></disp-quote><p>We appreciate this suggestion and fully agree with the reviewer that further analyses using additional endothelial cell markers for the fenestrated and BBB state will improve this part of the manuscript. Related to reviewer #1’s comments, we analyzed <italic>vegfab</italic>, <italic>vegfc</italic>, and <italic>vegfd</italic> mutants using the <italic>Tg(plvap:EGFP);Tg(glut1b:mCherry)</italic> double transgenic reporter line and have now added these results to our revised manuscript (Figure 5).</p><disp-quote content-type="editor-comment"><p>Vegfc and vegfd are made as precursor proteins that require proteolytic activation, which in turn regulates receptor binding specificity. Do the authors know if for example vegfd needs to be processed to ameliorate the vegfa deletion phenotype?</p></disp-quote><p>We appreciate this comment and agree with the reviewer that understanding whether or not proteolytic activation of Vegfc and Vegfd contributes to the regulation of mCP vascularization, and how this is achieved at the cellular and molecular levels, will be an important and interesting question to address next. To gain insights into this process, we focused on investigating the requirements for the proteolytic processing of Vegfc since its proteolytic enzymes have been better characterized than those for Vegfd. Prior studies suggest that Ccbe1, Adamts3, and Adamts14 serve to proteolytically cleave and convert the pro-active form of Vegfc into its mature form during lymphangiogenesis in zebrafish (Hogan et al., 2009; Le Guen et al., 2014; Wang et al., 2020). Among these three proteins, <italic>ccbe1</italic> appears to be highly expressed in the developing brain and meningeal compartments based on its BAC transgenic reporter expression at 48 hpf (Wang et al., 2020), while <italic>adamts3</italic> BAC transgenic reporter expression appear to be very low at the same stage. Since 48 hpf is a developmental time point when the DLV is extending toward the mCP, <italic>ccbe1</italic> could be a strong candidate that serves to activate Vegfc in this area of the brain based on these published data.</p><p>To investigate a role for Ccbe1 in mCP vascularization, we took the approach of injecting</p><p>ribonucleoprotein (RNP) complexes that were composed of <italic>ccbe1</italic>-specific CRISPR RNA (crRNA):transactivating crRNA (tracrRNA):Cas9 protein at the 1-cell stage. This approach using crRNA:tracrRNA:Cas9 protein RNP complexes was previously shown to be a highly efficient method to achieve bi-allelic inactivation of target genes, which allows for the generation of F0 embryos that recapitulate homozygous mutant phenotypes (Hoshijima K. et al., <italic>Dev Cell</italic> 51:645-657). We recently tested this method and observed that injection of three different crRNA RNP complexes targeted to a single gene works in a much more efficient manner to generate F0 embryos that lack target gene function and recapitulate homozygous mutant phenotypes. Thus, we co-injected three different <italic>ccbe1</italic> crRNA RNP complexes in order to investigate its role in mCP vascularization. We validated this approach by examining the formation of FGP/Mato cells in the dorsal surfaces of the brain meninges since <italic>ccbe1</italic> mutants exhibit severe defects in this process as shown in <italic>vegfc</italic> null mutants (van Lessen et al., 2017).</p><p>We hypothesized that if Vegfc requires Ccbe1-mediated proteolytic activation, these triple <italic>ccbe1</italic> crRNA injected embryos will lack Vegfc activation, thus recapitulating <italic>vegfc</italic> null mutant phenotypes. Since we have shown that 54% of the <italic>vegfc</italic> null mutants we analyzed at 54 hpf failed to form the DLV, we examined <italic>ccbe1</italic> crRNA-injected embryos at 54 hpf and observed that a significant fraction (20%) of the <italic>ccbe1</italic> crRNA-injected embryos, but not Cas9 protein-injected control embryos, lacked the DLV.</p><p>In addition, to examine whether combined genetic inactivation of <italic>ccbe1</italic> and <italic>vegfab</italic> enhances DLV and PCeV formation defects as observed in <italic>vegfab;vegfc</italic> double mutants, we injected <italic>ccbe1</italic> triple crRNA RNP complexes into 1-cell stage progeny derived from <italic>vegfab</italic> heterozygous incrosses and analyzed them at 96 hpf – the same developmental stage at which we analyzed progeny derived from <italic>vegfab;vegfc</italic> double heterozygous fish incrosses (Figure 2A–G). Intriguingly, similar to what we observed in <italic>vegfab;vegfc</italic> double mutants, we found that <italic>vegfab<sup>-/-</sup></italic> larvae injected with the <italic>ccbe1</italic> RNPs exhibit a markedly increased penetrance of the “No DLV” phenotype (52%) as compared to their <italic>vegfab<sup>-/-</sup></italic> siblings injected with the control solution (23%) or the <italic>ccbe1</italic> RNPs-injected <italic>vegfab<sup>+/+</sup> </italic>sibling larvae (3%). Strikingly enhanced defects were also observed in PCeV formation in the <italic>ccbe1</italic> RNPs-injected <italic>vegfab<sup>-/-</sup></italic> larvae. These results indicate that Ccbe1 and Ccbe1-mediated proteolytic activation of Vegfc are critical for DLV and PCeV formation.</p><p>We have now added all of these results to our revised manuscript (Figure 4).</p><disp-quote content-type="editor-comment"><p>The discussion is quite short and draws a few general conclusions that are important for our understanding. However, it leaves open the question of why vagfaa is not important for the formation of a fenestrated mCP, if in adult zebrafish it is necessary for the maintenance of mCP fenestrae. This is an issue that should be at least discussed.</p></disp-quote><p>We appreciate this comment. There is currently no direct evidence of Vegfaa’s function in maintaining mCP fenestrae or in the formation of fenestrated mCP vasculature in zebrafish. However, we agree with the reviewer that our findings leave these questions open, which will be important to address next. Since <italic>vegfaa</italic> mutants are known to exhibit severe early vascular defects that prevent us from understanding its precise role in mCP vascularization, we generated a new BAC transgenic line, <italic>TgBAC(vegfaa:gal4ff)</italic>, and performed expression analyses and chemogenetic cell ablation using this line, as conducted for the other <italic>vegf</italic> BAC lines (Figures 6 and 5E–M). We found that ablation of Vegfaa-expressing cells does not lead to compromised formation of the DLV and PCeV. We have now added all of these results to our revised manuscript (Figure 8).</p><p>In addition, as suggested by the reviewer, we have now expanded our discussions in the revised manuscript by including the discussions of these and another open questions that we deem important and also those of new experimental results obtained during manuscript revision.</p><disp-quote content-type="editor-comment"><p>Minor:</p><p>Please do not use abbreviations, such as CP or vEC in the Highlights, as they are not explained yet in this part.</p></disp-quote><p>We appreciate this suggestion and have removed the Highlights.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Significance (Required)):</p><p>This manuscript provides an important addition to our understanding of how the vegf family of growth factors works, and it is especially interesting for developmental and vascular biologists.</p></disp-quote><p>We appreciate the reviewer for highlighting the significance of this study in the fields of developmental and vascular biology.</p></body></sub-article></article>